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Abstract 
Feline calicivirus (FCV) is an important veterinary pathogen of domestic cats. It is highly 
variable and rapidly evolving such that many different strains of varying pathogenicity exist 
from avirulent, to mildly virulent and hypervirulent. FCV is one of only a small number of 
viruses within the Caliciviridae to propagate readily in vitro. This property has made FCV a 
model for the study of the viruses of the calicivirus family. However, relatively little remains 
known about the way in which these viruses affect host cellular mechanisms. Despite the 
increasing use of post-genomic technologies in other areas of science, what is known about 
the effects of calicivirus replication upon host cells has generally relied on relatively 
conventional technologies to target known defined pathways. 
In order to investigate FCV modulation of the host cell proteome a 2D-DIGE experiment 
was performed upon a single viral strain (FCV-F9) with four time points analysed. The 
results of this analysis showed that 30 host proteins were differentially expressed in the cells 
infected with FCV-F9 and of these 30 proteins, 14 were successfully identified using mass 
spectrometry and 11 of these had cytoskeletal proteins within their identifications.  
To further evaluate these host proteome changes and to explore whether variations in strain 
pathogenicity were associated with varying affects in the host proteome, a second 2D-DIGE 
experiment was performed upon four strains of FCV isolated from cats exhibiting a range of 
clinical signs. As in the first experiment, host cytoskeletal proteins appeared to be targeted 
for modulation during infection. Overall, this experiment uncovered 131 modulated host 
proteins with 61 proteins successfully identified by mass spectrometry and 16 of these had 
cytoskeletal proteins within their identifications. Also found within this experiment was 
evidence of the putative virulent FCV strain UKOS-A having a different affect upon 14 of 
the differentially expressed proteins to the other three FCV strains tested. UKOS-A was 
found to down-regulate these proteins whereas the other strains had an up-regulatory effect, 
these proteins could be a potential marker of hypervirulence but would need further study to 
confirm their validity. 
To follow the modulation of the identified host cytoskeletal proteins, immunofluorescent 
staining coupled with confocal microscopy was used to track FCV capsid protein and two 
cytoskeletal proteins vimentin and tubulin. Results showed that during infection with the 
four FCV strains tested both vimentin and tubulin were both significantly altered during 
infection with the intensity of fluorescent staining increasing in all cases.  
To complement the proteomic analyses, an experiment designed to discover differentially 
expressed gene transcripts was conducted using RNA-seq technology. Overall, there were 
354 genes found to be differentially transcribed within the infected cells at both four and 
seven hrs post infection (p.i.) with the majority of modulated genes experiencing down-
regulation at four hrs p.i. and up-regulation at seven hrs p.i.. Once again, genes within the 
cytoskeletal regulation pathway were up-regulated alongside genes from the apoptosis 
regulatory pathway and immune system response pathways. 
To further characterise the putative virulent strain used in earlier studies, attempts were 
made to sequence the rest of this virus using polymerase chain reaction and conventional 
Sanger sequencing technologies. Although almost 50% of the UKOS-A strain was 
sequenced, the sequence obtained was no more similar or different to other virulent systemic 
disease (VSD) causing strains. 
Overall, the most marked effects of FCV infection upon the host were found amongst the 
cytoskeletal genes and proteins which have been demonstrated to undergo extensive 
modification. This is a completely novel finding in this family of viruses. Further studies 
will be needed to identify the consequences of the identified cytoskeletal changes to both the 
host and the virus.  
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1 Chapter one 
Introduction 
In 1957, Fastier isolated a new virus whilst trying to induce an infection of feline 
panleukopenia virus in feline kidney cells (Fastier, 1957). The cells infected by this 
unknown virus were found to appear rounded and became detached from the glass 
culture surface. In this original article the virus was named „kidney cell-degenerating 
virus‟ in reference to the culture it was isolated in and it was later renamed feline 
picornavirus and classified within the calicivirus genera of the picornavirus family 
(Burki, 1965; Fenner, 1976). From the mid 1970s onwards, however, there were 
studies performed that found evidence for the reclassification of the calicivirus 
genera into a completely separate family based upon differences in virion size, 
translated polypeptide size (Burroughs & Brown, 1974) and viral RNA replication 
strategies (Black et al., 1978; Ehresmann & Schaffer, 1977) which were atypical of 
picornaviruses.  
1.1 Caliciviridae family 
The family Caliciviridae are members of Class IV of the Baltimore scheme 
(Baltimore, 1971) for virus classification alongside other positive stranded RNA 
viruses. The family gains its name from the Latin calyx meaning cup in reference to 
the cup-like depressions on the capsid discovered by electron microscopy 
(Zwillenberg & Burki, 1966). The Caliciviridae are further divided into five genera; 
vesiviruses, lagoviruses, sapoviruses and noroviruses (Fig 1.1) and the newest genus 
neboviruses (Carstens & Ball, 2009).  
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1.1.1 Sapovirus and norovirus genera 
The most common causes of human viral gastroenteritis are sapovirus and norovirus 
which are both found within the calicivirus family.  
Noroviruses gain their name from the first outbreak they were isolated from in 
humans in Norwalk, Ohio in 1968 (Adler & Zickl, 1969). Human noroviruses are 
now known to be the leading cause of non-bacterial gastroenteritis (Mead et al., 
1999) causing episodes of vomiting and diarrhoea. One major obstacle in the 
investigation of noroviruses are the lack of in vitro cultivation models despite efforts 
to propagate the virus in a number of cell lines (Duizer et al., 2004) which has lead 
to feline calicivirus often being used as a surrogate model of infection (Bidawid et 
al., 2003; Clay et al., 2006; Doultree et al., 1999). There are also a number of animal 
viruses found within the norovirus genus including Newbury agent II (Oliver et al., 
2006; Woode & Bridger, 1978) which cause diarrhoea and enteric disease in cows, a 
porcine norovirus recovered from pigs with diarrhoea (Bridger, 1980), an enteric 
canine norovirus  (Martella et al., 2008) and  a virus recovered from a lion cub which 
Figure 1.1. Phylogenetic analysis of capsid gene sequence from members of the 
Caliciviridae and Picornaviridae. Figure reproduced from Green et al (2000). 
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died from severe haemorrhagic enteritis (Martella et al., 2007). The general 
significance of these final two viruses to the health of dog and cat populations is 
currently uncertain. A murine norovirus (MNV) which can be propagated in cell 
culture has also been discovered (Karst et al., 2003) and this has led to a diversion 
from using FCV as a surrogate for human norovirus as MNV offers both an in vitro 
model and an in vivo model through laboratory mice.  
Sapoviruses also gain their name from the area of the first outbreak; in this case it 
arises from Sapporo, Japan after the virus was isolated from an outbreak of 
gastroenteritis within an orphanage (Chiba et al., 1980). The sapoviruses are known 
to cause gastroenteritis in humans (Pang et al., 2009) and pigs (Saif et al., 1980) and 
a porcine sapovirus has been adapted to grow in cell culture (Flynn & Saif, 1988). 
However, propagation can be difficult and will only occur in the presence of 
intestinal content fluid filtrate from gnotobiotic pigs (Chang et al., 2004) which 
makes it a difficult virus to use as a model for the calicivirus family. 
1.1.2 Nebovirus genera 
The neboviruses gain their name from the Newbury agent 1 virus recovered from a 
calf with diarrhoea (Bridger et al., 1984; Woode & Bridger, 1978) and classified as a 
calicivirus. The decision to include these viruses as part of a new genus arose with 
the discovery from full genome sequencing that there were only two predicted open 
reading frames (ORFs) on the genome and phylogenetic analyses showed the viruses 
clustering in a separate clade to the existing genera (Carstens & Ball, 2009; Oliver et 
al., 2006). 
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1.1.3 Lagovirus genera 
Rabbit haemorrhagic disease virus (RHDV) is an important veterinary viral pathogen 
and is found within the lagovirus genera of the calicivirus family. It is believed that 
RHDV evolved from a non-pathogenic version of a rabbit calicivirus (Moss et al., 
2002) circulating within Great Britain and Europe for centuries before developing 
hypervirulence during an outbreak in rabbits in China in 1984 (Liu et al., 1984). This 
virulent disease was typified by haemorrhagic lesions forming in the liver and lungs 
and a very high mortality rate. The causative agent was found to be a calicivirus 
(Ohlinger et al., 1990) and it was also noted that rabbits under 8 weeks of age were 
generally less affected by the disease and survived infection (Liu et al., 1984). The 
non-pathogenic form of the virus still appears to be circulating within the general 
rabbit populations of Europe, Australia and New Zealand (Le Gall-Recule et al., 
2011) and when administered to rabbits, this avirulent virus has been shown to offer 
protection against the highly virulent form of the disease (Capucci et al., 1996). 
European brown hare syndrome virus (EBHSV) is also found within the lagovirus 
genera and shares some of the same features as the virulent RHDV. It was first 
discovered to be infecting hares in Sweden in the 1980s and is again characterised by 
lesions forming in the liver and a high mortality rate (Gavier-Widen & Morner, 
1993). Although very similar to RHDV in morphology and clinical effects, EBHSV 
has been shown to be species-specific with infected rabbits not showing any signs of 
disease and are also not  protected against subsequent infection with RHDV (Chasey 
et al., 1992). 
1.1.4 Vesivirus genera 
FCV is found in the genera vesivirus alongside San Miguel sea lion virus (SMSV) 
and vesicular exanthema of swine virus (VESV).  
VESV has been dubbed the prototype of the calicivirus family (Burroughs et al., 
1978) and causes vesicular disease in pigs characterised by fever and vesicle 
formation within the oral mucosa and also on the extremities. SMSV has been shown 
to produce similar clinical signs within marine mammals (Smith et al., 1973) and 
when some SMSV isolates are used to infect swine they have been found to induce 
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disease which is identical to VESV (Smith et al., 1973; Smith et al., 1980). SMSV 
and VESV have also been shown to be phylogenetically close to each other through 
sequencing but distinct from FCV (Neill et al., 1995) and as such these viruses have 
been thought to have evolved together in a marine reservoir and are often termed 
together as marine caliciviruses (Reid et al., 2007). 
Within this thesis feline calicivirus (FCV) will be the virus used to study the effects 
of infection upon host cells and as such will be discussed in detail in section 1.2. 
However, it is worth noting at this point that whilst cats are the only known hosts of 
FCV, there have been incidents where FCV-like viruses have been recovered from 
dogs (Hashimoto et al., 1999; Martella et al., 2002; Roerink et al., 1999), but the 
role these viruses play in the epidemiology of FCV is not clear. 
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1.2 Feline Calicivirus 
1.2.1 FCV genome 
All members of the Caliciviridae have positive stranded RNA genomes. In direct 
comparisons to DNA viruses, RNA viruses have high mutation rates (Holland et al., 
1982), which offers a much quicker rate of genome evolution and as such may offer 
the virus a greater chance of survival and replication fitness (Domingo et al., 1997). 
Mutation rates for RNA viruses have been found to be ~ 1 spontaneous mutation per 
genome per replication (Drake, 1993) and may rise to 1.5 per round of cell infection 
(Drake & Holland, 1999). This high rate of spontaneous mutation has been attributed 
to the lack of any proofreading capability within viral polymerases (Steinhauer et al., 
1992) which otherwise would be able to find mismatched nucleotides copied from 
the genome and repair them before translation. 
The genome of FCV itself is relatively small, with full genome sequencing putting 
the length around 7.7 kb in length (Carter et al., 1992; Sosnovtsev & Green, 1995) 
and is comprised of three open reading frames (ORFs) (Fig 1.2) (Sosnovtsev et al., 
2002). As well as the genomic RNA, infected cells also contain a subgenomic RNA 
(Herbert et al., 1996; Neill & Mengeling, 1988; Neill et al., 1991) 2.4 kb in length 
(Neill & Mengeling, 1988) corresponding to the 3‟ end of the full genome from 
nucleotide base position 5227 (Herbert et al., 1996). 
 
 
 
 
 
2000 5000 7000 6000 4000 3000 1000 
7634 7317 
ORF3 
 
 
7317 5314 
ORF2 
5308 20 
ORF1 
Figure 1.2. Diagram showing the position of the three open reading frames (ORFs) 
found upon the FCV genome and also the position of the subgenomic RNA relative to 
FCV-F9 (Genbank accession number m86379). Annotated numbers refer to the 
nucleotide base positions. 
5‟ 3‟ 
 
Sub-genomic RNA 
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1.2.2 Proteins encoded by the FCV genome 
The proteins encoded by the FCV genome can be roughly divided into two 
categories; structural and non-structural proteins. The non-structural proteins are 
translated from ORF 1 and the structural proteins are coded for by ORFs 2 and 3. 
1.2.2.1 ORF 1 
ORF 1 is located between nucleotides 20 and 5308 and when translated encodes for 
the proteinase polymerase (pro-pol) (Wei et al., 2001), a nucleotide triphosphatase 
(NTPase) (Sosnovtsev et al., 2002), the VPg (Herbert et al., 1997) and other non-
structural proteins (Sosnovtsev et al., 2002). It has been discovered that the 
polyprotein encoded by ORF1 has five cleavage sites and is processed into six 
proteins (Sosnovtsev et al., 2002) (Fig 1.3) which includes three proteins of 
unknown function as well as the pro-pol, VPg and NTPase. 
The pro-pol is a precursor protein that is cleaved into the mature viral proteinase and 
RNA dependent RNA polymerase (RdRp) proteins. It is this proteinase that is 
responsible for the cleavage of the translated ORF1 polyprotein (Sosnovtseva et al., 
1999) and also for the cleavage of the precursor capsid protein into the mature 
protein (Sosnovtsev et al., 1998). Similar RdRp proteins are found in all positive 
strand RNA viruses and functions as a catalyst to viral replication (O'Reilly & Kao, 
1998). The uncleaved pro-pol protein has also been shown to interact with itself, 
VPg and the precursor to the capsid protein (Kaiser et al., 2006) and this 
dimerisation of the polymerase is also known to occur in RHDV (Ng et al., 2002) so 
may be an important feature of calicivirus replication. 
The VPg protein is covalently bound to the 5‟ end of the genomic RNA (Herbert et 
al., 1997). This protein has often been implicated in translation as the addition of 
proteinase K to remove VPg protein bound to viral RNAs caused a decrease in 
translation (Herbert et al., 1997) and sequence analysis has been shown to be similar 
in sequence to eIF1A a host translation initiation factor (Chaudhry et al., 2006). The 
VPg protein has also been shown to bind directly to translation initiation factor 
eIF4E during FCV infection and this interaction is necessary for FCV RNA 
translation (Goodfellow et al., 2005).  
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1.2.2.2 ORF 2 
ORF 2 encodes for the major viral capsid protein (VP1), which has been shown to be 
translated as a precursor capsid protein with a leader capsid sequence (LC) (Carter, 
1989) which is then cleaved to a smaller, mature capsid protein by the viral 
proteinase (Sosnovtsev et al., 1998). The cleavage points are shown in Figure 1.3. 
 
 
 
 
 
 
The capsid protein can be further divided into six regions (A-F) based upon sequence 
conservation and variability (Neill, 1992; Radford et al., 1999) (Fig 1.4). Region A 
is the leader capsid protein cleaved by the viral proteinase to create the mature capsid 
protein (Carter et al., 1989) and this area has shown to be moderately variable 
although the cleavage site itself is highly conserved (Glenn et al., 1999). Regions B, 
D and F are the most conserved areas of the capsid protein (Neill, 1992) which 
suggests that there is a functional importance of these regions. Region B has been 
shown to contain a putative ATP/GTP binding motif (Seal & Neill, 1995; Seal et al., 
1993), and there is homology between this region and the VP3 structural protein of 
picornaviruses (Neill, 1992; Tohya et al., 1991), suggesting that region B has a 
similar function and that this function is crucial for viral survival in both 
caliciviruses and picornaviruses.  
Regions C and E are both found to be variable between FCV strains (Glenn et al., 
1999; Neill, 1992; Seal, 1994; Seal & Neill, 1995; Seal et al., 1993) (Fig 1.4). 
Region E is further divided by areas of variability and conservation with 5‟- and 3‟-
hypervariable regions being separated by an area of conservation (Seal et al., 1993). 
Predictive 3D structuring of the FCV capsid protein has been used to show that these 
hypervariable regions map to the outer edge of the viral structure (Chen et al., 2006) 
p12 p62 p11 p13 p37 p76 p5.6 
ORF3 ORF2 ORF1 
VP1 VP2 LC p30 p32 NTPase VPg Pro-Pol 
Figure 1.3. Diagrammatic representation of the cleavage map of FCV. The proteins are 
named when a putative function is available. Where function is not known the proteins 
are labelled using the protein size. For example p30 is a non-structural protein of 30 kDa 
in size. Adapted from Sosnovtsev et al, 2002. 
5‟ 3‟ 
  
 
9 
and are under positive selection pressure during viral evolution within a colony of 
cats (Coyne et al., 2007), suggesting they contain the immunodominant antigenic 
regions of the virus. 
 
 
 
 
 
 
 
1.2.2.3 ORF 3 
ORF 3 has also been found to be translated into a capsid protein as a minor capsid 
protein (VP2), found as 1-2 copies per virion (Sosnovtsev & Green, 2000). This 
protein does appear to be essential to the virus as deletion of ORF3 is lethal and 
mutations within the ORF3 sequence prevent the virus from being infectious 
(Sosnovtsev et al., 2005). More recently, it has also been demonstrated that the viral 
capsid does not assemble correctly unless both VP1 and VP2 proteins are expressed 
(Di Martino & Marsilio, 2010). 
  
A B C D E F 5‟ 3‟ 
1-124 125-396 397-401 402-425 426-523 524-668 
5‟ Hypervariable Region 3‟ Hypervariable Region Con-E 
426-460 461-488 489-523 
Figure 1.4. Regions A-F of polyprotein translated from ORF2 of FCV genome. Numbers 
indicate the amino acid position of the region boundaries. Region E is further sub-divided 
into 5‟ and 3‟ hypervariable regions and an area of conservation (Con-E). Amino acid 
boundaries are marked. 
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1.2.3 FCV strain variability 
With the positive strand RNA genome offering FCV a high mutation rate, it can be 
expected that there are a number of strains in circulation within the cat population. In 
practice, this assumption holds true both within the general cat population (Sato et 
al., 2002)  and also within populations found in rescue shelters (Bannasch & Foley, 
2005; Radford et al., 2001) and private cat colonies (Radford et al., 2003). With 
colonies and shelters having larger populations of cats within a confined space than 
private households it has been suggested that they offer optimal conditions for strain 
evolution. In 2003, a study by Radford et al, showed that cat colonies often have 
their own strains of FCV circulating within them but the variation within these cat 
colonies in the immunodominant regions of the capsid gene could be as high as 16% 
(Radford et al., 2003). This diversity is consistent with the virus evolving from a 
common ancestor within the colony. A longitudinal study of virus diversity within an 
endemically infected cat colony showed that some cats were persistently infected 
with their own strains which gradually evolved. However, within the same colonies, 
other cats seemed to undergo cycles of re-infection such that they became infected 
and recovered from one strain of FCV before picking up a second strain (Coyne et 
al., 2007). In addition to evolution by substitution, such high prevalence colonies 
provide the ideal environment for mixed infections and recombination (Coyne et al., 
2006c). At the beginning of the Coyne et al, study (2006) the colony was found to be 
infected with only one strain but later sampling showed a second virus strain had 
entered the colony. Subsequent sampling showed that a recombinant virus containing 
the polymerase gene from the first strain and the capsid gene from the second strain 
was now circulating within the colony. The recombination event was mapped to the 
region of the ORF1 and ORF2 junction. Such recombination events may offer 
viruses found within closed populations a quicker method of mutation to avoid host 
immune responses and will aid viral diversity within a population.  
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1.2.4 Clinical signs 
Since there are a wide range of strains of FCV circulating within the feline 
population, it is perhaps not surprising that there are also a wide range of clinical 
signs associated with FCV infection (Radford et al., 2009; Radford et al., 2007).  
1.2.4.1 Upper respiratory tract disease 
A cat presenting with typical FCV infection will often be suffering from acute upper 
respiratory tract disease (URTD), symptoms often including ocular and nasal 
discharge and ulcers on the oral mucosa (Cai et al., 2002; Povey, 1974). The disease 
is not usually fatal except where the URTD develops into pneumonia and more 
serious respiratory conditions, although this is usually limited to young kittens (Love 
& Baker, 1972).   
1.2.4.2 Limping syndrome 
Feline calicivirus is also known to cause acute temporary arthritis in the joints of cats 
which cause symptoms often described as limping syndrome. These effects have 
been reproduced through infecting experimental specific pathogen free (SPF) cats in 
the laboratory (Dawson et al., 1994; TerWee et al., 1997). The experimentally 
infected cats in the Dawson et al study showed signs of pyrexia, lethargy, anorexia, 
oral ulceration and URTD in addition to severe lameness and FCV was recovered 
from the joints of the affected cats. 
1.2.4.3 Chronic stomatitis 
There is also some evidence of an association between chronic stomatitis, a 
condition typified by chronic ulcerative lesions in the gingival, fauces and sometimes 
the cheeks and tongue, and FCV (Healey et al., 2007; Knowles et al., 1989; Poulet et 
al., 2000; Waters et al., 1993). In the Knowles 1989 study, cats with chronic 
stomatitis were swabbed alongside a control population and where the control had an 
FCV prevalence of 0-19%, the chronic stomatitis suffering groups had an FCV 
prevalence of between 50-92%. Inducing chronic stomatitis experimentally has 
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proved impossible; however, an accidental infection of FCV in experimental cats 
previously infected with FIV caused 9/13 to develop chronic gingivitis which may 
point to co-infections being important in the ultimate development of the condition 
(Waters et al., 1993). 
1.2.4.4 Virulent systemic FCV 
More recently, a virulent, systemic form of FCV (VS-FCV) has emerged in 
outbreaks in the UK (Coyne et al., 2006b), USA (Hurley et al., 2004; Pedersen et al., 
2000; Schorr-Evans et al., 2003) and France (Reynolds et al., 2009). High mortality 
rates have been associated with all the outbreaks and a wider range of clinical 
symptoms has been observed. 
The first outbreak was reported by Pedersen et al in 2000 and occurred in a rescue 
centre and animal clinic in California, USA. In this outbreak a 4 month old kitten 
from the rescue shelter was found to be suffering from severe URTD and was 
hospitalised by the animal clinic. Whilst the kitten was hospitalised at the clinic, two 
other cats visited the clinic and became sick within 4-5 days and had to be re-
hospitalised. The clinical signs exhibited by these cats included fever, anorexia, 
lethargy, depression and ulceration, with oedema of the face and limbs; both cats 
made a full recovery. Four more cats were affected during this outbreak but these 
cats were not present in the hospital until they became sick through infection; three 
were housemates of the two re-hospitalised cats and one was the pet of one of the 
workers at the veterinary clinic. Of these four cats, two made a full recovery after 
showing signs of conjunctivitis, fever, oedema, lethargy, nasal congestion and 
sneezing but the other two cats died or were euthanised. The dead cats both exhibited 
similar clinical signs to the other infected cats but with more extensive swelling and 
oedema and deeper lesions which were severely encrusted.  
Feline calicivirus was recovered from one of the dead cats (FCV-Ari) and was 
subsequently used to experimentally infect SPF cats with all three kittens infected 
showing signs of fever, oedema of the face and limbs, nasal congestion, ocular 
discharge and anorexia with one of the kittens having to be euthanised. Whilst this 
experimental infection was being carried out, four other laboratory cats housed two 
rooms away from the experimentally infected kittens became infected by 
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contamination, suggesting this virus to be highly infectious even within the confines 
of an experimental facility. One of these cats was discovered dead within two weeks 
of the experimental infection commencing with the other three cats showing signs of 
fever and depression before the decision was made to euthanise them. The authors 
also performed some genetic analysis upon the FCV-Ari isolate and found that when 
the capsid gene was sequenced it was a typical FCV strain, with no apparent features 
to distinguish it from other field and vaccine strains found within the general cat 
population. 
Two further outbreaks have been reported in the USA (Hurley et al., 2004; Schorr-
Evans et al., 2003) and in both outbreaks a similar pattern of mortality and clinical 
signs was observed. In the Schorr-Evans et al, 2003 report, 24 cats in a small animal 
hospital were infected after cats from a neighbouring animal shelter were admitted 
showing signs of severe URTD. Several other cats hospitalised at the same time were 
readmitted to the hospital showing signs of fever and anorexia and later developing 
oedema of the face and limbs, jaundice and oral ulceration. Again in this outbreak a 
cat belonging to a hospital employee that had never been hospitalised during the 
outbreak was also found to be infected with the outbreak strain which suggests that 
the virus can be easily transmitted by fomites. This outbreak had an overall mortality 
rate of 32% with the virus isolated as the causative agent being designated FCV-
Diva. FCV-Diva was sequenced along the hypervariable region of the capsid gene 
and was found to group separately from both FCV-Ari and FCV-F9 which proves 
that this outbreak arose from a separate mutation event and not from transmission of 
the first outbreak strain (FCV-Ari).  
In the outbreak described by Hurley et al, (2004) the infection was spread across 
three veterinary practices, a rescue shelter and its associated foster homes, affecting 
54 cats in total. Again the clinical signs reported were similar to the first outbreak 
with fever, oedema of the face and limbs, oral ulcers, nasal discharge, ocular 
discharge and jaundice all being reported during the outbreak. The overall mortality 
rate found was 40% and it was also noted during this study that cats older than one 
year were more likely to get severe disease than kittens. The virus isolated was 
named FCV-Kaos and again, sequencing of the hypervariable region of the capsid 
gene showed that FCV-Kaos was a genetically distinct strain, different from both 
FCV-Ari and FCV-F9.  
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There have also been outbreaks of virulent systemic disease (VSD) associated with 
FCV infection in Europe. In France, there was an outbreak of VSD in a veterinary 
teaching hospital in 2005 with eight cats infected (Coyne et al., 2006b; Reynolds et 
al., 2009). As with the US cases, the infection appeared to be nosocomial where a cat 
was admitted to a teaching hospital with depression, hypothermia, oedema of the 
face and limbs and oral ulceration. The cat was euthanised two days after admission. 
Over the course of a month, seven more cats were infected with VS-FCV including 
two cats which were suspected to be infected at home through transmission via their 
owners who were students studying at the hospital at the time of the outbreak. All 
cats infected during this outbreak exhibited the clinical signs reported previously and 
the mortality associated was 63% which is also in keeping with the other outbreaks. 
In the UK outbreak of VS-FCV, reported by Coyne et al (2006b), three kittens were 
initially fostered from a local rescue shelter into the home of one of the workers at 
the shelter. These kittens showed some signs of lethargy but did not display the other 
clinical signs associated with VS-FCV. Two of the fostered kittens died over the 
next six days and over the course of two weeks after the fostering occurred three of 
the four cats already living in this household went on to exhibit signs of infection 
with VS-FCV. All three of these cats suffered pyrexia and voice loss with two of the 
three also suffering some form of pain in the leg/lameness.  However, only one of 
the three cats infected in the foster household suffered lethargy, oedema, vomiting 
and jaundice. A fourth adult cat was also infected during this outbreak from the 
household next-door to the foster home and this cat showed signs of fever, lethargy, 
voice loss and jaundice during the course of infection. The mortality rate found in 
this outbreak was 71% and once again the viruses isolated from the infected cats and 
sequenced showed that the FCV strains associated with this outbreak were 
phylogenetically different to the previously reported cases of VS-FCV. 
Attempts to identify the origin of these outbreaks by sequencing the capsid gene of 
VS-FCV strains from outbreaks has shown that each virus was phylogenetically 
distinct, representing a new strain or sequence type (Coyne et al., 2006b; Hurley et 
al., 2004; Pedersen et al., 2000; Reynolds et al., 2009; Schorr-Evans et al., 2003). As 
such it appears that each outbreak is caused by a newly emerged and hypervirulent 
virus, that rapidly spreads locally, before eventually being eradicated. These 
apparently conflicting observations suggesting high transmission as well as rapid 
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extinction have been hypothesised to be associated with behavioural changes in 
affected cats, such that infected animals become poor transmitters of the 
hypervirulent viruses (Coyne et al., 2006b).  
Several attempts have been made to identify markers of hypervirulent strains that 
could help explain the pathogenesis of this disorder, as well as act as a diagnostic 
marker for hypervirulence that could be used to aid disease control (Abd-Eldaim et 
al., 2005; Foley et al., 2006). Using full genome sequence of two hypervirulent 
strains, Abd Eldaim et al (2005), showed that whole sequence similarity was around 
80% for each strain examined. In addition, the authors reported a consistent motif 
within the amino acid sequence of the VS-FCV strains at position 443 of the capsid 
protein with asparagine being replaced by serine. This mutation was predicted to 
create an extra glycosylation site. In a similar study, sequence analysis of VS-FCV 
strains also predicted the generation of a conserved additional glycosylation site in 
hypervirulent strains (Foley et al., 2006) and led the authors to speculate that novel 
receptors or other host-virus interactions could occur as a result of mutated capsid 
protein structure, allowing VS-FCV strains to target epithelial or endothelial sites. 
Unfortunately, the two motifs identified within these studies are not consistent and as 
such may just be a reflection of the variability of the FCV genome, especially within 
the FCV capsid (Radford et al., 2007). 
More recently, studies on the kinetics of growth of FCV in cell culture have led to 
the suggestion that VS-FCV strains may grow more efficiently in vitro under 
multiple growth cycle conditions than non-VS isolates and this may be a phenotypic 
characteristic common to all VSD strains (Ossiboff et al., 2007).  
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1.2.5 Epidemiology 
Within the general cat population FCV has a relatively high prevalence of 10-25% of 
vet visiting cats (Harbour et al., 1991; Porter et al., 2008; Wardley et al., 1974) with 
prevalence generally increasing within multi-cat households, colonies and shelters up 
to 70-90% (Bannasch & Foley, 2005; Coyne et al., 2006a; Coyne et al., 2007). This 
higher prevalence within the multi-cat environments is thought to arise from there 
being a mixture of acutely infected cats, progressive evolution of the virus within 
cats undergoing long-term infections and subsequent re-infection of recovered cats 
with newly evolved viruses (Coyne et al., 2007). The virus has also been found to 
recombine within these closed environments (Coyne et al., 2006c) which again 
allows the opportunity of re-infection of cats which have previously recovered from 
FCV infection within the colony. The virus has also been shown to persist outside of 
the cat on fomites for up to three days (Clay et al., 2006) which allows the virus an 
advantage for finding a host and this trait has also been reported in being key in the 
outbreaks of VS-FCV (Coyne et al., 2006b; Hurley et al., 2004; Pedersen et al., 
2000; Reynolds et al., 2009; Schorr-Evans et al., 2003).  
These relatively high infection rates and prevalences are despite FCV vaccination 
being included annually for cats. Traditionally these vaccinations are based upon a 
single strain such as FCV-F9 (Bittle & Rubic, 1976; Bittle, 1960) or FCV-255, 
however, there have now been two vaccines developed that includes two FCV strains 
(Huang et al., 2010; Poulet et al., 2005), and another vaccine developed in Japan 
containing three strains of FCV (Masubuchi et al., 2010) which may offer increased 
protection against a greater number of FCV strains (Addie et al., 2008). One reason 
that the prevalence of FCV may have remained high despite vaccination is due to the 
fact that although vaccination reduces the severity of FCV associated clinical signs; 
it does not reduce infection (Binns et al., 2000; Dawson et al., 1991; Gaskell et al., 
1982).   
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1.2.6 Host-pathogen interaction 
As FCV has been used as a model of norovirus infection in humans for many years it 
may be expected that the mode of action of the virus within the cell has been well 
documented. However, as FCV only grows in feline cell lines the use of this non-
model organism has hampered these kinds of studies.  
In 2003, two separate studies into the role of FCV infection in cell death were 
performed and both showed that FCV-infected cells showed signs characteristic of 
apoptosis (Roberts et al., 2003; Sosnovtsev et al., 2003). Sosnovtsev et al, showed 
that during infection with FCV-Urbana, Crandell-Rees feline kidney (CRFK) cells 
displayed typical signs of cellular apoptosis. Staining of infected cells with 4', 6-
diamidino-2-phenylindole (DAPI) showed chromatin condensation from 5hrs post 
infection (p.i.) and DNA fragmentation was shown from 8-10hrs p.i.. The authors 
also showed that caspases were activated during infection with FCV and that 
although three cellular caspases were found to be activated, caspase-3 activity was 
found to be at a much higher level than caspase-8 and -9.  
Roberts et al, also found very similar results in their study with chromatin 
condensation being visualised and caspase-3 activation being confirmed by Western 
blotting. Further investigation of the role of these caspases and their importance in 
FCV infection by Al-Molawi et al (2003) demonstrated that caspases were important 
in the processing of the viral capsid protein. They showed that when the caspases 
were inhibited viral capsid processing was not observed and that viral capsid 
cleavage occurred concurrently with caspase activation.  
Further investigation has now shown that the apoptotic pathway being triggered in 
response to FCV infection is the mitochondrial pathway (Natoni et al., 2006) which 
again suggests that the signal to begin this process during infection is intrinsic within 
the cell. Many of the hypotheses regarding apoptosis within the Caliciviridae have 
been developed following the discovery that RHDV induces apoptosis especially 
within hepatocytes (Alonso et al., 1998; Jung et al., 2000). There are also parallels to 
be drawn with MNV infection as this norovirus has also been shown to induce 
apoptosis (Furman et al., 2009) and to down-regulate proteins known to inhibit the 
onset of apoptosis within the cell (Bok et al., 2009).  
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Other studies into the relationship between the host and FCV have shown that during 
infection host-cell protein synthesis is inhibited by cleaving of translation initiation 
factors (Willcocks et al., 2004). Levels of host-protein synthesis were measured 
using pulse labelling of amino acids and it was found that there was a 50% reduction 
of host protein synthesis by 5 hrs p.i.. A hypothesis was developed that FCV may act 
in a similar manner to picornaviruses and have an effect upon two translation 
initiation factors eIF4GI and eIF4GII (Krausslich et al., 1987), and these proteins 
were shown to be cleaved during FCV infection. The authors also tested whether this 
cleavage was as result of caspase activation. When caspases were inhibited, the 
cleavage of the initiation factors was delayed but not completely inhibited although 
the cleavage products produced were different to those from FCV infected cells. This 
led the authors to conclude that the cleavage of the translation initiation factors 
observed during infection is not a result of caspase activation but as a direct 
consequence of FCV infection. 
One of the most exciting developments in understanding the mechanisms of FCV 
infection has been the discovery of a possible receptor used during viral entry; feline 
junctional adhesion molecule (fJAM-1) (Makino et al., 2006). Previous studies had 
only been able to elucidate that FCV binds to feline cells more efficiently than other 
non-FCV permissive cells (Kreutz et al., 1994) but no receptor had been identified 
until Makino et al used an expression cloning method to identify surface molecules 
that interact with FCV. They identified fJAM-A as a binding receptor for FCV and 
tested this finding by binding the fJAM-A receptor with antibodies which decreased 
FCV infectivity. They also introduced JAM-A receptors to non-FCV permissive cell 
lines and found that these altered cell lines then became permissive to FCV infection. 
This receptor discovery has opened the way for further investigations into how the 
virus interacts with these glycoproteins in viral entry. The fJAM-A domains required 
for FCV entry into cells have been mapped (Ossiboff & Parker, 2007) along with the 
way it interacts with the viral capsid protein (Bhella et al., 2008; Ossiboff et al., 
2010). Analysis of fJAM-A distribution within feline cells has also lead to the 
development of hypotheses regarding the nature of vesicle formation during FCV 
infection; confocal microscopy has shown that where fJAM-A is normally found to 
be localised at cell-cell junctions during infection with FCV fJAM-A becomes 
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redistributed into the cytosol which may contribute to the breakdown of intercellular 
junctions (Pesavento et al., 2010).  
More recently, a further potential receptor for FCV has been described by Stuart et 
al, in the form of α2,6-linked sialic acid which may help to explain why the fJAM-A 
antibodies in the Makino et al study only reduced infection and did not eradicate it 
(Stuart & Brown, 2007). 
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1.3 Post-genomic technologies for investigation of host-pathogen 
interactions 
There are now many more technologies available for exploration of host-pathogen 
interactions at both the cellular transcription and translation level. At the inception of 
this PhD, these technologies were not being used to test modifications found in the 
host as a result of viral infection and as such we wanted to explore whether or not 
these techniques could be applied to virology. Feline calicivirus was chosen as a 
model virus as relatively little had been elucidated about the mechanisms used by 
FCV to infect cells but also as a strong in vitro system was already available to study 
this virus. 
1.3.1 Viral proteomics  
The proteome is the entire complement of proteins expressed by the genome of a cell 
or tissue at a particular time under certain conditions. The study of these proteomes 
has become known as proteomics. Developments in mass spectrometry coupled with 
an increased availability of full genome sequence have allowed for proteomic 
analysis to be applied to viruses and viral hosts. These techniques are also useful for 
examining interactions on a more global scale with many proteins available for 
analysis within a single proteomics experiment.  
Within this thesis, changes in the host cellular proteome in response to infection with 
FCV will be found using a technique known as two-dimensional difference in gel 
electrophoresis (2D-DIGE) (see section 1.3.1). 2D-DIGE has been used successfully 
in examination of host proteome changes during infection of porcine endothelial 
cells with classical swine fever virus, a positive stranded RNA virus from the 
Flaviviridae (Li et al., 2010). During this analysis 15 proteins were found to be 
differentially expressed and 8 were successfully identified by mass spectrometry 
showing that during infection the virus altered the host cell metabolism, proliferation 
and the cytoskeleton.  
2D-DIGE has also been used to attempt to find biomarkers in the blood plasma and 
urine of patients infected with hepatitis E virus (HEV) (Taneja et al., 2009). Within 
the Taneja et al study, the analysis found 30 proteins that were differentially 
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expressed in the HEV infected patients when compared to control samples from 
healthy controls. From these 30 modulated proteins, two were shown to be possible 
biomarkers for acute HEV infection and as such may be important in future 
diagnoses. 
1.3.1.1 2D-DIGE 
Relative quantification of protein changes between samples separated by two-
dimensional gel electrophoresis is a difficult process due to the poor reproducibility 
of the 2D polyacrylamide gels. One solution to this problem has been to label all the 
proteins in a sample with three fluorescent dyes allowing more than one sample to be 
run on a single 2D gel, this technique is known as two-dimensional difference in gel 
electrophoresis (2D-DIGE). 
The principal behind 2D-DIGE is the ability to visualise spots from different 
samples separately upon the same 2D polyacrylamide gel. For this to be possible 
three CyDye fluors have been developed which fluoresce at separate wavelengths 
but are also mass and charge matched so that any protein which is labelled with a 
CyDye migrates to the same position on a 2D gel (Unlu et al., 1997). With the ability 
to run three samples on one 2D gel comes the opportunity to use one of the three 
dyes to label an internal standard. The internal standard is a pool of all of the 
samples to be analysed which means that it contains every protein from every sample 
and this is included on each gel analysed as part of the experiment. With this internal 
standard included in every gel run, it allows for each gel to be matched to each other 
and for inter-gel analysis to be completed. A workflow for a DIGE experiment can 
be seen in Figure 1.5.   
   
Figure 1.5. Typical workflow for a 2D DIGE experiment (Image taken from GE 
Healthcare literature). 
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The internal standard also allows for standardisation across all gels within the 
experiment as every protein spot can be compared to its counterpart in the standard 
and a relative abundance calculated automatically using the associated software 
(DeCyder, GE Healthcare). This process helps to remove inter-gel variation as the 
abundance of each protein spot is calculated against the standard on that gel so if a 
spot is missing or enlarged in the sample then it can be referenced back to the 
standard to ensure that the change is real and not just a result of gel variation (Fig. 
1.6). 
 
 
 
Figure 1.6. Analysis of protein abundance without and with a protein standard present. (A) When 
analysed without the presence of an internal standard, spots from samples 3 and 4 appear to be up-
regulated. (B) When the same samples are analysed with the internal standard present, sample 3 is 
down-regulated and sample 4 has the same abundance as samples 1 and 2. (Image adapted from GE 
Healthcare literature) 
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1.3.2 Viral transcriptomics 
Alongside investigations into host proteome changes during infection, changes in 
host gene transcript levels will be investigated. The traditional method to do this is 
via microarray analysis or through Sanger sequencing. However, advances in next-
generation sequencing technologies have opened up new methodologies for 
transcriptomic investigations.  
1.3.2.1 Microarray 
For over a decade, gene transcription has been monitored and assessed by microarray 
analysis using techniques derived from southern blotting to target genes with specific 
oligo probes (Ramsay, 1998; Schena et al., 1995). In a typical microarray experiment 
a chip containing thousands of bound single stranded cDNA or cRNA probes is 
interrogated with a labelled sample of cDNA/cRNA where complementary genes 
hybridise with the probes. The hybridisation reaction can either be with many of the 
probes, with few of the probes or with none of the probes and when the array is 
excited with a laser the spectra produced can be used to determine the extent of the 
hybridisation of the sample with the probes. These hybridisation spectra can then be 
compared to a reference sample and differences in gene expression found and 
investigated.  
There are inherent problems with microarray technologies however, as although 
many thousands of genes can be interrogated in a single experiment, novel gene 
transcripts cannot be found using this kind of technology. Microarrays also have the 
limitation that despite being able to design chips that can detect SNPs and alternative 
gene splicing they do not allow the user to interrogate the sequence of the transcripts 
directly. The arrays are also limited in the methods used to quantitate the number of 
transcripts found in each experiment as they use a relative intensity from the 
hybridisation reactions to measure abundance and as such do not give an absolute 
quantification of transcription.  
In the analysis of the Caliciviridae, microarrays have only been used to interrogate 
host-pathogen interactions in a norovirus replicon system (Chang, 2009). It was 
discovered that genes in cholesterol and carbohydrate metabolic pathways were 
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significantly modulated and when these pathways were disrupted experimentally the 
levels of replication of the norovirus replicon reduced significantly.  Microarrays 
have also been employed in attempts to detect norovirus isolates in food (Ayodeji et 
al., 2009) and water sources (Brinkman & Fout, 2009). 
1.3.2.2 Serial analysis of gene expression 
The first examples of using sequencing technology to interrogate transcriptomes 
employed techniques based on Sanger method (Sanger et al., 1977) such as serial 
analysis of gene expression (SAGE) (Velculescu et al., 1995). However, the costs of 
deep sequencing using technologies developed from this method have proven to be 
prohibitive.  
1.3.2.3 RNA-seq 
More efficient and cost-effective sequencing techniques have since been developed 
and have become more commonly known as “next-generation sequencers” and these 
have been successfully employed in determining gene transcript levels in a technique 
called RNA-seq. The most commonly used platforms for this kind of sequencing are 
the Roche 454, ABI SOLiD, Illumina Genome Analyser and HeliScope with each of 
these using a different method to sequence samples. These new platforms allow for 
rapid, in depth sequencing which opens up the possibility of interrogating whole 
genomes in a very short space of time (Wang et al., 2009).  
1.3.2.3.1 Roche 454  
The Roche 454 systems works by first generating a single stranded template DNA 
library, amplifying each template read in the library separately using emulsion PCR 
and then sequencing the amplified templates through sequencing-by-synthesis 
(pyrosequencing) (Margulies et al., 2005). This method of sequencing works by 
adding nucleotides sequentially to the samples across a plate, if this nucleotide 
stream is complementary to the nucleotide found in the template sequence then the 
nucleotide is incorporated and a polymerase extends the complementary sequence. 
This addition of the nucleotide results in a reaction which emits a light signal which 
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can be recorded and the complementary sequence to the template elucidated. This 
methodology allows 1,000,000 individual reads to be determined per 10 h 
sequencing run with individual read lengths of 400-500 bp.  
1.3.2.3.2 Illumina 
The Illumina Genome Analyser (Bentley et al., 2008) uses a slightly different 
technique to sequence transcriptome libraries whereby the mRNA or cDNA sample 
is firstly fragmented, the ends polyadenylated before adaptors are attached to each 
end. A bridge PCR technique is used to amplify the library with a flow cell surface 
containing oligo probes being used to ligate to the adaptors attached to each piece of 
the fragmented library. From these ligations the template library can be cloned to 
produce an area upon the surface with a large concentration of the template to be 
sequenced. The reverse strands are cleaved and a cap is placed onto each piece of 
DNA before sequencing primers are hybridised and sequencing commences. The 
sequencing occurs base by base along the template, with all four nucleotides added 
in competition to try to ensure that only the correct complementary base is 
incorporated into the sequence. Each of the four nucleotides has a different 
fluorescent label so when it is integrated a different signal is emitted and this can be 
recorded by the sequencer. The Illumina system gives read lengths of up to 150 bp 
with up to 6.5 Gb generated in 24 h run with 100 bp read lengths.  
1.3.2.3.3 HeliScope 
The HeliScope sequencer is the first next generation sequencer not to employ an 
amplification or cloning phase as part of the sample preparation; rather the sequencer 
can employ single pieces of DNA or RNA as the template (Harris et al., 2008). 
Firstly, the entire sample is fragmented and if the sample is double stranded DNA 
the double-helix is melted into single strands before each strand is polyadenylated. 
The polyadenylated samples are then hybridised to a flow cell primed with oligo dT 
which capture each fragment and allows them to be interrogated base by base. 
Fluorescently labelled nucleotides are added one at a time to the flow cell and if they 
are complementary to the template they are added to the complementary strand and 
emit a fluorescent signal which is recorded by the sequencer to build up a sequence 
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complementary to the template. The HeliScope generates an average read length of 
35 bp with 21 to 35 Gb per run.  
1.3.2.3.4 SOLiD 
Finally, there is also the SOLiD sequencer from ABi available to use in sequencing 
the whole transcriptome or genome of a sample (Cloonan et al., 2008). SOLiD 
sequencing works by taking a whole DNA/RNA sample and fragmenting it with an 
enzyme, before each fragment is hybridised with SOLiD based adaptors. Each 
fragment is reverse transcribed and size selected to gain reads of the correct size 
before being amplified by PCR. This library is then placed through a phase of 
emulsion PCR where the adaptors on the fragmented templates hybridise to beads 
and an emulsion is created to isolate one bead and one DNA fragment in separate 
microreactions within the PCR mix. Over 30,000 copies of the templates are made 
within the microreactions on the bead and these beads are covalently attached to a 
glass slide for sequencing. SOLiD sequencing is performed by interrogating the 
templates with fluorescently labelled di-base probes and using multiple rounds of 
primer ligation. The primers used anneal in a position n-1 of the previous primer 
used to allow each base of the template to be sequenced more than once which 
should ensure a high accuracy of sequencing. The SOLiD sequencing process creates 
reads of 50 bp in length and up to 30 Gb from a 7 day sequencing run. 
1.3.2.4 Bioinformatic normalisation of RNA-seq 
With all of these sequencing technologies the whole transcriptome can be 
interrogated very quickly and sequenced transcripts can be mapped back to a 
reference genome. Very approximately, it could be said that the more transcripts 
mapping to a gene on the reference genome then the more transcription of that gene 
is occurring within the cell. In truth, with every system the reads mapping to the 
reference genome must be normalised either at the mapping stage by using a 
normalisation such as RPKM values (Reads Per Kilobase of exon model per Million 
mapped reads) (Mortazavi et al., 2008) or through an analysis package design to deal 
with the variance within transcription samples such as DeSeq (Anders, 2010). These 
normalised values can then be compared to other samples and comparisons drawn to 
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discover whether there is a pattern of differentially transcribed genes between the 
samples compared. 
1.3.2.5 Applications of RNA-seq 
With next-generation sequencing technology being so new and RNA-seq still being 
in its infancy at the time of writing there are only a few hundred studies currently 
published in which RNA-seq is used in transcriptome analysis. There are even fewer 
studies published using RNA-seq to examine viruses and at time of writing there is 
only a single study published that concentrates on the effects the virus has upon the 
host. Woodhouse et al (2010) have published a study which uses RNA-seq, 
microarrays and proteomics to investigate infection with hepatitis C virus (HCV). 
This study found that microarray analysis identified the greatest number of non-
redundant differentially transcribed genes with almost twice as many as found by 
RNA-seq. The proteomic analysis identified a smaller number of non-redundant 
differentially expressed proteins than either of the methods analysing gene 
transcription levels. Analysis was also undertaken to find any genes/proteins which 
were identified as modulated by all three of the techniques employed and the authors 
discovered that there was only a single gene/protein from over 2000 separate gene 
and protein identifications which was common to all three methods. The results from 
this study give further evidence to the usefulness of employing more than one 
technique when studying host-pathogen interactions as the full picture is often 
missed if only one technique is used.  
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1.4 Aims 
The overall aim of this thesis was to discover the ways in which host cellular 
proteins and genes are manipulated in vitro by feline calicivirus during infection and 
to use these findings to generate further hypotheses. More specifically the aims were: 
 To use proteomic methods in the form of 2D-DIGE to discover changes in 
the host proteome over a time course of infection with a single FCV strain. 
 To use 2D-DIGE to determine whether changes in the host proteome differ 
during infection with FCV strains of varying virulence. 
 To further investigate host protein changes found during the proteomics 
experiments through immunofluorescent staining and confocal microscopy. 
 To use next-generation sequencing technology to determine whether any 
changes occur at the transcriptional level and whether those changes are 
consistent with changes observed at the protein level. 
 To attempt to gain whole genome sequence for the putative virulent FCV 
strain obtained from the UK outbreak of virulent systemic disease. 
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2 Chapter two 
Analysis of differentially expressed host cell proteins during 
infection with FCV-F9 
2.1 Introduction 
To understand the mechanisms of viral infection and replication, it is very important 
to consider the effects the virus has upon the host cell machinery which often 
involves changes both at the gene and protein level. In the past these changes have 
often had to be elucidated and studied one pathway at a time. In the study of 
calicivirus infections, hypotheses have often been developed and tested based upon 
discoveries made in the Picornaviridae leading to discoveries such as FCV 
inhibiting cellular protein synthesis through selective cleavage of eukaryotic 
initiation factors (Willcocks et al., 2004) and that FCV induces apoptosis to allow 
cleavage of viral capsid proteins by caspase enzymes (Al-Molawi et al., 2003). 
Whilst the one pathway at a time approach is useful in discovering whether FCV 
behaves in a similar way to viruses that have already been extensively studied, it 
makes it much more difficult to discover any novel pathways being targeted during 
infection. For these situations it may be beneficial to use a more global approach to 
find changes induced within the cell as a result of viral infection.  
Recent advances in technology have allowed proteomic techniques to be developed 
that aid discoveries at a whole cell proteome level and allow for large groups of 
proteins to be analysed in a single experiment. These techniques have been 
successfully employed in discovering host-pathogen interactions in intracellular 
parasite invasion (Nelson et al., 2008) uncovering novel protein modulation as well 
as confirming previous hypotheses of host-pathogen interactions. More recently, 
these approaches have begun to be employed in virology to elucidate changes in 
whole cell proteomes induced by infection (Vester et al., 2009; Xiao et al., 2010) 
and in this chapter these proteomic techniques will be used to interrogate cells 
infected with FCV-F9.   
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Through using 2D-DIGE upon FCV-F9 infected cells in this chapter it is hoped that 
a picture of changes in protein expression in response to infection can be established. 
It is therefore important to be sure that the strain used is truly FCV-F9 and not a 
mixture of viral strains, such as is sometimes used in vaccination to offer a wider 
cross-protection (Huang et al., 2010; Poulet et al., 2005) and also can be found 
naturally within cats (Coyne et al., 2007). The decision was therefore made that an 
aliquot of FCV-F9 should be plaque purified and sequenced to ensure only one strain 
was analysed and that the strain used was truly FCV-F9.  
To inform the decision as to the time points to be analysed by 2D-DIGE, a growth 
curve was performed upon the plaque purified FCV-F9 and from the results four 
time points were selected. These time points were chosen to allow a full picture of 
protein changes over a time course of infection to be deduced and then the 
modulated proteins could be identified using mass spectrometry. These modulated 
host proteins could then be assessed for functions within the cell and host-pathogen 
interactions could be inferred. 
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2.2 Materials and methods  
2.2.1 Cells and viruses 
2.2.1.1 Cell culture 
All cell culture media and reagents were made up according to standard laboratory 
protocol and are listed in Table 2.1.  
A FCV permissive, undifferentiated, diploid cell line called feline embryo cell line A 
(FEA) (Jarrett et al., 1968) was used through the entire study with passage levels 
between 43 and 60. FEA cells were chosen as they are an undifferentiated cell line 
and as such offer the closest in vitro equivalent to the whole cat.   
The cells were cultured in Eagle‟s minimum essential medium (Sigma-Aldrich) 
supplemented with the appropriate amount of fetal calf serum (FCS) (PAA 
Laboratories Ltd) for growth medium (GM) or maintenance medium (MM) (Table 
2.1). 
Cells were grown to confluence in either flasks or plates (Corning, Fisher scientific) 
within an incubator set at 37°C and 5% CO2. The cells were passaged every three or 
four days by removing the media and washing twice with PBS before adding 1 ml 
PBS/EDTA/Trypsin and leaving in the incubator for 1 min to detach the cells from 
the plastic. The cells could then be used to seed flasks and plates in a split ratio of 
1:3. All passaging steps were performed in a sterile hood. 
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Cell culture media stock Stock concentration Recipe 
PBS 10x 90 g NaCl 
2.25 g KCl 
13 g Na2HPO4 
2.25 g KH2PO4 
Make up to 900 ml with 
ddH2O 
PBS 1x Add 88 ml 10x PBS to 
800 ml ddH2O 
PBS/EDTA 1x Add 0.18 g EDTA to 900 
ml 1x PBS 
PBS/EDTA/Trypsin 1x Add 1 ml to 50 ml 
PBS/EDTA 
L-Glutamine (G3126, 
Sigma Aldrich) 
100x 
200 mM 
2.92 g in 100 ml ddH2O  
Penicillin/Streptomycin 
(P4333, Sigma Aldrich) 
100x 
10 mg/ml 
As bought  
Amphotericin B 
(solubilised) (A9528, 
Sigma Aldrich) 
1000x Add 100 mg to 50 ml 
with ddH2O 
Sodium bicarbonate 
7.5% solution (S8761, 
Sigma Aldrich) 
100x As bought 
Eagles minimum 
essential media (MEM)  
(D2429, Sigma Aldrich) 
10x As bought 
Non-essential amino 
acids (NEAA) (M7145, 
Sigma Aldrich) 
100x As bought 
Stock media 1x 100 ml EMEM 
10 ml NaHCO3 
10 ml NEAA 
10 ml L-glutamine 
10 ml 
Penicillin/Streptomycin 
1 ml Amphoterocin B 
ddH2O to 1 litre 
Growth media (GM) 7% 100 ml stock media plus 
7 ml fetal calf serum 
(FCS) (F6178, Sigma 
Aldrich) 
Maintenance media 
(MM)  
1%  100 ml stock media plus 
1 ml FCS 
Table 2.1. Stock solution recipes used in cell culture. 
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2.2.1.2 Plaque Purification 
Unless otherwise stated, the strain of virus used throughout the study was FCV-F9 
(Bittle & Rubic, 1976; Bittle, 1960) with an unknown high passage number, which 
was plaque purified using the following method to ensure that there was only one 
strain being used. 
 A 10-fold dilution series of FCV-F9 down to 10
-9
 was prepared using maintenance 
media (MM) (Table 2.1). A confluent monolayer of FEA cells on a 12-well plate was 
infected with 200 µl of diluted virus or mock infected with 200 µl of MM and then 
incubated at 37°C for 90 min with gentle agitation. Wells were then overlaid with 
equal amounts of 2x MM and 2x sterile agarose (2 g in 100 ml dd H2O) and left at 
room temperature for 20 min. The plates were then incubated at 37°C for 24 h. After 
24 h a plaque plug was picked and transferred to 1 ml MM and a second dilution 
series prepared. A confluent 12-well plate of FEA cells was infected as before with 
the dilution series and overlaid as described previously. After a further incubation for 
24 h a plaque plug was again picked and underwent one further round of 
purification. The plaque picked after the third purification was then used to inoculate 
a 75 cm
2
 flask of confluent FEA cells which was incubated at 37°C for 24 h before 
undergoing three freeze thaw cycles. The cells were then harvested and centrifuged 
at 2000 × g for 10 min before the supernatant was collected and aliquoted for storage 
at -80°C. 
2.2.1.3 Titration 
In order to determine how much virus was present in a given sample a viral titration 
was performed. 
A 10-fold dilution series was prepared down to 10
-9
 using MM and confluent FEA 
cell monolayers in a 96-well plate were inoculated with 50 µl of diluted virus and 
controls mock infected with MM. The plate was then incubated for 1 h at 37°C 
before 100 µl of MM was added and the plate left to incubate at 37°C for 4 days. 
After 4 days the Reed-Munch calculation (Reed, 1938) was used to find the TCID50 
of the sample virus. 
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2.2.2 Sequencing 
Wherever sequencing has been used throughout this study the following protocol 
was used unless otherwise stated. 
2.2.2.1 RNA extraction 
RNA was extracted from the viral samples using QIAamp Viral RNA mini kit 
(Qiagen), following the manufacturers protocol under RNAse-free conditions.  
2.2.2.2 Reverse transcription 
Reverse transcription was performed to create cDNA using the following recipe:  1 
µl random hexamer oligos (Abgene), 2 µl dNTP mix (Abgene), 5 µl molecular grade 
H2O (Sigma Aldrich) and 5 µl RNA prepared as above. The mixture was incubated 
at 65°C for 5 min and then left on ice for 1 min. The following recipe was then 
added to the tube: 4 µl 5x first strand buffer (Abgene), 1 µl DTT (Abgene), 1 µl 
RNAse out (Abgene) and 1 µl Superscript III (Abgene). This mixture was incubated 
at 25°C for 5 min, 42°C for 60°C min and 70°C for 15 min.  
2.2.2.3 Polymerase chain reaction 
Polymerase chain reaction (PCR) was used to target a portion of the capsid gene 
which incorporates the variable region C and the 5‟ and 3‟ hypervariable regions of 
region E. The single stage PCR was performed using the following recipe: 45 µl 
Reddy Mix (Abgene), 100 ng primer 1, 100 ng primer 2 (primers synthesised by 
Eurofins MWG Operon), 1 µl molecular grade H2O and 2 µl cDNA. 
Primer 1 (p2 ext): 5‟- CCT CAC CTA TAC CAG TGT AAC CAA G-3‟ 
Primer 2 (p1 degenerate): 5‟- GAG CGG ATA ACA ATT TCA CAC AGG CCG 
TTY GTG TTY CAR GCA AAY CG-3‟ 
Thermal cycling condition for PCR consisted of: 
95°C for 2 min 
95°C for 30 s, 55°C for 30 s and 72°C for 1 min 30 s x40 cycles 
72°C for 5 min 
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2.2.2.4 PCR purification 
The PCR product was purified of excess primers and unincorporated single 
nucleotides using QIAquick PCR purification kit (Qiagen) following the 
manufacturer‟s protocol. 
2.2.2.5 Sequencing of purified PCR products 
Sequencing was performed bidirectionally by Eurofins MWG Operon 
(http://www.eurofinsdna.com/home.html) according to their instructions to produce 
a consensus sequence. The primers used in sequencing the products were the forward 
and reverse primers used in amplifying the PCR products (p2ext and p1 degenerate). 
2.2.2.6 Sequence analysis 
The forward and reverse sequences obtained from each PCR product were aligned in 
Chromas Pro (Technelysium Pty Ltd) and a consensus sequence produced for each 
amplicon. 
The consensus sequence was then exported as a FASTA file and the sequence was 
searched within the NCBI (National Centre for Biotechnology Information) database 
using the BLASTn tool which searches the nucleotide databases using a nucleotide 
query. The sequenced amplicons were compared to the whole genome sequence of 
FCV-F9 (Genbank number m86379) using the megablast algorithm optimised for 
highly similar sequences.  
2.2.3 Growth curve 
A viral growth curve was constructed in order to establish the progression of 
infection over the course of 14 h.  
Eight x 25 cm
2
 flasks of confluent FEA cells, passage number 43, were infected with 
FCV-F9 at a multiplicity of infection (m.o.i.) of 10. The flasks were incubated at 
37°C for 1h before being washed three times with sterile PBS. A flask was harvested 
at this point by freezing at -80°C. The remaining flasks were re-fed with 10 ml MM 
and returned to the incubator. At 2 h post infection (p.i.) another flask was harvested 
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and intracellular and extracellular virus fractions were stored separately. This 
process was repeated every 2 h until 14 h p.i.. A mock infected control was also 
included which was composed of FEA cells treated in exactly the same manner as 
the infected cells except for mock infection with MM instead of virus and harvested 
at 14 h p.i.. At each time point the extracellular virus, intracellular virus and virus 
found in dead cells no longer found adhered to the flask were calculated by titration 
as described previously (section 2.2.1.3). Extracellular virus was taken directly from 
the media and virus from non-adherent cells was isolated by pelleting the cells from 
the media by centrifugation at 2000 × g. Intracellular virus was isolated by washing 
the flask twice with sterile PBS and scraping the adherent cells before pelleting by 
centrifugation at 2000 × g. 
2.2.4 Immunofluorescence Assay 
To visualise virus in the cells at the time points chosen for use in the 2D-DIGE 
infections (1 h, 4 h, 7 h and 10 h p.i.) immunofluorescent staining was performed in 
parallel to the 2D-DIGE infections. 
Four x 96-well plates of confluent FEA cells, passage number 43, were infected with 
50 µl FCV-F9 at an m.o.i. of 10 whilst control wells were mock infected with 50 µl 
MM. The plates were incubated at 37°C for 1 h before being washed with sterile 
PBS. One plate was fixed with 70% ethanol at this point. The remainder were re-fed 
with 150 µl MM and returned to the incubator. The plates were then fixed at 4 h, 7 h 
and 10 h p.i. with 70% ethanol. Once fixation was complete the plates were washed 
three times with sterile PBS and overlaid with 50 µl of primary antibody raised 
against the capsid protein of FCV-F9 (G784h (Porter, 2004)), diluted 1:20 with PBS. 
The plates were incubated at 37°C for 1 h and washed in sterile PBS three times 
before being overlaid with 50 µl of anti-rabbit goat fluorescein isothiocyanate (FITC, 
Sigma-Aldrich), diluted 1:40 with PBS. The plates were incubated at 37°C for 1 h 
and washed with PBS before 50% glycerol was added to each well. The plates were 
viewed under a UV microscope to detect immunofluorescence and pictures were 
taken using a UV microscope (Zeiss Axiovert 200M with Axiocam hrc camera and 
Axiovision 3.1 software). 
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2.2.5 2D-DIGE  
2.2.5.1 Viral infection 
Cells were virally infected to allow protein to be extracted for proteomic 
examination. 
Eight x 75 cm
2
 flasks of confluent FEA cells, passage number 43, were infected with 
1 ml of FCV-F9 at an m.o.i. of 10 and eight x 75 cm
2
 flasks were mock infected with 
1 ml MM. The flasks were incubated at 37°C for 1 h before being washed with 
sterile PBS. Two infected flasks and two mock infected flasks were harvested and 
the collected cell pellets frozen at -20°C. The remaining flasks were re-fed with 20 
ml MM and incubated at 37°C. Two each of the infected and mock infected flasks 
were harvested at 4 h, 7 h and 10 h p.i. and the cell pellets frozen at -20°C. 
2.2.5.2 Cell lysis 
The cell pellets were lysed in 500 µl of lysis buffer (30 mM Tris, 2 M Thiourea, 7 M 
Urea, 4% CHAPS) plus 10 µl DN/RNases (Roche) and 5 µl of protease inhibitors 
(complete tablet kit, Roche). The samples then underwent five cycles of freeze-
thawing (freezing in liquid nitrogen, thawing at 30°C and vortexing) before 
centrifuging at 13 000 × g for 10 min to remove any remaining cell debris. To 
remove any salts, detergents, lipids, phenolics and nucleic acids still present in the 
samples a 2D-clean up kit (GE Healthcare) was used. All clean up steps were carried 
out on ice unless stated otherwise. 300 µl of precipitant was added to each sample 
and mix thoroughly by vortexing before being incubated on ice for 15 min. After 
incubation, 300 µl of co-precipitant was added to each sample mixture and vortexed 
briefly before centrifugation at 13 000 × g for 5 min. The supernatant was discarded 
and the tubes centrifuged again to ensure that any remaining supernatant was 
removed. 40 µl of co-precipitant was layered on top of the pellet, carefully so as to 
avoid disturbing the pellet, and the tubes were incubated on ice for 5 min. The 
samples were centrifuged again at 13 000 × g for 5 min and the wash removed and 
discarded. 25 µl of ddH2O was added to each pellet and the tubes vortexed where the 
pellet was dispersed but not dissolved in the solution. 1 ml of wash buffer (pre-
chilled at -20°C for at least 1 h) was added alongside 5 µl of wash additive and the 
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tubes were incubated at -20°C for at least 30 min with the samples being vortexed 
for 20-30 s every 10 min. The samples were then centrifuged at 13 000 × g for 5 min 
and the supernatant discarded before the pellet was left to air dry for a maximum of 5 
min. The protein pellets were resuspended in 40 µl of 2x sample buffer (2 M 
Thiourea, 7 M Urea, 2% CHAPS) before determining the protein concentration of 
each sample by protein assay. 
2.2.5.3 Protein assay 
For each protein assay used throughout this work the protein concentration of each 
sample by a Bradford method based protein assay (Biorad Protein Assay) (Bradford 
1976). Briefly, bovine serum albumin (BSA) standards were made up which range in 
concentration from 10 µg/ml to 50 µg/ml and these were placed in duplicate in a 96-
well plate along with blanks containing no BSA. The Coomassie plus reagent was 
diluted down 1 in 4 with ddH2O to provide the working solution. 100 µl of blank, 
sample, and standards were added to the appropriate wells and the samples were 
subjected to a serial dilution series. 200 µl of the working Coomassie solution was 
added to each well and the protein concentration was read within an hour of the 
solution being added to the samples. The absorbancies of the plate were read using a 
Labsystems Multiscan Ascent at 620 nm. A straight-line graph was produced from 
the blanks and standards and protein concentration of the samples calculated from 
this graph.  
2.2.5.4 2D-DIGE labelling 
The optimal protein concentration for 2D-DIGE labelling is 5 mg/ml with a pH 
between 8 and 9. Both these conditions were tested and the samples were diluted 
with 2x sample buffer or pH raised with 1 µl of 10 mM NaOH if necessary.  
The dry CyDyes first had to be reconstituted with high quality anhydrous 
dimethylformamide (DMF) (5 µl per 5 nmol CyDye), mixed by vortexing and 
centrifuged at 12 000 × g for 30 s to give a stock solution of 1 mM which could be 
used immediately or kept at -20°C for 2 months. To make a working solution, one 
volume of CyDye stock solution was added to 1.5 volumes of high grade DMF to 
make a 400 pmol/µl solution.  
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50 µg of each protein sample was labelled with 1 µl of the appropriate CyDye (Table 
2.2). An internal standard was created from equal proportions of all 16 samples 
analysed and 50 µg of the internal standard was labelled with Cy2 for each gel. The 
mixtures were then mixed and centrifuged briefly before incubating on ice for 30 
min in the dark. To stop the reaction 1 µl of 10 mM lysine was added to each 
reaction and mixed by pipetting and spun briefly in a centrifuge before being 
incubated on ice for a further 10 min in the dark.  
 
 
The labelled samples were combined into eppendorfs according to the gel they 
would be loaded onto (gel 1 including 300 µg of unlabelled pooled protein to allow 
spot picking after analysis) and each mixture added to a pH 3-10 IPG strip (GE 
Healthcare) by cup loading. The IPG strips were rehydrated overnight using 450 µl 
rehydration buffer (8 M urea, 2% CHAPS, 0.002% bromophenol blue) containing 10 
mg/ml DTT and 5 µl/ml IPG buffer containing ampholytes (pH 3-10, GE 
Healthcare). Once the strips were rehydrated they were each placed onto a ceramic 
manifold and sample loading cups placed towards the acidic end of the strips. 
Rehydration buffer was added to each sample mixture up to a maximum volume of 
100 µl and these were loaded into the sample cups for isoelectric focussing.  
Gel Number Cy2 Cy3 Cy5 
Gel 1 (pick 
gel) 
Internal Standard 1hr p.i. mock infected 1 4hrs p.i. infected 2 
Gel 2 Internal Standard 7hrs p.i. mock infected 2 4hrs p.i. mock infected 1 
Gel 3 Internal Standard 4hrs p.i. infected 1 7hrs p.i. infected 2 
Gel 4 Internal Standard 10hrs p.i. mock infected 1 1hr p.i. infected 1 
Gel 5 Internal Standard 1hr p.i. infected 2 7hrs p.i. mock infected 1 
Gel 6 Internal Standard 7hrs p.i. infected  1 10hrs p.i. mock infected 2 
Gel 7 Internal Standard 4hrs p.i. mock infected 2 10hrs p.i. infected 2 
Gel 8 Internal Standard 10hrs p.i. infected 1 1hr p.i. mock infected 2 
Table 2.2. Experimental design for 2D-DIGE performed on samples infected with FCV-F9 at four 
time points.  
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2.2.5.5 2D gel electrophoresis 
First dimension separation by isoelectric focussing (IEF) was performed using the 
Ettan IPGphor II (GE Healthcare) at 30 v for 5 h, 500 v for 1 h, 100 v for 1 h, 8000 v 
for 2 h and 8000 v for 9 h with current limited to 50 µA/strip. The focussed strips 
then had to be equilibrated firstly in 10 ml SDS equilibration buffer (2% SDS, 50 
mM Tris-HCl pH 8.8, 6 M urea, 30% (v/v) glycerol, 0.002% bromophenol blue) 
with 10 mg/ml DTT for 15 min to reduce the protein and then for 15 min in 10 ml 
SDS equilibration buffer with 25 mg/ml iodoacetamide to alkylate the cysteine 
residues.  
The proteins were separated in the second dimension using a manually cast 12.5% 
acrylamide gel which was stuck to low fluorescence glass plates by pretreating each 
glass plate with bind silane solution (80% (v/v) ethanol, 18% (v/v) ddH2O, 2% (v/v) 
acetic acid, 0.1% (v/v) γ-methacryloxypropyltrimethoxysilane) and allowing to dry 
completely before casting. Fluorescence reference markers were added to each 
treated glass plate to allow for references to be picked out when using the automated 
spot picker (Ettan spot picker, GE Healthcare) and the treated plates were 
sandwiched with larger untreated plates and placed into a gel casting unit. The 
12.5% acrylamide solution was made up (40% (v/v) bis-acrylamide, 25% (v/v) Tris-
HCl, pH 8.8, 30% (v/v) ddH2O, 10% SDS and 0.001% (v/v) TEMED) and left in the 
fridge for at least 1 h. 0.01% (w/v) ammonium persulphate (APS) was added finally 
and poured immediately into the casting unit before being overlayed with a 0.1% 
solution of SDS and leaving to polymerise at room temperature (~20-25°C) 
overnight. The equilibrated strips were laid on top of the gels and sealed in with an 
agarose sealing solution (0.5% (w/v) agarose, trace bromophenol blue). The gels 
were run at 5 W per gel for 30 min and then adjusted to 17 W per gel for 4 h in an 
Ettan DALTsix electrophoresis unit (GE Healthcare). 
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2.2.5.6 Ettan DIGE scanner parameters 
Once the gels were run they were scanned immediately in an Ettan DIGE imager 
(GE Healthcare) set at 100 pixels and 0.800 exposure on all three CyDye channels. 
The pick gel (gel 1) containing an extra 300 mg of unlabelled protein from the 
pooled samples was then fixed overnight in 40% methanol, 10% acetic acid before 
staining overnight in Sypro Ruby stain on a rocker. The gel was washed for an hour 
in 10% methanol, 7% acetic acid then rinsed twice in ddH2O before scanning in the 
Ettan DIGE imager under Sypro Ruby conditions at the same exposure as before. 
2.2.5.7 DeCyder analysis 
DeCyder software is recommended for use with 2D-DIGE gels as it a fully 
automated image analysis suite which allows for detection, quantitation, matching 
and analysis of scanned DIGE gel images.   
DeCyder software was used for all image analysis of 2D-DIGE gels in this work. 
The DeCyder software package is made up of four modules; the Image Loader, the 
Differential In Gel (DIA) module, the Biological Variation Analysis module (BVA) 
and the Batch Processor.  
2.2.5.7.1 Image loader 
The image loader module is a tool included in the DeCyder software which allows 
the user to import the images gained from the Ettan DIGE scanner into separated 
projects within the DeCyder database with the CyDye chemistry already assigned to 
the correct image. 
2.2.5.7.2 DIA module 
The DIA module processes all images from a single gel, allowing parameters to be 
calculated for dust particle exclusion which can then be filtered against all the other 
gels analysed. For this experiment dust particles were eliminated from analysis by 
setting the following parameters; max slope >1.6, max volume <7800.  
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2.2.5.7.3 Batch Processor 
The batch processor is a tool which automates the process of adding the gel images 
to the DIA and BVA modules as well as allowing the user to include spot exclusion 
filters which were calculated from analysing one of the gels in the DIA module. The 
batch processor also enables each gel image to be assigned to a group e.g. standard, 
infected, and uninfected.  
2.2.5.7.4 BVA module 
 The BVA module is the tool which allows multiple gel images to be matched 
together and as such allows inter-gel comparisons and relative quantitations to be 
performed. A master gel is assigned from one of the Cy2 labelled gel images made 
up of the internal standard and all the remaining gel images are matched to the 
master first by the software‟s matching algorithm and then by manual curation 
through finding common spots across all gels and landmarking them. The BVA 
module also allows the user to perform statistical analyses on the matched spots such 
as students t-test and analysis of variance (ANOVA). In this experiment the spots 
were subjected to student t-test statistical analysis based on variance between 
infected and uninfected states at each time point and those with a p-value of ≤0.05 
were selected for spot picking.  
2.2.5.8 Spot picking 
The selected spots were picked from the pick gel using an Ettan spot picker (GE 
Healthcare) which is able to automatically calculate the locations of the selected 
spots based upon the defined reference markers attached to the glass plates during 
gel casting.  
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2.2.5.9 Tryptic digestion 
The picked spots were then subjected to tryptic digestion to produce peptides 
suitable for analysis by mass spectrometry. The gel plugs picked were each placed 
into an eppendorf and 10 µl of 50 mM ammonium bicarbonate (ambic) and 50% 
acetonitrile (HPLC grade) was added before incubation at 37°C for 10 min. This step 
was performed to remove any stain on the gel plugs and so the liquid is removed 
before the steps are repeated again to ensure no stain remains. 10 µl of 100% 
acetonitrile was then added to each gel spot and incubated at 37°C for a further 15 
min. This step dehydrates the gel plug and should turn it white and opaque, if this 
did not happen then the solvent was discarded and this step was repeated. The 
solvent was removed from the dehydrated gel plug and the tubes were incubated at 
37°C until all traces of the solvent had disappeared (usually about 10 min). Stock 
solutions of trypsin (100 ng/µl) were diluted 1 in 10 with 25 mM ambic and 10 µl of 
this was added to each plug and the solution was incubated at 37°C for 1 h. A further 
10 µl of 25 mM ambic was added to each spot and incubated overnight 37°C. The 
digest was either analysed immediately by mass spectrometry or stored at -20°C. 
2.2.6 Mass spectrometry 
2.2.6.1 LTQ parameters 
Samples were analysed using high performance liquid chromatography (HPLC) 
(UltiMate 3000, Dionex) coupled with tandem mass spectrometry (MS/MS) 
(Finnegan LTQ, Thermo Scientific). The samples were prepared for analysis by the 
addition of 2 µl of 2.6 M formic acid to each digested sample followed by 
centrifugation at 13 000 × g for 30 min. In loading the samples onto the machine 10 
µl of sample was mixed with 10 µl of 1% formic acid although if more than three 
samples were being analysed the volume of 1% formic acid added increased by 2 µl 
every three samples to allow for evaporation.  
The samples were first fractionated by the HPLC system (Ultimate 3000, Dionex) on 
a C18 reverse phase column over a total run time of 50 min per sample. 10 µl of 
tryptically digested peptides were injected onto the column and eluted over a linear 
gradient of 0-50% (v/v) acetonitrile/0.1% (v/v) formic acid over 30 min before a 
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final elution at 80% (v/v) acetonitrile/0.1% formic acid (v/v) for 5 min. The column 
was then equilibrated in 98.9% water/2% acetonitrile/0.1% (v/v) formic acid for 5 
min.  
The LTQ was calibrated before and after each run with glufibrinopeptide (500 
fmol/µl solution) to ensure that all samples were run under optimal conditions. For 
analysing samples the LTQ was run in “triple play” mode, where the detector uses 
information from the data in the experiment to make decisions about the next step 
automatically. In these experiments a full MS survey was taken (threshold = 400-
1500 total ion current) and from this the three most abundant ions were determined. 
These peptides were then fragmented further in the collision cell with collision 
energy set at 35% for 30 min. The charge state of each of the fragmented ions was 
then calculated using the “zoom scan” which uses the presence of 13C atoms to 
determine the charge state and the ions were finally interrogated with a full MS/MS 
scan. 
The resulting MS/MS data files were merged into a .mgf file which could then be 
analysed using Mascot searching (www.matrixscience.com). 
2.2.6.2 Mascot search parameters  
The resulting MS/MS spectra were analysed using a Mascot search database (Matrix 
Sciences) with the following parameters. 
 
 
Parameter Selected Option 
Database Feline predicted protein database/MSDB 
and FCV proteins 
Enzyme Trypsin 
Missed Cleavage 1 
Fixed modification Carbamidomethylation 
Variable modification Oxidation of methionine 
 
Table 2.3. Parameters used when searching spectra against databases using the Mascot search 
programme 
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The feline predicted protein database was downloaded from the Ensembl website 
(http://www.ensembl.org/Felis_catus/Info/Index) and the version used was from the 
July 2008 genebuild of the March 2006 assembly of the 1.87x coverage genome 
containing 13 074 projected protein-coding genes. The mass spec database (MSDB) 
used was locally installed from http://ftp.ncbi.nih.gov/repository/MSDB/msdb.nam, 
version 20052909.  
2.2.6.3 Mascot output 
The resulting Mascot output from each spectral search was analysed in the 
knowledge that it is the ion scores for the individual peptide matches that are 
statistically significant and that the Mascot programme generates a peptide summary 
report which groups the peptides matched into protein hits. A protein score is 
generated from the combined ion scores of the matched peptides and any protein 
with a score >35 had the protein identification accepted. 
2.2.7 Protein identification from the predicted cat proteins 
The protein hits identified using the predicted proteins from the cat database required 
further processing as the cat genome had not been fully annotated at the time of 
analysis. The full protein sequence from each protein hit was searched against the 
non-redundant protein sequence NCBI (National Centre for Biotechnology 
Information) database using the BLASTp tool which searches the protein databases 
using a protein query. The nucleotide sequence was also obtained from the Ensembl 
assembly using the location and direction specified within the protein hit ID. The 
obtained nucleotide sequence was then subjected to BLASTn search against the 
NCBI nucleotide collection. These steps were then used to assign each protein hit an 
identification. 
2.2.8 Functional categorisation of identified proteins 
The Gene Ontology (GO) terms for biological processes were obtained by 
downloading those available for the annotated genes found on the cat genome from 
Ensembl using the BioMart tool (Durinck et al., 2005).  
  
 
46 
2.3 Results 
2.3.1 Plaque purification of FCV-F9 strains 
To ensure that only one strain of FCV-F9 was being used throughout this study, 
plaque purification was used upon a lab strain of FCV-F9. Three rounds of plaque 
purification were performed and from this three plaques were picked and propagated. 
The resultant viral aliquots were sequenced by RT-PCR to ensure that the virus that 
had been propagated was FCV-F9. Figure 2.1 shows the PCR products produced 
from primers designed to amplify the capsid gene. 
 
 
 
 
 
 
These PCR products were purified and sent for sequencing and once the results 
returned it showed that each plaque purified FCV-F9 virus had 99% identity across 
the capsid region with the published FCV-F9 sequence (Genbank accession number 
m86379) (data not presented). 
To discover how much virus was present in each set of plaque purified aliquots a 
series of viral titrations were performed to produce a 50% tissue culture infective 
dose figure (TCID50). The average titration for plaque A gave a TCID50 = 10
7.41
/50 
µl, plaque B gave a TCID50 = 10
8.15
/50 µl and plaque C gave a TCID50 = 10
8.47
/50 µl. 
Based upon these results it was decided that plaque C should be used in future 
experiments as it gave the highest titre.  
MM Neg Neg Neg B C A MM 
1078 bp 
1353 bp 
603 bp 
872 bp 
Figure. 2.1. PCR products from amplification with capsid flanking primers. Lanes A-C are 
amplified from plaque purified FCV-F9. Lanes labelled Neg are negative controls and lanes 
labelled MM the molecular marker φX174 HaeIII digest. 
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2.3.2 Growth curve 
In order to calculate which time points would be most suitable for 
immunofluorescence and 2D-DIGE analysis a growth curve over 14 h was calculated 
(Fig. 2.2). The results show that rather than the one-step growth curve expected 
using an m.o.i. of 10, a two-step growth curve was seen with a second round of viral 
replication appearing to occur between 10 and 14 h p.i.. It was decided that the best 
course of action was to investigate the host response to the virus during the initial 
round of viral replication and proliferation, therefore, the time points selected for 
immunofluorescence and DIGE investigation were 1, 4, 7 and 10 h p.i.. 
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Figure. 2.2. 14 h growth curve of FCV-F9. Three fractions were taken at each time; 
extracellular virus in media, intracellular virus from cells still adhering to flask 
surface and intracellular virus from cells which had become detached from the flask 
surface. Vertical lines show time points selected for further analysis using 2D-DIGE. 
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2.3.3 Immunofluorescence assay 
In order to visualise the amount of virus present at each of the time points selected 
for 2D-DIGE analysis an immunofluorescence assay was conducted. The results of 
immunofluorescent staining for FCV-F9 capsid protein (Fig. 2.3) show again that not 
all of the cells are infected during the first stage of infection. This may have been 
down to the differences in susceptibility to infection within the cell culture or due to 
inaccuracies in titration. 
 
 
 
Figure. 2.3. Cells stained with anti-FCV-F9 capsid protein antibody and visualised with FITC 
conjugated secondary antibody. The FCV capsid protein is stained in green. White light and 
immunofluorescent channels have been merged in these images.  
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2.3.4 2D-DIGE analysis 
Two biological replicates of infected and mock infected FEA cells at each of the four 
chosen time points (1, 4, 7 and 10 h p.i.) were analysed by 2D-DIGE. The eight 2D 
gels produced were fluorescently scanned and the images were uploaded into the 
DeCyder software for analysis. The gels were processed through the DIA module 
and matched to each other using the BVA module of the software before statistical 
testing could be applied. Each of the protein spots from the infected time points was 
subjected to a student‟s t-test analysis against the mock infected counterparts and an 
ANOVA of all the infected protein spots versus mock infected protein spots. From t-
test and ANOVA analysis it was found that there were 30 spots which were 
significantly (p≤ 0.05) differentially expressed between infected and mock infected 
groups. The location of the picked spots can be seen in Figure 2.4. 
 
 
 
Figure. 2.4. Pick gel showing the positions of the proteins significantly differentially expressed 
during infection with FCV-F9 and assigned spot number. Proteins were resolved by IEF over a 
non-linear pH3-10 range and by molecular weight on a 12.5% acrylamide gel. Staining was 
performed using Sypro Ruby and visualised using an Ettan DIGE imager at an exposure of 
0.800. 
60kDa 
12kDa 
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pH3 pH 10 
Mw 
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Of these 30 protein spots, 14 were identified by LTQ analysis and Mascot searching 
against a cat protein database as described in section 2.2.6.2 (Table 2.4).  
 
 
 
Protein 
Spot No 
Ensembl ID hit  Mascot 
Score 
No of 
peptide 
hits 
Identification Gene ID 
2319 ENSFCAP00000010586  41 2 Filamin-A FLNA 
3032 Scaffold_101245_108936_112
032_-1 
92 6 Beta-actin ACTB 
3129 Scaffold_101245_108936_112
032_-1 
62 4 Beta-actin ACTB 
3351 Scaffold_101245_108936_112
032_-1 
110 4 Beta-actin ACTB 
3357 GeneScaffold_2254_325966_3
33780_1 
100 5 Thrombospondin, 
type I, domain 
containing 4 
THSD4 
3516 Scaffold_101245_108936_112
032_-1 
959 34 Beta-actin ACTB 
3538 Scaffold_101245_108936_112
032_-1 
1447 64 Beta-actin ACTB 
4290 Scaffold_101245_108936_112
032_-1 
334 8 Beta-actin ACTB 
4293 GeneScaffold_2798_18850_78
140_1 
151 12 Solute carrier 
family 22 
 
   - 
4370 Scaffold_101245_108936_112
032_-1 
849 27 Beta-actin ACTB 
4376 Scaffold_101245_108936_112
032_-1 
170 5 Beta-actin ACTB 
4777 ENSFCAP00000008491 45 4 Cyclophilin A PPIA_FEL
CA 
4797 ENSFCAP00000012591 125 7 Transgelin TAGLN 
5074 ENSFCAP00000004426 84 2 Thioredoxin TXN 
 
As the cat database is not fully annotated, the spectra were also interrogated with the 
mass spec database (MSDB) which is a non-identical protein sequence database built 
from a number of primary source databases and as such contains information from a 
number of different species of animal.  Using this approach gave confirmed 
identifications for 11 of the 14 protein spots identified from searching against the cat 
database as well as allowing a further 2 protein spots to be identified. The MSDB 
Table 2.4. Top Mascot identification for the 14 proteins identified via interrogation of the feline 
protein database downloaded from Ensembl. 
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search also offered some alternative identifications for some of the protein spots. For 
example spots 3516 and 3357 show very strong hits for vimentin from searches 
against the MSDB.  The full table of identifications and Mascot scores can be found 
in Appendix I. 
DeCyder also allows the user to calculate average ratio of the spot intensity between 
groups, Figure 2.5 shows the results of comparing the infected spots at each time 
point with their mock infected counterparts. 
 
 
 
Comparison with the mock infected counterparts show that of the picked spots, none 
were consistently up- or down-regulated in infected cells across the four time points. 
There were nine spots that showed changes in the later stages of infection; 2319, 
3032, 3351 and 3503 all showed a trend of changing from a down-regulated presence 
of proteins in infected cells to an up-regulation at 7 or 10 h p.i..  Unfortunately there 
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Figure 2.5. Graph showing average ratios of picked spots in infected samples at each time point 
versus uninfected controls. Protein identifications shown are top Mascot hit for each spot number. 
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were no database hits for spot number 3503 but spot number 2319 was identified as 
filamin A from MSDB searching and spots 3032 and 3351 were both found to be 
actin. The up-regulation of actin and filamin A in the latter stages of infection could 
indicate that the virus needs these proteins in order to aid replication and egress from 
the cell. Further implications of these finding will be discussed in section 2.4. 
Spot numbers 2775, 3174, 3516, 3538, 3991, 4370, 4797 and 5074 all show the 
opposite trend where the proteins appear to be up-regulated early in infection and 
then become down-regulated in the latter stages.  Of these eight protein spots, three 
had no identification hits against either database searched and the other five were all 
found to have multiple identifications. Within these multiple identifications actin 
was identified within four of the modulated host protein spots, suggesting that this 
protein and its derivatives undergo extensive remodelling during infection with FCV. 
This fluctuation in expression can be observed in Figure 2.6, which shows a 3D 
representation of spot number 3538, a protein spot found to include actin. This 
graphic representation shows the up-regulation of the protein in infected cells at 1 h 
p.i. and subsequent down-regulation in the cells at 4-10 h p.i.. 
 
 
Figure 2.6. 3D modelling of protein expression, calculated within the DeCyder software from 
intensity of fluorescent protein labels from 2D-DIGE. The output shown has been calculated for 
spot number 3538, identified as a mixture of actin, roundabout axon guidance receptor and 
peroxiredoxin-2. 
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There are also a number of spots in which the amount of protein seems to fluctuate 
over the course of infection. Spot numbers 1084, 3129, 3357, 3595, 3881 and 4924 
all show signs of up-regulation at 1 h and 10 h p.i. but are down-regulated during the 
middle phases of infection. Again these protein spots are a mixture of those without 
identification and those with multiple identifications making them difficult to 
analyse, however, once again actin was found within two of these modulated host 
protein spots.  
2.3.5 Gene Ontology 
In order to assign some functional information to the proteins identified from 
searching against the cat database, the BioMart tool from Ensembl was used to 
download a full list of biological processes attributed to the proteins by the Gene 
Ontology (GO) project. Each GO term generated was manually curated into broad 
definition groupings and a chart constructed (Fig. 2.7).  
 
0% 2% 4% 6% 8% 10% 12% 14% 16% 18% 20%
Transport (2%)
Transcription (5%)
Signalling (5%)
Response to stress (2%)
Response to external stimulus (1%)
Response to chemical stimulus (3%)
Regulation of viral reproduction (2%)
Regulation of biological process (2%)
Protein modification (5%)
Protein localisation (5%)
Organelle organisation (1%)
Metabolic process (10%)
Immune response (3%)
Homeostasis (5%)
Extracellular structure organisation (1%)
Developmental process (16%)
Cytoskeletal (19%)
Cell proliferation (4%)
Cell migration (2%)
Cell cycle (2%)
Cell adhesion (3%)
Apoptosis (5%)
Fig. 2.7. Gene Ontology analysis of the biological processes of the proteins found to be 
differentially expressed in response to FCV-F9 using 2D-DIGE. 
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The breakdown of biological process analysis shows that there appears to be a large 
representation of proteins with a cytoskeletal role within the cell, almost one in five 
of the functions attributed to this protein set are from the cytoskeletal area. There are 
also a large amount of functions attributed to developmental processes within the cell 
and also metabolic mechanisms with these making up over a quarter of the processes 
found. There are also a number of functions which may be directly related to the 
viral infection such as those proteins with an immune response function and those 
which have been found to regulate viral reproduction within the cell.  
2.3.6 Cytoskeletal proteins 
Throughout the analysis of the differentially expressed proteins found in this 2D-
DIGE experiment it has become clear that cells infected with FCV are undergoing 
profound changes to their cytoskeletal function. Actin appears as an identification in 
11 of the 16 modulated proteins and there are also multiple hits for other cytoskeletal 
proteins such as vimentin, tubulin, desmin and lamin. The implications of 
modification of these proteins will be investigated further in section 2.4 but it was 
clear from these results that further examination of the interactions of the virus and 
these cytoskeletal proteins was needed. 
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2.4 Discussion 
Interrogation of cells infected with FCV-F9 using 2D-DIGE technology suggests 
that infection causes a number of proteins to be differentially expressed. These 
changes may be a direct result of the virus manipulating the cell machinery in order 
to replicate or it may be due to a number of different factors such as a cellular 
response to infection or cellular degradation. 
FCV has been shown in previous studies to induce apoptosis within the cell from 6-8 
h p.i. (Natoni et al., 2006) and as such the proteins found to be down-regulated at 7 
and 10 h p.i. in the 2D-DIGE experiment may be as a result of programmed cell 
death. 11 of the 30 protein spots were found to be down-regulated at the latter stages 
of infection and may be a result of apoptotic degradation; however, there are also 14 
protein spots up-regulated at 10 h p.i. which suggests that not all cellular proteins 
were being broken down at this point.  
Within the whole comparison of infected and mock infected cells across the 
experimental time course the greatest proportion of differentially expressed proteins 
had cytoskeletal functions. There are three different types of cytoskeletal component; 
microfilaments, microtubules and intermediate fibres. Microfilaments are mostly 
made up of actins, microtubules consist of tubulins and intermediate fibres include 
vimentin and keratin (Sodeik, 2000). Within the identifications obtained from the 
modulated protein spots in this experiment, there were numerous hits to actin, 
tubulin and vimentin which suggests that the entire cytoskeletal system is important 
in FCV infection.  
Actin is an important cellular component involved in cellular motility, movement of 
vesicles and organelles around the cell, cellular division and maintenance of cellular 
shape. The microfilaments, especially actin, have been found to be essential in 
infection with a large range of viruses with both human and animal hosts. Vaccinia 
virus from the pox virus family has been shown to use actin to promote cell-to-cell 
spread and replication (Cudmore et al., 1995) by stimulating actin tail formation 
beneath virions to move around the cell and through the formation of actin 
projections to contact neighbouring cells. Herpesviruses have also been shown to use 
actin to promote viral spread (Gill et al., 2008) by polymerising actin to produce 
branches from the plasma membrane to provide a network along which the virions 
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can move and transmit cell-to-cell. Treatment with actin inhibitors has also been 
shown to reduce viral replication in cells infected with a virus from the α-herpesvirus 
family (Kuhn et al., 2005), canine distemper virus (Klauschies et al., 2010) and 
influenza A (Arcangeletti et al., 2008) which would suggest that the actin network is 
vital for efficient viral replication in wide range of viruses and hosts.  
The microtubules and microfilaments have also been found to have a role to play in 
cellular movement of virions around the cell. Tubulin has been shown to be 
necessary for movement of the viral nucleocapsid of hantaviruses through the cell to 
the golgi region (Ramanathan & Jonsson, 2008) and for hepatitis C entry into the cell 
(Roohvand et al., 2009). Vimentin is also very important in viral infection and it has 
been shown in dengue virus infection (Chen et al., 2008) that if the vimentin 
network is disrupted it significantly affects viral replication whereas disruption of the 
microtubule network did not. With vaccinia virus infection it has been shown that the 
manipulation of the microtubule and microfilament networks has an effect on the cell 
morphology throughout the course of infection (Schepis et al., 2006). In the early 
phase of infection the cells are seen to become rounded as microtubules retract from 
the periphery of the cell and vimentin is found to retract around the nucleus. By the 
latter stages of infection the cells reflatten and become branched at the periphery. 
This has been shown to be as a result of microtubules re-entering the peripheral 
regions and extending into protrusions which has been shown to coincide with actin 
tail formation and viral egress. Calculations show that without the use of a cellular 
transport system a vaccinia virion would take 5.7 h to move 10 µm by diffusion 
alone (Sodeik, 2000) and so it would seem that the use of host cytoskeletal networks 
are vital.  
The evidence from these findings would suggest that one hypothesis for the 
modulation of so many host cytoskeletal proteins in this 2D-DIGE experiment is that 
FCV requires these proteins for movement around the cell as well as entry and exit.  
Cyclophilin A was another protein to be identified in multiple protein spots within 
this experiment and in cells has a protein folding function which may be useful to 
FCV during replication. It is also found to associate closely with human 
immunodeficiency virus type 1 (HIV-1), becoming incorporated into the HIV-1 
virions (Franke et al., 1994) and having a role in HIV-1 attachment to target cells 
(Saphire et al., 2000). This is unlikely to be occurring in FCV infection but it is 
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useful to remember that the link between host proteins and viruses can be essential in 
viral replication.  
The use of 2D-DIGE as a means to compare proteomes from different infection 
states gives a good first impression of the differences in protein expression between 
the cellular proteomes. However, it is not a perfect technique. 2D-DIGE separates 
the proteins from the lysed cells using 2D gel electrophoresis which is a hydrophilic 
method of separation which prevents hydrophobic proteins such as membrane 
proteins from entering the gel and being analysed. There has also been some 
evidence uncovered that using 2D gels to separate proteins for identification of 
differentially expressed proteins can lead to similar proteins being found as 
modulated (Petrak et al., 2008). It is therefore important to ensure that the proteins 
identified as differentially expressed within a 2D-DIGE experiment are confirmed 
using alternative methods. Alternative methods for quantitating protein expression 
without using gels for separation are available such as SILAC (stable isotope 
labelling by amino acids in cell culture) coupled with off-gel separation (Ong et al., 
2002). SILAC uses cell lines grown in media depleted of a key amino acid but 
supplemented with an isotope labelled form of the missing amino acid ensuring that 
the proteins found inside the cells are labelled with the isotope. The labelled cells 
can then be compared to an unlabelled set of cells that have been infected/mock 
infected as necessary through mass spectrometry by comparing the amount of 
labelled and unlabelled protein in the samples. This kind of comparison should allow 
whole cell proteomes to be interrogated without losing proteins during separation. 
Another method currently in use which allows absolute quantitation of proteins 
within a sample is QconCAT which is a technique which employs specifically 
synthesised proteins to absolutely quantitate proteins from samples (Pratt et al., 
2006). The QconCAT itself is a concatamer of tryptic peptides from a number of 
proteins which are labelled with a stable isotope and added to the protein mixture of 
interest in known quantities. The proteins found within the mixture of interest can 
then be analysed by mass spectrometry and compared to the labelled QconCAT 
peptides to discover the amount of protein in the sample.  
Another issue confronted during this 2D-DIGE analysis was the difficulties 
encountered using a non-model genome. As the cat genome is currently only at 
1.97x coverage and annotation has been completed through cross-referencing against 
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six other genomes (Pontius et al., 2007) the protein database used to compare the 
mass spectrometry outputs does not contain the full set of proteins found in the cat. 
In this analysis it has lead to 14 out of the 30 modulated host proteins remaining 
unidentified as the reference database did not contain enough information to provide 
accurate identification when the mass spectrums were searched against it using 
Mascot.      
The overall results from the 2D-DIGE experiment conducted in this chapter have 
shown evidence of the modulation of a number of proteins within the host cell 
proteome as a consequence of infection with FCV-F9. The stand out group of 
proteins affected by infection appear to be the cytoskeletal proteins and while there 
is evidence from the literature that this association may be common within viral 
infections the results of the 2D-DIGE experiment are not conclusive. It was therefore 
necessary to investigate the association using other methods to confirm the effects, 
the results of which will be reported in chapter 4. 
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3 Chapter three 
Investigation of in vitro pathogenesis of different strains of FCV 
including a putative virulent strain 
3.1 Introduction 
In the previous chapter (chapter 2), the in vitro pathogenesis of a single strain of 
FCV was investigated by 2D-DIGE. However, it is difficult to state that this is a 
definitive analysis for FCV infection. As a plus strand RNA virus, FCV has a 
genome with a great plasticity and this leads to a wide range of strains being 
exhibited within populations, therefore using a single strain within an analysis may 
lead to conclusions being drawn that do not hold true across a number of strains.  
3.1.1 FCV strain variability 
With the positive strand RNA genome offering FCV a high mutation rate (Drake, 
1999), there are a number of strains in circulation within the general cat population 
(Sato et al., 2002) and also within populations found in rescue shelters (Bannasch & 
Foley, 2005; Radford et al., 2001) and private cat colonies (Radford et al., 2003). 
These colonies and rescue shelters also appear to offer optimal conditions for strain 
evolution with a large population of cats in confined spaces allowing natural strain 
diversification (Radford et al., 2003). Longitudinal analysis with endemically 
infected cat colonies has confirmed this (Coyne et al., 2007). In addition, such high 
prevalence colonies provide the ideal environment for both mixed infections and 
viral genome recombination (Coyne et al., 2006c).  
3.1.2 Diversity of FCV clinical signs 
With the large degree of viral diversity found within cat populations, it might be 
expected that strains act differently within the cat and cause cats to exhibit different 
clinical signs during infection. This assumption proves to be true, with FCV being 
associated with a number of patterns of disease including upper respiratory tract 
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disease, chronic stomatitis, limping syndrome and a virulent systemic disease 
(Radford et al., 2009; Radford et al., 2007).  
Upper respiratory tract disease (URTD) is found to be the most widely reported sign 
of FCV infection and is usually a relatively mild condition with a low mortality rate. 
Cats presenting with FCV induced URTD usually show signs of ocular and nasal 
discharge, pyrexia, anorexia, lethargy and ulceration of the oral mucosa and tongue 
(Cai et al., 2002; Povey, 1974).  
FCV is also associated with acute arthritis which can cause the limping syndrome 
sometimes observed in infected cats and these limping effects have been recreated 
experimentally (Dawson et al., 1994; TerWee et al., 1997). A link between FCV and 
chronic stomatitis, a condition typified by chronic ulcerative lesions in the gingival, 
fauces and sometimes the cheeks and tongue, has been implied in a number of 
studies (Healey et al., 2007; Knowles et al., 1989; Poulet et al., 2000; Waters et al., 
1993). 
Recently, another set of more severe symptoms have been reported with FCV 
infections in the UK (Coyne et al., 2006c), USA (Hurley et al., 2004; Pedersen et al., 
2000; Schorr-Evans et al., 2003), and France (Reynolds et al., 2009). These 
outbreaks have been termed virulent systemic disease (VSD) due to the systemic 
nature of the clinical signs associated with these highly virulent strains of FCV (VS-
FCV). Cats with VSD present variably with high fever, facial and limb oedema, 
depression, anorexia, sores on the face, pinnae and feet, pancreatitis and hepatic 
necrosis. The mortality rate associated with these virulent systemic strains of FCV 
are also very high, with up to 50% of the cats affected dying or being euthanised. 
3.1.3 Genotypic and phenotypic strain markers 
Attempts have been made to sub-classify FCV strains, or to find markers associated 
with the different clinical signs, especially for the hypervirulent VSD strains. Virus 
neutralisation tests have been developed in an attempt to categorise strain based on 
antibody neutralisation capabilities (Dawson et al., 1993a; Knowles et al., 1989; 
Poulet et al., 2000). These studies have shown that while a lot of the virus strains 
react similarly to the sera and cannot be typed in this way, there are occasions where 
strains associated with specific clinical signs, especially chronic stomatitis, group 
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separately according to virus neutralisation tests. This was suggested to be a 
reflection of the chronic nature of this condition, providing an opportunity for 
viruses in such cats to evolve away from host immunity (Dawson et al., 1993b; 
Poulet et al., 2000). Enzyme-linked immune-flow-assays (ELIFA) using monoclonal 
antibodies have also been used in an attempt to differentiate FCV strain (McArdle et 
al., 1996). However, whilst strains were able to be differentiated these did not reflect 
their clinical origins. 
There have also been numerous attempts to sequence various regions of the genome 
to try to identify specific mutations that alter the nature of the strains (Abd-Eldaim et 
al., 2005; Geissler et al., 1997; Glenn et al., 1999; Ossiboff et al., 2007). They have 
all found that whilst all the strains are different from one another, the sequences do 
not phylogenetically cluster according to the disease state they originated from, nor 
have consistent mutations been identified in hypervirulent strains.   
Ossiboff et al, 2007, have managed to find one potential marker of hypervirulent 
strains. They found that when the VSD strains were grown in cell culture at a lower 
m.o.i. which allows for multiple rounds of viral replication, the VSD strains grew at 
a significantly quicker rate than the typical FCV strains included in comparison. This 
finding was consistent for the three VSD strains analysed versus three typical FCV 
strains including FCV-F9, suggesting that in vitro growth rate could act as a 
diagnostic marker for virulence. Such assays are however, difficult to perform and 
not easy to standardise between laboratories. 
3.1.4 Aims 
The aim of this study was to further explore the effects of FCV infection with 
differing strains of virus upon the host cell proteome in cell culture. By using diverse 
strains from cats with a range of clinical diseases (a potentially hypervirulent strain, 
a typical FCV strain, a chronic stomatitis strain and vaccine strain), we aimed to 
characterise the diversity of the proteomic response to infection and to identify any 
potential host cell protein markers associated with virulence.  
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3.2 Materials and methods 
3.2.1 Viral strains 
Several approaches were used to identify the FCV strains to be used for subsequent 
proteomic analysis using 2D-DIGE. To capture the range of clinical disease 
associated with FCV infection, FCV-F9 (Bittle & Rubic, 1976; Bittle, 1960) was 
included again and also LS015 (Knowles, 1988). FCV-F9 is a vaccine strain often 
used in yearly boosters given to cats. LS015 is a virus isolated from a cat suffering 
from chronic gingivostomatitis and has anecdotally been known to always grow to 
high titre in cell culture. At the time of writing, no known VSD-causing strain was 
available to the author; therefore, we used a putative hypervirulent strain isolated 
from a cat with clinical signs and pathology consistent with VSD (Coyne et al., 
2006b). However, it is important to note that formal proof that this strain causes 
VSD in the form of an experimental infection has not been satisfied. In addition to 
this putative hypervirulent strain, we had access to several other strains available 
from the same rescue shelter (Coyne, 2005), that were isolated from clinically 
normal cats (strains R560-R602, Fig. 3.1). 
3.2.2 Genetic diversity 
It has previously been shown that FCV-F9, LS015 and UKOS-A represent 
genetically distinct strains (Coyne et al., 2006b; Glenn et al., 1999). We have also 
shown that R591 is genetically distinct from UKOS-A, whereas R580 and R581 
represent variants of the UKOS-A strain having recently shared a common ancestor 
(Coyne, 2005) and Fig. 3.1. 
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3.2.3 Growth in cell culture  
Previous work (Ossiboff et al., 2007) has shown that there are differences between 
the virulent systemic strains of FCV and other more typical FCV isolates. 
Specifically that VSD causing strains of FCV grow more efficiently under multiple-
cycle growth conditions and show cytopathic effects earlier than in cells infected 
with non-VSD strains of FCV. Therefore, in order to further characterise the strains 
in this study, growth curves were also carried out.   
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Figure. 3.1. Phylogenetic analysis of FCV polymerase gene sequence obtained from a rescue 
shelter involved in the suspected outbreak of VSD-FCV in the UK. This figure is reproduced 
from Coyne (2005). Viruses selected for analysis within this chapter are R581, R580, R591 
and UKOS-A. 
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3.2.3.1 Experimental design 
The six viral strains selected were used in constructing growth curves over 40 h at 
two incubation temperatures; 37˚C the temperature typically used to culture FCV 
and 39˚C, the natural body temperature of a cat, to discover whether temperature had 
any effect on the growth kinetics.  
The six viral strains used were UKOS-A (Coyne et al., 2006b), R591, R581, 
R580(Coyne, 2005), LS015 (Knowles, 1988) and FCV-F9 (Bittle & Rubic, 1976; 
Bittle, 1960). Passage numbers for UKOS-A, R591, R581 and R580 were all less 
than 5 with FCV-F9 and LS015 having unknown, high passage histories. 
3.2.3.2 Infection plan 
16 x 24-well plates of confluent FEA cells were infected with an m.o.i. of 10 for 
each viral strain (four wells per strain) with 50 µl being added to each well. Eight 
plates were then incubated at 37°C and stopped by freezing at -80°C at 4, 8, 12, 16, 
20, 24, 32 and 40 h p.i.. A further eight plates were incubated at 39°C and stopped in 
the same way at 4, 8, 12, 16, 20, 24, 32 and 40 h p.i.. Two more 24-well plates were 
also mock infected with MM and incubated at 37°C and 39°C to control for possible 
laboratory contamination. 
Each plate was freeze-thawed at -80˚C and the contents of the four wells from each 
virus were combined for each time point and temperature, centrifuged at 2000 × g to 
pellet the debris and then the homogenate was titrated using methods previously 
described (section 2.2.1.3) alongside the mock infected controls. 
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3.2.4 2D-DIGE analysis of the effects of four strains of FCV upon 
the host cell proteome 
As a further study into the effects FCV has upon the host cell proteome a 2D-DIGE 
comparison was performed upon cells infected using multiple strains of FCV. 
3.2.4.1 Viral strains and cell culture 
For each viral strain chosen for proteomic analysis two x 75 cm
2
 flasks were infected 
with a 1 ml aliquot of each virus strain and two x 75 cm
2
 flasks were mock infected 
with 1 ml of MM. The flasks were then frozen at -80°C 4 h p.i. and thawed the 
following day to allow for cell scraping. The scraped cells were collected in a 
centrifuge tube and pelleted at 2000 × g at room temperature for 10mins before the 
supernatant was discarded and the cell pellet stored at -20°C until lysis.  
3.2.4.2 2D-DIGE analysis 
The cell pellets were lysed in 500 µl of lysis buffer (30 mM Tris, 2 M Thiourea, 7 M 
Urea, 4% CHAPS) plus 10 µl DN/RNases and 5 µl of protease inhibitors. The 
samples were then treated as before (section 2.2.5.2) by freeze-thawing and removal 
of salts via the 2D-clean up kit (GE Healthcare). The protein pellet was resuspended 
in 2x sample buffer (2 M Thiourea, 7 M Urea, 2% CHAPS) before determining the 
protein concentration of each sample by a Bradford method based protein assay 
(Biorad Protein Assay) (Bradford 1976). The concentration of each sample was 
adjusted to 5 µg/µl using 2x sample buffer and the pH checked and adjusted to 
between 8 and 9 if necessary. The samples were CyDye labelled according to the 
manufacturer‟s instructions as previously described (section 2.2.5.4) and the labelled 
samples combined in the following order for isoelectric focussing (IEF) (Table 3.1). 
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Once the appropriate samples were combined into 1.5 ml eppendorfs an equivalent 
volume of rehydration solution (2x sample buffer plus 5 µg/ml pH 3-10 IPG buffer 
(GE Healthcare) and 10 mg/ml DTT) was added to each and the samples were 
prepared for rehydration loading by vortexing and leaving on ice for 10 min. More 
rehydration buffer was added to each eppendorf to make the volume of solution up to 
450 µl and this was added to a pH 3-10 24cm IPG strip in a reswelling tray, covered 
with 3-4 ml of DryStrip cover fluid and left to rehydrate overnight.  
IEF was performed using the Ettan IPGphor II (GE Healthcare) at 30 v for 5 h, 500v 
for 1 h, 100 v for 1 h, 8000 v for 2 h and 8000 v for 9 h with current limited to 50 
µA/strip. The focussed strips then had to be equilibrated as described previously 
(section 2.2.5.5) firstly in 10 ml SDS equilibration buffer (2% SDS, 50 mM Tris-HCl 
pH8.8, 6 M urea, 30% (v/v) glycerol, 0.002% bromophenol blue) with 10 mg/ml 
DTT for 15 min to reduce the protein and then for 15 min in 10 ml SDS equilibration 
buffer with 25 mg/ml iodoacetamide to alkylate the cysteine residues.  
The second dimension was carried out using a manually cast 12.5% polyacrylamide 
gel as previously described (section 2.2.5.5) and the equilibrated strips were laid on 
top of the gels and sealed in with an agarose sealing solution (0.5% (w/v) agarose, 
trace bromophenol blue). The gels were at 5 W per gel for 30 mins and then adjusted 
to 17 W per gel for 4 h in an Ettan DALTsix electrophoresis unit (GE Healthcare).  
Once the gels were run they were scanned immediately in an Ettan DIGE imager set 
at 100 pixels and 0.800 exposure on all 3 CyDye channels. After scanning, the prep 
Gel number Cy2 Cy3 Cy5 
1 Standard F9_a R591_b 
2 Standard R591_a LS015_b 
3 Standard Mock_ a UKOS-A_b 
4 Standard LS015_a Mock_b 
5 Standard UKOS-A_a F9_b 
6 Prep Gel 
Table 3.1. Experimental design for DIGE performed on samples infected with four strains of 
FCV.  
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gel was fixed overnight in 40% methanol, 10% acetic acid then stained overnight in 
Sypro Ruby stain (Invitrogen) with gentle agitation. Before scanning again the gel 
was washed for an hour in 10% methanol, 7% acetic acid then rinsed twice in ddH2O 
before scanning in the Ettan DIGE imager under Sypro Ruby conditions at the same 
exposure as before. 
DeCyder analysis was carried out as described previously (section 2.2.5.7) with the 
following parameters to eliminate dust particles from inclusion in analysis; max 
slope >2.81, max area <179, max volume <6949. The spot maps were subject to 
strain-to-strain student t-test analysis and infected vs. uninfected student t-test 
analysis. All spots which were found to have a p-value ≤0.05 were selected for spot 
picking. 
The spot picking was performed automatically as before (section 2.2.5.8) using the 
Ettan spot picker and the gel plugs tryptically digested using the same protocol 
(section 2.2.5.9). The resulting digests were all analysed using HPLC MS/MS under 
the same conditions as previously described (section 2.2.6.1). 
MASCOT searching was performed on the resulting spectra as previously described 
(section 2.2.6.2). 
3.2.4.3 Functional categorisation of identified proteins 
 The GO terms for biological processes were obtained by downloading those 
available for the annotated genes found on the cat genome from Ensembl using the 
BioMart tool as described in section 2.2.8. 
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3.3 Results 
3.3.1 Viral growth curves 
In order to discover whether the putative virulent strain isolated during the UK 
outbreak of virulent systemic FCV disease in the UK shares the same phenotypic 
growth patterns as other characterised virulent FCV strains (Ossiboff et al., 2007) 
growth curves were constructed. The resulting growth curves at 37˚C and 39˚C are 
shown in Figures 3.2 and 3.3. The two temperatures were used as although all cell 
culture for feline cell lines is performed at 37˚C, the actual body temperature of a cat 
is 39˚C. Both temperatures were analysed in case the growth characteristics of the 
stains were different at the two temperatures.  
Both of the growth curves show a similar pattern with LS015 growing to the highest 
titre at 37˚C and 39˚C, while strain R591 appeared to grow to a lower titre than the 
other FCV strains at most time points and at both high and low temperatures. These 
growth curves also show two peaks in TCID50 indicating that each of the virus 
strains underwent two rounds of replication over the 40 h of incubation. There does 
appear to be a difference in the rate of growth of the viruses at the two temperatures. 
At 37˚C (Fig. 3.2) each of the virus strains reaches the first peak in titre between 16 
and 20 h p.i. whereas at 39˚C (Fig. 3.3) this peak is reached much earlier with all 
strains peaking at 12 h p.i..  
The putative hypervirulent strain UKOS-A does not show in vitro characteristics 
which can be characterised separately from the other strains within the growth curve 
experiment, it does not grow to the highest titre at either 37˚C or 39˚C and does not 
reach peak titre any quicker than the other FCV strains grown.  
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Figure. 3.2. Graph showing growth curves of six strains of FCV growing in FEA cells incubated 
at 37˚C sampled at 8 time points between 0 and 40 h p.i.  
Titre peak 
FCV-F9 
R  
R58  
R  
UKOS-A 
L  
Figure. 3.3. Graph showing growth curves of six strains of FCV growing in FEA cells 
incubated at 39˚C sampled at 8 time points between 0 and 40 h p.i.  
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3.3.2 2D-DIGE analysis of the effects of four strains of FCV upon 
the host cell proteome 
As a result of the genetic phylogeny and growth curve analysis, four strains were 
selected to have their effects upon the host cell proteome analysed by 2D-DIGE at 
37°C.  Namely FCV-F9 (vaccine strain, lab attenuated), LS015 (isolated from a cat 
with chronic stomatitis and had the highest titre in the growth curves), UKOS-A 
(isolated from a possible case of VSD and had intermediate titre on growth curves) 
and R591 (isolated from the same colony as UKOS-A but from a clinically healthy 
cat, is genetically distinct to UKOS-A and had low titres in cell culture). 
3.3.2.1 Protein identifications 
The six gels produced for 2D-DIGE analysis were scanned and uploaded into the 
DeCyder software for gel to gel matching and analysis. From the protein statistic 
examinations (t-test and ANOVA) performed in the BVA module of DeCyder 131 
host proteins were found to be significantly differentially expressed and were picked 
and tryptically digested. Of these 131, 61 proteins were successfully identified by 
HPLC coupled ESI-MS/MS and Mascot ion searches and the positions of the 
successfully identified protein spots are shown in figure 3.4. The full list of protein 
identifications can be found in Appendix II. 
 
pH3 pH10 
60kDa 
30kDa 
17kDa 
95kDa 
Mw 
Figure. 3.4. Pick gel showing the positions of the proteins significantly differentially expressed during 
infection with FCV-F9, LS015, UKOS-A and R591with assigned spot number. Proteins were resolved by IEF 
over a non-linear pH3-10 range and by molecular weight on a 12.5% acrylamide gel. Staining was performed 
using Sypro Ruby and visualised using an Ettan DIGE imager at an exposure of 0.800. 
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The BVA module was also used to calculate average ratios between proteins from 
cells infected with each of the four strains and the proteins from the mock infected 
control cells. Within the proteins identified 16 were consistently up-regulated and 
three consistently down-regulated in the cells infected with each of the different 
strains of FCV (Fig 3.5 and Table 3.2). 
 
Spot 
number 
Identification(s) Modulation 
2551 elongation factor Tu GTP-binding domain-containing protein 1, 
ubiquitin-conjugating enzyme E2O 
+ 
2758 protein kinase C substrate 80K-H - 
3235 laminin alpha 1 + 
3292 Obscurin, laminin alpha 1, albumin + 
3612 Chaperonin, vimentin, protein tyrosine phosphatase, Heat shock 
protein 60 
+ 
3839 Obscurin, Cytochrome b, Putative glycine-rich RNA-binding 
protein 2, Myosin a tail domain interacting protein mtip 
+ 
3892 Actin, eukaryotic translation initiation factor 3, Cytochrome b + 
4104 cathepsin d precursor, sulfate ABC transporter, Lamin-A + 
4985 annexin A2, ATP synthase beta subunit + 
5105 annexin A1, Sodium channel protein type XI alpha, Lipocortin-
1 
- 
5106 voltage-dependent anion channel 2, annexin A2, intestinal cell 
kinase 
+ 
5456 Obscurin, multiple C2 and transmembrane domain-containing 
protein 1 
+ 
5806 multiple C2 domains, transmembrane 1, ATP synthase beta 
subunit 
- 
6113 multiple C2 domains, transmembrane 1 + 
6440 Peptidase, beta-lactoglobulin, sorcin + 
7732 alpha 2 macroglobulin + 
Table 3.2. Identifications of proteins consistently up- or down-regulated in FEA cells 
infected with all FCV strains. Consistent up-regulation in infected cells is indicated with 
green highlight/+. Consistent down regulation infected cells is indicated with red highlight/-. 
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Figure 3.6 shows an example of the 3D modelling provided by the DeCyder software 
used to analyse relative protein abundance for spot number 3612. This modelling 
illustrates the up-regulation in expression of the proteins identified within this spot 
(chaperonin, vimentin, protein tyrosine phosphatase and heat shock protein 60) in 
response to infection with each of the FCV strains studied when compared to the 
mock infected control. 
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Figure 3.5. Graph showing 16 proteins consistently up- and down-regulated in response 
to all four FCV strains at 4 h p.i.. Protein identifications shown are top Mascot hit for 
each spot number. 
Figure 3.6. 3D modelling of protein expression, calculated within the DeCyder software from 
intensity of fluorescent protein labels on 2D-DIGE gels. The output show has been calculated 
for spot number 3612 which was consistently up-regulated in infected cells and was identified 
as a mixture of chaperonin, vimentin, protein tyrosine phosphatase and heat shock protein 60. 
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As these host proteins are consistently modulated in the same way by all four FCV 
strains examined it could be assumed that these proteins are in some way essential to 
viral replication within the cell. The significance of these proteins in terms of viral 
propagation will be discussed in section 3.4.2.  
There are also possible signs of the putative virulent UKOS-A strain acting in a 
different way to the other three virus strains examined. For 14 of the 62 proteins 
identified, infection with UKOS-A causes these proteins to be down-regulated when 
compared to the mock infected control; whereas the other three viruses cause these 
proteins to be up-regulated (Table 3.3 and Fig. 3.7).  
 
Spot 
number 
Identification(s) 
2954 Lamin a/c, dihydrolipoamide S-acetyltransferase, calsyntenin 2 
3256 Obscurin 
3289 Lamin a/c 
3389 Lamin a/c 
3777 Mitochondrial ATP synthase, vimentin, protein disulphide isomerase 
associated 6, desmin, cathepsin d, actin 
4256 Lamin a/c 
4270 Lamin a/c 
4271 Peptidase, sortilin-related receptor, lamin a/c, envelope glycoprotein 
syncytin-B, pleckstrin and Sec 7 domain containing 2 
4852 Annexin A1/A2 
4859 Annexin A1/A2, acidic ribosomal phosphoprotein P0 
4869 ATPase, Annexin A1 
5666 Prohibitin, actin 
7246 40S ribosomal protein S14 
7401 Myosin 
Table 3.3. Identifications of proteins down-regulated in FEA cells infected with UKOS-A 
and up-regulated in the remaining three strains when compared to mock infected cells.  
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Within this group of proteins are some identifications which appear in the list more 
than once such as lamin a/c and annexin A1/A2. It is possible that the putative 
virulent strain is modulating these proteins in a different manner to the other 
„typical‟ FCV strains and these could be a marker of virulent systemic disease. The 
significance of these differences in protein expression will be discussed further in 
section 3.4.2.  
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Figure 3.7. Graph showing 14 proteins down-regulated in the FEA host cell in response 
to UKOS-A infection but up-regulated in the response to the other FCV strains at 4 h p.i.. 
Protein identifications shown are top Mascot hit for each spot number. 
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Figure 3.8 shows the average ratio of the remaining 31 modulated host cell proteins 
in comparison to the mock infected cells and this graph shows that there is a 
complex pattern of protein expression in response to infection. In the case of spot 
number 5676, the obscurin protein appears to be greatly down-regulated in response 
to three of the strains. However, it became up-regulated in response to LS015 which 
is a marked difference within the modulation of this protein. The 60S ribosomal 
protein (6970) also showed a marked difference in modulation in the response to 
infection with the strains examined as it had a large up-regulation during UKOS-A 
infection but a large down-regulation during the infection with LS015. The 
implications of these inconsistencies will be discussed in section 3.4. 
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Figure 3.8. Graph showing expression for the remaining 31 identified proteins relative to the mock infected control at 4 h p.i.. Protein identifications shown are 
top Mascot hit from searching the feline database for each spot number. 
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3.3.2.2 Gene Ontology analysis 
The biological processes assigned from the Gene Ontology (GO) project to each of 
the annotated genes on the cat genome were downloaded from the Ensembl website 
and the identified protein set was interrogated against it. Each GO term found was 
manually curated into broad definition terms and a chart was constructed (Fig. 3.9). 
 
  
0% 1% 2% 3% 4% 5% 6% 7% 8% 9%
Vesicle fusion (3%)
Transport (7%)
Translation (4%)
Transcription (2%)
System process (1%)
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Response to chemical stimulus (1%)
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Immune response (2%)
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Cytoskeletal (6%)
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Cell cycle (3%)
Cell adhesion (2%)
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Figure 3.9. Gene Ontology analysis of the biological processes of all 61 proteins found to be 
differentially expressed in response to infection with FCV-F9, UKOS-A, R591 and LS015 using 
2D-DIGE. 
.  
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This breakdown of the biological processes of the proteins identified shows a similar 
pattern to that constructed from the 2D-DIGE analysis of a time course of infection 
(chapter 2). There are a large proportion of proteins which have a function in 
metabolism, developmental processes and regulation within the cell. There are also a 
number of proteins which have a cytoskeletal role present again in the list. Although 
these are less abundant than in the previous 2D-DIGE analysis, there are enough 
present in the identifications and functional categorisation to suggest that further 
examination of the effect of viral infections upon the cellular cytoskeleton is needed.  
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Figure 3.10. Gene Ontology analysis of the biological processes of the 14 proteins found to be 
down-regulated in response to UKOS-A infection but up-regulated in response to infection with 
the other three FCV strains analysed. 
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A further breakdown of biological processes was performed for those proteins found 
to be modulated differently in response to infection with the UKOS-A strain 
compared to the other three viral strains (Fig 3.10). The chart shows that the majority 
of these proteins have regulatory functions such as involvement with metabolism, 
transport and biological processes. Within this subset of proteins there is also a larger 
proportion involved in organisation of the nucleus with the percentage involved 
rising to 8% from 3% in the functional analysis of all modulated proteins (Fig 3.9). 
This may be expected as 6 of the 14 proteins found within this grouping have been 
identified as lamins, which are known to be a key component in the structure of the 
nucleus and as such will be involved in nuclear organisation.   
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3.4 Discussion 
The results from the viral growth curves showed that under both temperature 
conditions the UKOS-A strain of FCV does not grow to a higher titre or significantly 
quicker than the other FCV strains grown in parallel as a comparison. This is a 
different finding to that of Ossiboff et al, 2007, whose experiments showed that 
when using a high m.o.i., 4/6 VSD strains of FCV grew to a higher titre than the 
comparison strains and at the low m.o.i., they found that all three of the VSD strains 
tested grew at a significantly quicker rate than the comparison strains. This suggests 
that either UKOS-A is not a VSD causing strain of FCV or that the ability to grow 
quickly and to a higher titre in cell culture is not characteristic of all VS-FCV strains. 
In the analysis of the growth curves produced at both 37˚C and 39˚C, the results 
showed that the pattern of infection produced at both temperatures were very similar. 
The main differences found between the two growth curves were a higher and faster 
titre peak which can be explained simply by the increase in incubation temperature 
as most reactions will occur quicker at a higher temperature. There were also no 
strain specific differences found during the incubation at 39˚C which shows that 
incubation temperature has no significant effect upon any of the strains examined 
and further incubations can be carried out at 37˚C without affecting in vitro growth 
kinetics.  
The results of the 2D-DIGE analysis showed that there were 16 proteins that were 
up- or down-regulated consistently across all of the strains which indicate that these 
proteins are important to the virus. Within these protein identifications actin and 
vimentin were found to be up-regulated again in all viral samples which is consistent 
with the results in chapter 2. This again shows that these two proteins appear to be 
important in viral replication. Other proteins identified to be consistently up-
regulated included elongation factor Tu GTP-binding domain-containing protein 1. 
This protein is of particular interest as x-ray crystallography has shown that 
Norovirus, another member of the Caliciviridae, has a domain upon the capsid 
protein that is very similar to translation elongation factor-Tu (EF-Tu) (Prasad et al., 
1999) and this domain was hypothesised to have a similar function to EF-Tu. 
Whether this domain is conserved within the FCV capsid protein is unknown but in 
the cell EF-Tu is a GTP binding protein involved in bringing aminoacyl-tRNAs to 
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ribosomes during translation thus if the capsid of FCV does not contain a domain 
similar to this protein it is logical that this protein might be useful in the translation 
of the viral polypeptide. 
Of the other consistently modulated proteins spots only three were down-regulated in 
all viral samples and protein number 2758 (protein kinase C substrate) was the only 
one with a single identification. The protein kinase C are a family of enzymes used 
to control the functions of other proteins through phosphorylation including the 
nuclear lamins (Gruenbaum et al., 2003). The down-regulation of the protein kinase 
C substrate could indicate that cellular protein kinases are freed to act upon other 
proteins within the cell during FCV infection. Lamins were identified within 9 of the 
modulated protein spots found during 2D-DIGE analysis and as a known substrate of 
protein kinase C it could be hypothesised that these proteins were modulated through 
phosphorylation catalysed by protein kinase C. This process has been shown to occur 
with herpesvirus infection (Leach & Roller, 2010). As herpesvirus capsid proteins 
are assembled inside the nucleus the virus needs the nuclear lamina to be disrupted to 
allow the capsid to exit into the cytosol. When the protein kinases were inhibited 
within the Leach et al (2010) study it was found that viral growth was reduced 
fivefold and capsid proteins were unable to egress from the nucleus. This mode of 
action may not prove true in the case of FCV as replication is thought to occur in the 
cytoplasm near the endoplasmic reticulum (Bailey et al., 2010). However, movement 
of viral proteins into and out of the nucleus may still be necessary in replication and 
so phosphorylation of nuclear lamins may be an important part of viral infection. 
With the other two down-regulated protein spots there are multiple identifications 
which make it difficult to decipher whether it is one protein responsible for the 
down-regulation or a combination of all the host proteins identified in the spot. In the 
case of spot number 5105, annexin is shown as one of the proteins present in the spot 
and annexin is also found in spot 5106. Looking at the position of these spots on the 
gel (Fig. 3.2) the molecular weights of the protein spots match and the position of 
each spot is separated only by isoelectric point resolution which possibly means that 
the annexin proteins found in both spots may have been modified post-translationally 
during infection to alter the isoelectric point. Annexin has been shown play a role in 
hepatitis C virus assembly (Backes et al., 2010) and also in the entry of rabbit 
vesivirus (RaV) into cells (Gonzalez-Reyes et al., 2009). Annexin A2 was shown to 
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be bound to RaV virions in the membrane fraction of infected cells and when 
infecting annexin A2 knock out cells with RaV the titre recovered was significantly 
lowered. As this study was performed in another member of the Caliciviridae it may 
be that FCV acts in a very similar manner and that annexin or a post-translationally 
modified form of annexin is important in FCV entry into the cell.  
As well as finding proteins which are modulated consistently in response to infection 
with a number of different FCV strains, a further aim of this study was to try to 
identify potential markers of virulence using a putative VSD strain of FCV, UKOS-
A. The 2D-DIGE results show that there were 14 proteins that were expressed 
differently in cells infected with the UKOS-A strain compared to the response to the 
other FCV strain used to infect cells. All of these proteins were down-regulated in 
the UKOS-A infected samples which may imply that the UKOS-A strain is acting in 
an independent manner to more typical FCV strains. This different mode of action 
within the cell may be able to explain why this virus strain was recovered from a cat 
that showed a number of clinical signs associated with VSD-FCV strains and 
eventually died. Of the 14 proteins found in Table 3.3, actin and vimentin were again 
present although as they were down-regulated in the UKOS infected cells, it is 
possible that the virus is not using them to move around the cell in the same fashion 
as the non-virulent strains but only further individual analysis of these proteins will 
elucidate the true action of virus. The proportion of proteins found to be differently 
expressed in response to infection with the UKOS-A strain was greater than with the 
other viruses examined within this 2D-DIGE experiment which also suggests that the 
UKOS-A strain is acting in a different manner within the cell. 
The overall results from this chapter have shown that while in vitro growth 
characteristics have not been found to be a marker of virulence for the UKOS-A 
strain there are differences to be found in the effects of the UKOS virus upon the 
host cell proteome. There were certain proteins identified that were consistently 
modulated in response to all of the infections with different FCV strains, however, 
the vast majority of proteins identified within this study appeared to be affected 
differently depending on the strain used for infection. This shows that infection with 
strains isolated from cats exhibiting varied clinical signs produces a very varied 
proteomic response from infected cells and as such leaves a complex picture of 
infection.  
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As only one time point (4 h p.i.) was examined in this 2D-DIGE experiment, there 
may also be a timing effect being seen within this study. It is impossible to 
determine whether any of the proteins which are not consistently modulated by all 
strains are merely exhibiting a time delay and at latter stages of infection there may 
be more proteins found to be consistently changed between all the viruses tested. 
There are however, proteins found within this 2D-DIGE analysis which echo the 
findings of the previous 2D-DIGE experiment performed upon a single FCV strain 
(FCV-F9) (chapter 2). Cytoskeletal protein modulation was found once again to be 
important within this analysis with the proteins actin and vimentin becoming 
differentially expressed in response to infection. These findings reaffirm the 
conclusion that cytoskeletal remodelling is important in FCV infection and as such 
these proteins should be examined on an individual basis to try to discover the 
mechanisms of host-pathogen interaction involving them. 
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4 Chapter Four 
Investigation of host cell cytoskeletal rearrangement during 
infection with four strains of FCV using confocal microscopy 
4.1 Introduction 
Experimental analysis with 2D-DIGE (chapters 2 and 3) has shown that during 
infection with FCV host cell cytoskeletal proteins are modulated. The cytoskeleton is 
comprised of three kinds of filaments, categorised into microfilaments, microtubules 
and intermediate filaments and in this chapter, attempts will be made to visualise and 
calculate the extent to which one protein from each of these categories is rearranged. 
The three proteins chosen for further analysis were actin, vimentin and tubulin. 
Actin is one of the most abundant host cell proteins and as such is a very important 
protein for the survival of the cell. Actin is found in the cell as both a monomer and 
polymerised as filaments with the polymerised filaments able to provide structural 
rigidity to the cell by forming a cross-linked network (Pollard & Cooper, 2009). The 
polymerisation process is directionally driven (Wegner, 1976) which allows the cell 
to “crawl” and also internalise vesicles within the cell. There is also a close 
relationship found between actin and myosin which allows force to be generated to 
produce contractions which can move organelles and cellular components short 
distances along these actin filaments (Pollard & Cooper, 2009). As discussed in 
previous chapters (chapters 2 and 3), these functions have been shown to be very 
useful in enabling viruses to move both with the cell and also from cell-to-cell. It has 
been established a number of years ago that vaccinia virus needs an intact actin 
cytoskeleton in order to exit the cell (Payne & Kristensson, 1982) and subsequent 
studies have shown that actin tails are formed below the virion to allow movement 
around the cell and also actin based protrusions are used by the virus in egress 
(Cudmore et al., 1995).  
The second protein chosen for further investigation is a member of the intermediate 
filaments called vimentin. Again the main function of the intermediate filaments 
within cells is to provide cellular structure and integrity although they are also 
credited with involvement in cell migration and signal modulation (Coulombe & 
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Wong, 2004). Vimentin specifically has also been implicated with interaction with 
organelles such as the endo-lysosome complex (Styers et al., 2004) and the golgi 
body (Gao & Sztul, 2001) giving the impression that this is another important group 
of proteins within the cell and disruption to this network would be detrimental to the 
cell in most cases. In virology, vimentin has been specifically linked with dengue 
virus infection (Kanlaya et al., 2010) and also bluetongue virus infection 
(Bhattacharya et al., 2007), with viral proteins in both cases associating closely with 
vimentin proteins in cell culture and aiding the virion in egress from the cell. 
Tubulin is the main protein making up the microtubule component of the 
cytoskeleton and so was chosen to be included in the analysis in this chapter. Within 
the cell, tubulin is found as monomers of α- and β-tubulin which can polymerise to 
form microtubules. Initiation of microtubule polymerisation occurs when γ-tubulin 
forms a ring and acts as a scaffold for the growth of new microtubules (Tassin & 
Bornens, 1999). This also gives the microtubule polarity with growth heading from 
the centrosome where the γ-tubulin is found into the cytosol. These polymerised 
microtubules function as pathways for movement of organelles and cellular 
components around the cell (Howard & Hyman, 2003) and as such are also a target 
for viruses to use as a means of movement within a host. There are a number of 
viruses that have been proven to use microtubules to their advantage to increase their 
infectivity and chances of replication. Human immunodeficiency virus 1 (HIV-1) 
uses the microtubule network to move the virus and its genome from the membrane 
site of entry into the nucleus for reverse transcription (McDonald et al., 2002) and 
alphaherpesvirus has been shown to remodel the cytoskeleton in a similar manner to 
vaccinia virus to form cellular projections made up of tubulin and actin in order to 
contact neighbouring cells and promote viral spread (Favoreel et al., 2005). 
Each of the proteins chosen for further analysis has been shown not only to be 
important to the host cell but also vital in pathogenesis for a number of other viruses. 
In order to examine these changes closer in this chapter, confocal microscopy was 
used alongside immunofluorescent staining to visualise viral proteins and host 
cytoskeletal proteins. Using these techniques will allow any rearrangements of these 
proteins to be discovered and visualised and for their effects to be traced back to 
viral infection. 
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4.2 Materials and methods 
4.2.1 Viral infection 
Eight chamber slides (Nunc, Lab-Tek II CC2 chamber slide system, Sigma Aldrich) 
were seeded with FEA cells, passage number 42, and left to become confluent for 
four days. Once confluent the cells were either infected with previously plaque 
purified FCV-F9 (vaccine strain) (Bittle & Rubic, 1976; Bittle, 1960), LS015 (from a 
cat with chronic gingivostomatitis) (Knowles, 1988), UKOS-A (putative VS-FCV 
strain) (Coyne et al., 2006a) or R591 (typical FCV strain) (Coyne, 2005) at a 
multiplicity of infection (m.o.i.) 10 or mock infected with supernatant from a freeze-
thawed flask of FEA cells.  The cells were infected for a period of 7 and 13 h before 
being stopped by washing three times with PBS and fixing. 
4.2.2 Fixation and staining 
Cells were fixed using 70% ethanol to fix and permeabilise the cells without 
interfering with the signal from the conjugated antibody stain. The ethanol was left 
to incubate at room temperature for two min before being washed three times with 
PBS. All dilutions were performed using PBS (1x solution, see Table 2.1 for recipe) 
with 0.5% BSA added as a blocking agent to prevent non-specific binding by the 
antibodies. The staining was performed as follows: 
4.2.2.1 Vimentin 
Vimentin proteins were stained using a primary antibody raised against vimentin and 
a secondary fluorescent antibody raised against the primary antibody. The primary 
antibody used was a monoclonal anti-vimentin antibody (mouse IgM isotype) 
(V5255, Sigma-Aldrich) diluted to a 1 in 20 concentration with blocked PBS before 
50 µl was added to each well. The chamber slides were left to incubate at 37°C for 1 
h before being washed three times in PBS. The secondary fluorescent antibody used 
was Alexa Fluor 633 (goat anti-mouse IgM) (A21046, Invitrogen) diluted to a 1 in 
100 concentration and 50 µl was added to each well. Again the chamber slides were 
left to incubate at 37°C for 1 h before being washed three times in PBS. 
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4.2.2.2 Tubulin 
Tubulin proteins were stained using a primary and secondary antibody in the same 
manner as the vimentin staining. The primary antibody used was a monoclonal anti-
α-tubulin (mouse IgG isotype) (T5168 Sigma-Aldrich) diluted to a 1 in 50 
concentration with blocked PBS with 50 µl being added to each well before being 
incubated at 37˚C for 1 h and washed three times with PBS. The secondary 
fluorescent antibody used was Alexa Fluor 633 (goat anti-mouse IgG) (A21050, 
Invitrogen) diluted to a 1 in 100 concentration and 50 µl was added to each well. 
Again the chamber slides were left to incubate at 37°C for 1 h before being washed 
three times in PBS. 
4.2.2.3 Actin 
 The same procedure of using a primary antibody and secondary fluorophore was 
attempted to stain cellular actin, however, a preliminary investigation using a 
monoclonal anti-actin antibody (A3853, Sigma Aldrich) showed this staining to be 
unsuccessful. Therefore, the decision was made to use phalloidin staining. Phalloidin 
is a toxin derived from the mushroom Amanita phalloides which binds to cellular 
actin and can be conjugated with fluorescent proteins (Faulstich et al., 1988).  
Phalloidin conjugated with Alexa Fluor 633 (A22284, Invitrogen) was diluted to a 
concentration of 1 in 50 and 50 µl added to each well before incubating at 37˚C for 1 
h and washing three times with PBS. 
4.2.2.4 FCV capsid 
FCV capsid proteins were stained using an anti-FCV primary antibody previously 
found to be broadly cross-reactive against many strains of FCV and a fluorescent 
secondary antibody. The primary anti-FCV capsid antibody G784h (Porter, 2004) 
was used at a concentration of 1 in 20 and 50 µl added to each well. The chamber 
slides were then incubated at 37˚C for 1 h before washing three times with PBS. The 
secondary antibody used was Alexa Fluor 488 (goat anti-rabbit IgG) (A11008, 
Invitrogen) diluted to a 1 in 100 concentration. 50 µl was added to each well before 
incubation at 37˚C for 1 h followed by washing with PBS three times.  
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4.2.2.5 DAPI 
All cells were finally stained with DAPI (4',6-diamidino-2-phenylindole) nucleic 
acid stain, to allow the nucleus of each cell to be visualised, at a concentration of 300 
ng/ml.  
The chambers were then removed from the slides to allow coverslips to be mounted. 
Each well was protected with Vectashield (Vector labs) to prevent rapid loss of 
fluorescence and coverslips were fixed into place with clear nail varnish.  
Imaging was performed with the help of Dr Dave Spiller, Centre for Cell Imaging, 
University of Liverpool. The slides were visualised using a Zeiss Axio Observer Z1 
confocal microscope with a x40 lens, pinhole of 272 and an optical slice <3.4 µm.   
4.2.3 Image analysis with ImageJ software 
To allow comparable analyses to be performed against each sample, images were 
interrogated with ImageJ software (Abramoff et al., 2004). A line of 20 µm in length 
was drawn from one DAPI stained nucleus to another. Where the DAPI stained 
image was unavailable, the line was drawn from the unstained centre of one cell into 
the centre of the next. In order to make comparison between images possible, data 
was only recorded when this line terminated at both ends within the area of a 
nucleus. A plot profile was performed along the line drawn and grey scale values 
taken for each of the fluorescent channels. This process was repeated 15 times per 
time point and virus strain to allow average grey scale values to be calculated and 
plotted against the other fluorescent channels.  
Statistical analysis was performed with the assistance of Dr Karen Coyne, Infection 
Biology, University of Liverpool. Mann Whitney U tests were performed upon the 
values collected from the grey scale plots with values taken along the line from 0-10 
µm being identified as infected cells and values taken from 10.1-20 µm designated as 
values from uninfected cells. The cut-off was defined as 10 µm as it was the mid-
point of the line and defining cell boundaries accurately for each measurement would 
be difficult, especially as cells have been known to alter morphology during 
infection with FCV (Knowles, 1988). Statistical significance was set at p≤0.01. 
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4.3 Results 
During infection with each of the strains of FCV, characteristic cytopathic effects 
could be seen using light microscopy including the infected cells rounding and 
becoming refractile by 7 h p.i. (Figs. 4.1 and 4.2) (Knowles, 1988). The mock 
infected cells did not show any signs of these effects and remained flat and 
completely adherent to the surface of the slide (Figs. 4.1 and 4.2). 
4.3.1 Actin staining 
Attempts were made to stain the cells with phalloidin which binds to cellular actin to 
visualise any actin remodelling as a result of infection with FCV. Unfortunately the 
conjugated phalloidin used in this study was also not compatible with the feline cells 
used and the pattern of fluorescence was indistinct (data not presented) and could not 
be used in this investigation. 
4.3.2 Tubulin staining 
The fixed, infected and mock infected cells were also stained for host cell tubulin 
proteins to discover whether the modulation seen during the 2D-DIGE experiment in 
chapters 2 and 3 could be visualised by confocal microscopy. Figures 4.1-4.5 show 
examples of cells infected with each of the four viruses studied at 7 and 13 h p.i.. 
Figures 4.1 and 4.2 also show mock infected cells at 7 and 13 h p.i. stained for FCV 
capsid proteins and tubulin alongside light microscope images of the same cells.  
The pattern of tubulin staining within the mock infected control shows a circular gap 
within the centre of each of the cells where no staining is shown, this is most 
probably where the nucleus of each cell is located (Figs. 4.1 and 4.2). Whilst tubulin 
staining is widespread throughout the cytosol of each cell it is not uniformly 
distributed, there are areas of high intensity and areas of relatively low intensity. 
This pattern is typical of tubulin staining as areas of high microtubule distribution 
will stain with a greater intensity (Armer et al., 2008). 
Within each of these images, those cells which show viral capsid protein expression 
by emitting green fluorescence also appear to show increased intensity of the red 
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tubulin staining and different distribution. In Figures 4.1, 4.3 and 4.5 there are also 
signs of cellular modification in the form of blebbing at 7 h p.i., which have been 
found before during infection with FCV (Fig. 4.6, (Knowles, 1988)). However, these 
effects disappear at 13 h p.i. and were much less distinct with the cells infected by 
UKOS-A. There were also differing patterns of viral antigen within the blebs 
themselves, with strain R591 showing clear staining of FCV capsid within blebs 
(Fig. 4.5) whereas the blebs found in cells infected with FCV-F9 and LS015 show no 
signs of viral staining within the blebs (Figs. 4.1 and 4.3). 
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Figure 4.1. Tubulin stained FEA cells infected with FCV-F9 and mock infected at 7 h p.i.. FCV capsid staining was performed using an anti-FCV 
primary antibody, visualised using an Alexa Fluor 488 conjugated secondary antibody and is coloured green. Tubulin staining was performed using a 
mouse monoclonal anti-α-tubulin primary antibody, visualised using an Alexa Fluor 633 conjugated secondary anti-mouse IgG antibody and is coloured 
red. White arrows indicate cells showing signs of blebbing structures. 
Tubulin stain Merged image FCV capsid stain 
Mock 
7 h p.i. 
FCV-F9 
7 h p.i. 
10µm 10µm 10µm 
10µm 10µm 10µm 
10µm 
10µm 
Light microscope 
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FCV capsid stain Tubulin stain Merged image Light microscope 
FCV-F9 
13 h p.i. 
Mock 
13 h p.i. 
10µm 10µm 10µm 10µm 
10µm 10µm 10µm 10µm 
Figure 4.2. Tubulin stained FEA cells infected with FCV-F9 and mock infected at 13 h p.i.. FCV capsid staining was performed using an anti-FCV 
primary antibody, visualised using an Alexa Fluor 488 conjugated secondary antibody and is coloured green. Tubulin staining was performed using a 
mouse monoclonal anti-α-tubulin primary antibody, visualised using an Alexa Fluor 633 conjugated secondary anti-mouse IgG antibody and is coloured 
red. 
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Tubulin stain 
Figure 4.3. Tubulin stained FEA cells infected with LS015 at 7 and 13 h p.i.. FCV capsid staining was performed using an anti-FCV primary antibody, 
visualised using an Alexa Fluor 488 conjugated secondary antibody and is coloured green. Tubulin staining was performed using a mouse monoclonal anti-α-
tubulin primary antibody, visualised using an Alexa Fluor 633 conjugated secondary anti-mouse IgG antibody and is coloured red. White arrows indicate cells 
showing signs of blebbing structures 
10µm 10µm 10µm 
10µm 10µm 10µm 
LS015 
13 h p.i. 
LS015 
7 h p.i. 
Merged image FCV capsid stain 
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UKOS-A 
7 h p.i. 
UKOS-A 
13 h p.i. 
10µm 10µm 10µm 
10µm 10µm 10µm 
Figure 4.4. Tubulin stained FEA cells infected with UKOS-A at 7 and 13 h p.i.. FCV capsid staining was performed using an anti-FCV primary 
antibody, visualised using an Alexa Fluor 488 conjugated secondary antibody and is coloured green. Tubulin staining was performed using a mouse 
monoclonal anti-α-tubulin primary antibody, visualised using an Alexa Fluor 633 conjugated secondary anti-mouse IgG antibody and is coloured red. 
Merged image Tubulin stain FCV capsid stain 
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10µm 10µm 10µm 
10µm 10µm 10µm 
Figure 4.5. Tubulin stained FEA cells infected with R591 at 7 and 13 h p.i.. FCV capsid staining was performed using an anti-FCV primary antibody, 
visualised using an Alexa Fluor 488 conjugated secondary antibody and is coloured green. Tubulin staining was performed using a mouse monoclonal anti-
α-tubulin primary antibody, visualised using an Alexa Fluor 633 conjugated secondary anti-mouse IgG antibody and is coloured red. White arrows indicate 
cells showing signs of blebbing structures 
R591 
13 h p.i. 
R591 
7 h p.i. 
Merged image Tubulin stain FCV capsid stain 
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To determine whether any of the changes observed in the infected cells are 
consistent for each infected cell, the intensity of fluorescence along a 20 µm line was 
calculated (full results Appendix III). Unfortunately in the case of the tubulin stained 
samples DAPI stained pictures were unobtainable due to technical difficulties so the 
line was drawn from the centre of an infected cell into the centre of an uninfected 
cell.  
The graphs created from each of the infected samples and a mock infected control 
can be seen in Figure 4.7. In the mock infected controls (Fig. 4.7i and j) the pattern 
of fluorescence in both the 7 and 13 h p.i. samples is similar with tubulin 
fluorescence peaking towards the middle of the line drawn suggesting that tubulin 
staining was greatest at the cell periphery. In both cases the pattern was symmetrical 
around this cellular border suggesting as expected, that patterns of tubulin expression 
were similar in both cells. Within the FCV-F9 infected cells (Fig. 4.7a and b) the 
tubulin fluorescence peaks are found alongside FCV capsid staining peaks showing 
that the intensity of tubulin staining increases in the cell expressing FCV-F9 capsid 
proteins. This pattern is mirrored in the LS015 infected samples (Fig. 4.7c and d) at 
both 7 and 13 h p.i. with the intensity of tubulin staining being almost twice as high 
in the cells expressing FCV compared to the uninfected cells. In the UKOS-A 
infected cells (Fig. 4.7e and f), the pattern is slightly different. At 7 h p.i. (Fig. 4.7e) 
the tubulin fluorescence intensity once again peaks with FCV capsid protein 
Figure 4.6. Evidence of cellular blebbing during infection with FCV. Image a. is a cell 
showing FEA cell blebbing as a result of infection with strain R591 taken with light 
microscope during this thesis. Image b. is taken from Knowles (1988), FEA cells are 
infected with FCV strain A4 and stained with peroxidise anti-peroxidase (PAP). 
Magnification is x~7100  
a b 
10µm 
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expression but at 13 h p.i. the pattern is less defined and the peak tubulin 
fluorescence intensity actually occurs after the FCV capsid expression has dropped 
suggesting that any effect the virus was having upon the tubulin proteins within the 
cell was not being exhibited at 13 h p.i.. In Figure 4.7g and h, R591 appears to act in 
a similar way to the UKOS-A strain, at 7 h p.i. (Fig. 4.7g) the tubulin staining 
intensity peaks with viral capsid staining whereas at 13 h p.i. (Fig. 4.7h) the 
fluorescence pattern of the tubulin staining does not show a peak alongside FCV 
capsid expression.  
To determine whether or not the trends observed within the graphs were statistically 
significant, Mann-Whitney U tests were performed (Table 4.1). The test specifically 
looked at the median grey scale value along the line from 0-10 µm (infected cells) 
vs. the median grey scale value along the line from 10.1-20 µm (uninfected cells). 
The greyscale values from the mock infected cells were also tested. Full results can 
be found in Appendix V. 
 
 
Viral strain Time point 
(hrs p.i.) 
p-value Change in median expression in 
infected cells 
FCV-F9 7 0.0002 29% increase 
FCV-F9 13 <0.0001 48% increase 
LS015 7 <0.0001 53% increase 
LS015 13 <0.0001 99% increase 
UKOS-A 7 <0.0001 27% increase 
UKOS-A 13 <0.0001 32% increase 
R591 7 <0.0001 48% increase 
R591 13 <0.0001 26% increase 
Mock 7 0.3911 5% increase 
Mock 13 0.0012 17% decrease 
Table 4.1. Table showing p-value results of Mann-Whitney U tests on the median values from 
tubulin staining of infected and uninfected FEA cells for each strain and time point. Also shown 
is the percentage increase/decrease of the median value from the infected cells. 
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Results showed that all viral strains at both time points tested had significantly 
increased tubulin within the infected cells when compared to the uninfected cells 
(p≤0.01). In the Mann-Whitney U tests of the mock infected cells, the comparison 
made at 7 h p.i. came back as not significant as it had a p-value of 0.39, however, the 
comparison made at 13 h p.i. did come back as significant at p=0.0012. This result 
may be a reflection of the boundary drawn between the two cells, as there was no 
DAPI stain available it was difficult to know whether the boundary was a good 
estimation of the cell-cell junction. This was less of a problem within the infected 
cells as the disappearance of FCV capsid staining could be used as a guide to the 
cellular boundaries. 
Within the virally infected cell comparisons the largest increase in tubulin staining 
intensity was found in cells infected with LS015 at 13 h p.i. with the amount of 
tubulin staining almost doubling within the infected cells. Most of the viruses caused 
the greatest increase in tubulin staining at 13 h p.i. but strain R591 had the greatest 
effect on tubulin at 7 h p.i.. Strain R591 also had the least pronounced effect overall 
at 13 h p.i..  
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Figure 4.7. Graphs showing average tubulin and FCV capsid protein expression along a 20 µm 
line drawn from the centre of an infected FEA cell into the centre of an uninfected FEA cell. 
Tubulin expression is coloured red, FCV capsid protein expression is coloured green. Graphs a, c, 
e, g and i were all from samples at 7 h p.i. and graphs b, d, f, h and j were from 13 h p.i.. Graphs a 
and b were infected with FCV-F9, c and d were infected with LS015, graphs e and f were infected 
with UKOS-A, graphs g and h were infected with R591 and graphs i and j show mock infected 
samples. The vertical line defines the boundary between two cells. 
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b. 
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4.3.3 Vimentin staining 
To assess the amount of vimentin remodelling occurring as a result of infection with 
four different strains of FCV, host cell vimentin proteins were stained and confocal 
microscope images captured. Figure 4.8 shows vimentin staining in mock infected 
cells at 7 and 13 h p.i.. The cells show signs of typical vimentin staining (Armer et 
al., 2008) with vimentin forming a ring around the nucleus and being more disperse 
in the remainder of the cytosol. 
Figures 4.9-4.12 show examples of the images taken of infected cells with FCV 
capsid protein staining in green, vimentin protein staining in red and DAPI nuclear 
staining in blue. In each of the images, the cells expressing FCV capsid protein from 
each of the strains appear to also show an increased fluorescence pattern from the 
vimentin staining. Again, as observed with some of the infected tubulin stained cells, 
there are signs of blebbing within the cells infected with strain R591 (Fig. 4.12) 
except in this case the blebbing appears to have continued to 13 h p.i. with viral 
antigen appearing stained within the blebs again.  
 
 
  
Figure 4.8. Images showing mock infected FEA cells used as controls stained for 
vimentin using a primary mouse monoclonal anti-vimentin antibody which was 
visualised using a secondary anti-mouse IgM antibody conjugated with Alexa Fluor 
633 at 7 and 13 h p.i.. Vimentin protein staining is coloured red. 
Mock 7 h p.i. Mock 13 h p.i. 
10µm 10µm 
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Figure 4.9. Vimentin stained FEA cells infected with FCV-F9 at 7 and 13 h p.i.. FCV capsid staining was performed using an anti-FCV primary 
antibody, visualised using an Alexa Fluor 488 conjugated secondary antibody and is coloured green. Vimentin staining was performed using a mouse 
monoclonal anti-vimentin primary antibody, visualised using an Alexa Fluor 633 conjugated secondary anti-mouse IgM antibody and is coloured red. 
DAPI nuclear stain is coloured blue. 
Vimentin stain 
FCV-F9 
13 h p.i. 
FCV-F9 
7 h p.i. 
Merged image DAPI stain FCV capsid stain 
10µm 10µm 10µm 10µm 
10µm 10µm 10µm 10µm 
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Figure 4.10. Vimentin stained FEA cells infected with LS015 at 7 and 13 h p.i.. FCV capsid staining was performed using an anti-FCV primary 
antibody, visualised using an Alexa Fluor 488 conjugated secondary antibody and is coloured green. Vimentin staining was performed using a mouse 
monoclonal anti-vimentin primary antibody, visualised using an Alexa Fluor 633 conjugated secondary anti-mouse IgM antibody and is coloured red. 
DAPI nuclear stain is coloured blue. 
FCV capsid stain 
LS015 
13 h p.i. 
LS015 
7 h p.i. 
Merged image Vimentin stain DAPI stain 
10µm 10µm 10µm 10µm 
10µm 10µm 10µm 10µm 
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Figure 4.11. Vimentin stained FEA cells infected with UKOS-A at 7 and 13 h p.i.. FCV capsid staining was performed using an anti-FCV primary 
antibody, visualised using an Alexa Fluor 488 conjugated secondary antibody and is coloured green. Vimentin staining was performed using a mouse 
monoclonal anti-vimentin primary antibody, visualised using an Alexa Fluor 633 conjugated secondary anti-mouse IgM antibody and is coloured red. 
DAPI nuclear stain is coloured blue. 
Vimentin stain FCV capsid stain 
10µm 
10µm 10µm 10µm 10µm 
10µm 10µm 10µm 
UKOS-A 
13 h p.i. 
UKOS-A 
7 h p.i. 
Merged image DAPI stain 
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Figure 4.12. Vimentin stained FEA cells infected with FCV-F9 at 7 and 13 h p.i.. FCV capsid staining was performed using an anti-FCV primary 
antibody, visualised using an Alexa Fluor 488 conjugated secondary antibody and is coloured green. Vimentin staining was performed using a mouse 
monoclonal anti-vimentin primary antibody, visualised using an Alexa Fluor 633 conjugated secondary anti-mouse IgM antibody and is coloured red. 
DAPI nuclear stain is coloured blue. White arrows indicate cells showing signs of blebbing structures. 
 
10µm 10µm 10µm 10µm 
10µm 10µm 10µm 10µm 
R591 
13 h p.i. 
R591 
7 h p.i. 
Merged image Vimentin stain FCV capsid stain DAPI stain 
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Again, an analysis of fluorescence along a 20 µm line was performed except as 
DAPI stained images were available the line was drawn from the nucleus of an 
infected cell to the nucleus of an uninfected cell (full results see Appendix IV). The 
graphs produced from this analysis are shown in Figure 4.13. The mock infected 
controls (Fig. 4.13i and j) show a similar pattern of expression for vimentin staining 
in both the cells fixed at 7 h p.i. and the cells fixed at 13 h p.i., from nucleus to 
nucleus the expression is constant except for a small peak in the area between the 
nuclei towards the cell periphery at 7 h p.i. (Fig. 4.13i). In the FCV-F9 infected cells 
(Fig. 4.13a and b), the pattern of the intensity of vimentin staining peaks in the 
infected cells at both time points examined although the peak intensity in the cells 
fixed at 13 h p.i. is much lower than at 7 h p.i.. The pattern is similar in the cells 
infected with strain R591 (Fig. 4.13g and h) with a larger difference in peak intensity 
being visible at 7 h p.i. compared to 13 h p.i.. The LS015 and UKOS-A infections 
gave the most consistent peak intensities for vimentin staining at 7 and 13 h p.i. (Fig. 
4.13c-f) with the peak intensities in the cells expressing FCV capsid protein roughly 
double that of the cells not expressing capsid.  
Again, Mann-Whitney U statistical analysis was performed upon the grey scale 
values from the vimentin staining in infected cells (values from 0-10 µm) compared 
to the uninfected cells (values from 10.1-20 µm) (Table 4.2). Full results can be 
found in Appendix V.  
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Viral strain Time point 
(hrs p.i.) 
p-value Change in median expression in 
infected cells 
FCV-F9 7 <0.0001 38% increase 
FCV-F9 13 <0.0001 28% increase 
LS015 7 <0.0001 93% increase 
LS015 13 <0.0001 26% increase 
UKOS-A 7 <0.0001 52% increase 
UKOS-A 13 <0.0001 102% increase 
R591 7 <0.0001 56% increase 
R591 13 <0.0001 73% increase 
Mock 7 >0.05 1% decrease 
Mock 13 0.2599 1% increase 
 
The results showed that for each strain and for both time points the results showed 
that vimentin was significantly altered within the infected cells when compared to 
the uninfected cells. The most pronounced alteration is vimentin staining is found in 
response to infection with the UKOS-A strain at 13 h p.i. with the intensity of 
staining doubling within infected cells. Response to infection with LS015 produced 
the smallest increase in vimentin staining at 13 h p.i., showing only a 26% increase. 
Within the mock infected samples, there was no significance observed at either time 
point (p>0.05) and the levels of vimentin staining were within 1% of each other. 
This suggests that the cut-off for the cell boundary was correctly defined within this 
experiment and the trends observed with the DAPI staining reaffirm this (Fig. 4.13).  
Table 4.2. Table showing p-value results of Mann-Whitney U tests on the median values from 
the vimentin staining in infected and uninfected FEA cells for each strain and time point. Also 
shown is the percentage increase/decrease of the median value from the infected cells. 
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Figure 4.13. Graphs showing average vimentin, FCV capsid protein and DAPI expression along a 20 µm line drawn 
from the centre of an infected FEA cell into the centre of an uninfected FEA cell. Vimentin expression is coloured 
red, FCV capsid protein expression is coloured green and DAPI strain is coloured blue. Graphs a, c, e, g and i were 
all from samples at 7 h p.i. and graphs b, d, f, h and j were from 13 h p.i.. Graphs a and  b were infected with FCV-
F9, c and d were infected with LS015, graphs e and f were infected with UKOS-A, graphs g and h were infected 
with R591 and graphs i and j show mock infected samples. The vertical line defines the boundary between two cells. 
j. 
h. 
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4.4 Discussion 
The aim of this chapter was to discover whether the modulation of cytoskeletal 
proteins found within the 2D-DIGE experiments could be visualised and confirmed 
at the cellular level within individual FCV-infected cells.  
Within infected cells, increases in vimentin and tubulin staining were seen in cells 
infected with each strain of FCV (Figs. 4.1-4.5 and 4.9-4.12). The use of 
microtubules and intermediate filaments in viral movement around the cell has been 
documented for a number of viruses such as hepatitis C virus (Roohvand et al., 
2009) and dengue virus (Chen et al., 2008).  
Not all viruses use these proteins in the same manner and differences have even been 
observed within viral families. Within the Picornaviridae, foot-and-mouth disease 
virus (FMDV) and bovine enteric virus (BEV) have been shown to use microtubules 
and intermediate filaments in opposing manners (Armer et al., 2008). FMDV 
disrupts the tethering of microtubules, made up from the polymerisation of tubulin, 
to the microtubule organising centre but BEV does not. There were also differences 
found in the alteration of vimentin expression within the cell, FMDV was shown to 
draw vimentin around the site of viral replication whereas BEV proteins co-localise 
with vimentin at the site of replication. There were some differences observed in the 
degree of vimentin and tubulin increase in response to the different FCV strains. 
Strain R591 was the only viral strain not to cause the greatest increase in tubulin 
staining in the latter stages of infection (Table 4.1) and this may be indicative of a 
different mode of viral egress for this strain which is not as dependent on wholesale 
changes in tubulin expression in the latter stages of infection. The pattern of 
vimentin staining is even more varied in response to infection with each of the four 
strains with both LS015 and UKOS-A having the greatest effect upon expression but 
at different time points. LS015 appears to induce a large increase in vimentin 
expression relatively early in infection (7 h p.i.) whereas the cells infected with the 
UKOS-A strain express large amounts of vimentin towards the end of infection 
which may mean that UKOS-A needs vimentin to aid viral exit. 
Also of interest from this study are the blebbing structures observed in Figures 4.1, 
4.3, 4.5, 4.6 and 4.11. Blebbing is often taken to be indicative of apoptosis (Bovellan 
et al., 2010) and may therefore perhaps be used to support the findings of others that 
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suggest FCV itself induces apoptosis (Al-Molawi et al., 2003; Natoni et al., 2006). 
No evidence of apoptotic proteins were found during the 2D-DIGE studies but there 
were modulations found at the transcriptional level and these will be demonstrated in 
chapter 5.  
It is not certain that the blebs observed in this experiment are definitely a 
consequence of apoptosis as apoptotic blebs are often only present for minutes at a 
time which would make capturing them using fixed cells difficult and they are 
characterised by a lack of cytoskeletal protein involvement (Charras, 2008) whereas 
in the images captured in this experiment tubulin and vimentin are often present 
within the blebs. Also present within the blebs themselves during infection with 
R591 are viral capsid proteins which may prove that rather than being a by-product 
of apoptosis, the blebs are protrusions used by this strain of FCV to aid viral egress 
and promote cell-to-cell transmission in a similar manner to vaccinia virus infection 
(Carter et al., 2003; Cudmore et al., 1995).  
Neither of these hypotheses can be confirmed or discarded using the data obtained in 
this chapter. Further analysis upon FCV infected cells will have to be performed. 
Ideally this would be carried out using live cell imaging to fully track the virus 
within the cell and analyse viral-host protein interactions within a series of images 
from the same live cells. To make this possible there is now an infectious clone of 
FCV available that expresses fluorescent proteins, thereby allowing the virus to be 
visualised during live cell imaging (Abente et al., 2010). If this clone could be 
combined with a cell line which expresses fluorescent proteins then studies could be 
performed which are similar to experiments already carried out with vaccinia virus 
(Mercer & Helenius, 2008) allowing closer inspection of the interactions between the 
virus and the host cytoskeletal proteins. However, the availability of a cell line that is 
able to express fluorescently labelled proteins and is able to be infected by the FCV 
clone may be a problem for the foreseeable future as currently FCV strains are only 
culturable in feline cell lines and most fluorescent proteins have only been expressed 
in human and mouse models.  
An experiment that may be able to be performed with more ease and deliver results 
quicker is one that utilises flow cytometry to examine whether host cytoskeletal 
changes occur before or after the start of apoptosis. Flow cytometry has already been 
used to investigate caspase-3 activation and induction of apoptosis during FCV 
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infection (Natoni et al., 2006) and if the changes seen in the cytoskeletal proteins 
during infection could be quantified by flow cytometry then the effects of infection 
on both these sets of proteins could be examined simultaneously.  
All of the cells infected with all strains used in this experiment showed increases in 
the expression of both cytoskeletal proteins examined which indicates that these 
cytoskeletal changes are important for every strain of FCV examined. However, 
UKOS-A was the only strain not to show any signs of inducing blebbing within 
these cells. This difference found in the UKOS-A infected cells may simply be an 
artefact of timing, if the blebs are transient then the cells may have been fixed at the 
wrong time, or it may be indicative of a different mode of action for this putative 
hypervirulent strain. This difference also mirrors the results of the 2D-DIGE analysis 
(chapter 3) upon these four strains of FCV with cells infected by UKOS-A being 
found to have a number of proteins modulated in a different manner to cells infected 
with the other three virus strains. Both of these experiments have shown that closer 
examination of the UKOS-A strain is warranted, ideally alongside a hypervirulent 
strain of FCV that has been used to recreate VSD experimentally to discover whether 
any of these differences are consistent for hypervirulent strains of FCV. 
Unfortunately images could only be satisfactorily obtained for two of the three 
proteins targeted; the staining of FEA cells with phalloidin to visualised cellular 
actin was unsuccessful. Phalloidin was used as a toxin which binds preferentially to 
F-actin within the cell and in this case was conjugated to a fluorescent stain, 
however, the staining observed in this experiment was not specific and one reason 
for this may be due to the use of a feline cell line. Although actin is generally 
considered to be a conserved protein within eukaryotes there may have been 
differences in the phalloidin binding site present in the cell line used and so specific 
staining could not be performed. To circumvent this problem in future studies, other 
types of staining will have to be considered such as using other brands of phalloidin 
or using a specific anti-actin primary antibody that has been raised against the actin 
proteins found in the cell cultures studied. Secondary staining with a fluorescent 
antibody could then be performed in the same manner as with the tubulin and 
vimentin staining in this experiment.  
Overall, the data collected within this chapter has shown that the modulations of the 
cytoskeletal proteins found within the two 2D-DIGE experiments were confirmed at 
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the cellular level by direct cell imaging using immunofluorescent confocal 
microscopy. Both vimentin and tubulin expression were significantly increased in 
cells infected with all strains of FCV although there were no real differences found 
between each FCV strain examined which may prove that the alteration of the host 
cytoskeleton is an essential part of FCV virion replication.     
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5 Chapter five 
Investigation of host gene transcript changes as a result of 
infection with FCV-F9 using RNA-seq 
5.1 Introduction 
In the previous chapters, changes in the cellular proteome in response to infection 
with FCV have been studied whereas in this chapter the focus will be upon the 
changes in gene transcription levels.  
At time of writing there have been no attempts made to discover the effects of FCV 
infection upon global cellular transcription; however, one study has been successful 
in examining cells infected with a norovirus replicon system with a microarray 
(Chang, 2009). It was discovered that genes in cholesterol and carbohydrate 
metabolic pathways were significantly modulated and when these pathways were 
disrupted experimentally the levels of replication of the norovirus replicon reduced 
significantly. As discussed previously (chapter 1) there are limitations with using a 
microarray system especially as the probes used to interrogate transcripts are user 
defined and with using a non-model system such as the feline genome, designing 
these probes may be problematic and novel genes would be overlooked completely. 
Real-time PCR has also been employed to target the host cytokine response to 
infection with VS-FCV (Foley et al., 2006). They used the skin lesions formed 
during infection with VS-FCV and targeted 9 host cytokines and found that on 
average, 3.8 were significantly elevated in the tissue infected with VS-FCV. Again, 
this is a limited method of investigation as only a few gene transcripts can be 
targeted at a time during each experiment and novel genes will be overlooked. 
To overcome these limitations with microarray and real-time PCR analysis the 
decision was made to employ next-generation sequencing technologies to investigate 
gene transcript changes as a result of infection with FCV. These next-generation 
sequencers are still a very new technology and as such there are only a few studies in 
which they have been used to interrogate the whole transcriptome and only one 
example of this technology being used to investigate the transcriptional changes as a 
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result of viral infection (Woodhouse et al., 2010). Other viral studies using next-
generation technologies have focussed upon the virus itself and have used the 
sequences obtained to reveal viral transcript boundaries and novel transcripts 
(Legendre et al., 2010) and also to find novel splice sites (Lin et al., 2010). 
In this chapter, next generation sequencers were employed to interrogate the 
transcriptome of samples in a technique known as RNA-seq. The transcriptome of 
FEA cells infected with FCV-F9 was sequenced by SOLiD sequencing at 4 and 7 h 
p.i. along with mock infected counterparts. By sequencing the transcriptome of 
infected and mock infected cells, comparisons can be made between the samples and 
genes which are differentially transcribed as a result of infection with FCV. The 
experimental design included two biological replicates of each condition to allow for 
natural variance between samples to be normalised, however, the decision was made 
not to include any technical replicates within the experiment as there have been 
previous studies performed showing that the techniques used in RNA-seq are highly 
reproducible and that technical replicates are largely unnecessary (Marioni et al., 
2008). The results obtained from RNA-seq were then compared to the modulated 
proteins identified from the 2D-DIGE experiment performed upon FCV-F9 in 
chapter 2. This was performed to discover whether any correlation between the two 
data sets existed or whether this experiment would follow the pattern of others 
performed using microarrays and proteomics and show poor correlation between the 
differentially transcribed genes and proteins (Barros et al., 2010). 
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5.2 Materials and methods 
5.2.1 Viral infection 
FEA cells (passage 45) were infected with FCV-F9 (Bittle & Rubic, 1976; Bittle, 
1960) at an m.o.i. 10. The virus was added in a 1 ml solution of MM and incubated 
at 37°C for 1 h. The flasks were then washed three times with PBS and re-fed with 
20 ml MM. The infections were then stopped either 4 or 7 hours post infection by 
freezing at -80°C. Mock infected flasks were created by seeding with 1 ml MM 
instead of virus solution and treated in the same way as their infected counterparts.  
Cell pellets were created by scraping the monolayer and spinning the supernatant at 
2000 × g for 10 min. 
5.2.2 RNA isolation 
RNA was isolated from the infected and mock infected cell pellets using a Purelink 
RNA mini kit (Invitrogen 12183018A) following the manufacturers protocol.  
This involved preparing fresh lysis buffer by adding 20 µl of 2 M DTT per ml of the 
lysis buffer included in the kit. 0.6 ml of the freshly prepared lysis buffer was added 
to each cell pellet and vortexed at high speed until the cell pellet is completely 
dispersed. The cells were then homogenised at room temperature using a pellet 
pestle to ensure that the cells were completely lysed. 0.6 ml of 70% ethanol was then 
added to each cell lysate and vortexed at high speed to disperse any precipitate that 
forms as a result of the ethanol addition. Up to 700 µl of sample at a time is added to 
the spin cartridge included in the kit and is then centrifuged at 12 000 × g for 15 s 
with the flow through being discarded. This is repeated until all of the lysate has 
been passed over the spin column. 700 µl of wash buffer I is then added to each spin 
cartridge and centrifuged at 12 000 × g for 15 s. The flow through is once again 
discarded and the spin column placed into a clean collection tube for the next step. 
Wash buffer II has 96-100% ethanol added at first use and 500 µl of this is passed 
through the spin column by centrifuging at 12 000 × g for 15 s discarding the flow 
through once centrifugation is completed and repeating the second wash once more. 
The membrane with the attached RNA is then dried thoroughly by centrifuging the 
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spin column at 12 000 × g for 2 min before the collection tube is discarded and the 
column is inserted into a clean recovery tube. 30 µl of RNase-free water was then 
added to the centre of the spin cartridge and incubated at room temperature for 1 
min. The spin cartridge is then spun at 15 000 × g for 2 min to elute the RNA from 
the membrane into the recovery tube. At this stage the extracted RNA is either kept 
on ice to be used immediately or stored at -80˚C for longer term storage.  
5.2.3 rRNA depletion 
As the most abundant RNA in the cell is ribosomal RNA this must be depleted to 
allow other RNA to be found and analysed by RNA-seq. The rRNA was depleted in 
this experiment using the Ribominus Eukaryote Kit for RNA-seq (Invitrogen 
A10837-08). 
2-10 µg of extracted RNA in a volume of less than 20 µl was combined with 10 µl of 
Ribominus probe and 300 µl of hybridisation buffer in a sterile, RNase-free 1.5 ml 
tube. The samples were then incubated at 75˚C for 5 min to denature the RNA and 
then cooled slowly over 30 min to a temperature of 37˚C to promote sequence 
specific hybridisation. Magnetic beads were prepared by washing them several times 
before resuspending in hybridisation buffer. The cooled samples are then added to 
the prepared beads and incubated at 37˚C for 15 min. The tubes were then placed on 
a magnetic separator to pellet the rRNA-probe complex attached to the magnetic 
beads. The supernatant is collected and added to another batch of prepared beads and 
the process repeated. This ensures that the supernatant is totally depleted of rRNA. 
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5.2.4 Creation of cDNA library for SOLiD sequencing 
In order to create a library of cDNA suitable for sequencing with the SOLiD high 
throughput sequencer the rRNA depleted samples must be fragmented, reverse 
transcribed, size selected and then amplified.  
5.2.4.1 Fragmenting the RNA 
The RNA is fragmented using RNase III (Applied Biosystems AM2290) to produce 
fragments of a size suitable for SOLiD sequencing (50-100 bp). 
0.5 µg-1 µg of each rRNA depleted sample was made up to 8 µl with nuclease free 
water and added to 1 µl of RNase III and 1 µl of 10x RNase III reaction buffer on 
ice. The mixture was mixed thoroughly and incubated in a thermocycler set to 37˚C 
for 10 min. Immediately after incubation 90 µl of nuclease-free water was added and 
the resulting fragmented RNA mix is immediately cleaned up using parts from the 
Ribominus Concentration Module (Invitrogen K1550-05). 100µl of binding buffer 
(L3) and 250 µl of 100% ethanol is added to the digested RNA mix and then loaded 
onto a spin column and centrifuged at 12 000 × g for 1 min. The flowthrough is 
discarded and 500 µl of the wash buffer (W5) is added to the spin column. The 
column is spun at 12 000 × g for 1 min and the flowthrough is discarded before the 
spin column is placed into a clean wash tube and spun again at maximum speed for 2 
min. To elute the RNA from the spin column 20 µl of RNase-free water was added 
to the centre of the spin column and incubated at room temperature for 1min before 
centrifuging at maximum speed for 1 min. The fragmented RNA was collected from 
the flowthrough and the yield assessed by running 1 µl on a Nanodrop 
Spectrophotometer (Thermo Scientific). 
5.2.4.2 Hybridisation and ligation of the RNA 
The fragmented RNA was then hybridised and ligated with an adaptor mix included 
in the SOLiD Small RNA Expression Kit (Ambion 4397682). Inside the adaptor mix 
is a set of oligonucleotides with a single-stranded degenerate sequence at one end 
and a defined sequence required for the SOLiD system sequencing at the other end.  
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3 µl of fragmented RNA sample (equivalent to 50-100ng of RNA) was mixed with 2 
µl of adaptor mix A and 3 µl of hybridisation solution on ice. The mix was then 
incubated in a thermocycler at 65˚C for 10 min and 16˚C for 5 min. Once the 
incubation was completed 10 µl of 2x ligation buffer was added followed by 2 µl of 
ligation enzyme mix. Once mixed the ligation reaction was placed in a thermocycler 
set to 16˚C for a 16 hr incubation.  
5.2.4.3 Reverse transcription of RNA 
A reverse transcription master mix was made up for each sample using components 
from the SOLiD Small RNA Expression Kit. This mix consisted of 13 µl of 
nuclease-free water, 4 µl of 10x reverse transcription buffer, 2 µl of 2.5 mM dNTP 
mix and 1 µl of ArrayScript Reverse Transcriptase. Once the master mix was added 
to the RNA ligation reaction and mixed it was incubated in a thermocycler at 42˚C 
for 30 min. The cDNA was then purified using components from the MinElute PCR 
Purification Kit (Qiagen 28004). 60 µl of nuclease-free water and 500 µl of buffer 
PB/PBI was added to all of the cDNA created in the reverse transcription stage. This 
mix was then loaded onto the MinElute column and spun at 13 000 × g for 1 min and 
the flowthrough discarded. To wash the sample adhered to the MinElute column, 750 
µl of buffer PE was added to the column and spun at 13 000 × g for 1 min before 
discarding the flowthrough, returning the column to a new tube and spinning again at 
13 000 × g for 1 min. The cDNA was eluted from the column by adding 10 µl of 
buffer EB to the centre of the MinElute column and spinning at 13 00 × g for 1 min.  
5.2.4.4 Size selection of cDNA. 
In order to amplify cDNA of the correct size the samples must be run on a gel and 
bands of the correct size for SOLiD sequencing excised. This was performed using 
the precast Novex 6% TBE-Urea Gels, 1.0 mM, 10-well (Invitrogen EC6865BOX), 
Novex TBE running buffer 5x (Invitrogen LC6675) and Novex TBE-Urea sample 
buffer 2x (Invitrogen  LC6876). The TBE-Urea gels were placed into a tank filled 
with 1x TBE running buffer and the cDNA and DNA ladders were prepared. 5 µl of 
the cDNA samples/50 bp DNA ladder and 5 µl of 2x TBE-Urea sample buffer were 
mixed together and heated at 95°C for 3 min before snap cooling on ice. Before 
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loading the samples, the wells of the gel were flushed through with 1x TBE running 
buffer to ensure that there was no urea left in with the samples and to obtain sharp 
bands. The samples and ladder were loaded onto the gel and it was run at 180 V for 
~17 min. The gel was then stained with Sybr Gold nucleic acid stain (Invitrogen 
S11494) for 40 min before illumination with a UV transilluminator. The 100-200 nt 
material was then excised from the gel using a clean scalpel and split vertically into 
4 pieces and placed in separate 1.5 ml microcentrifuge tubes.  
5.2.4.5 Amplifying the cDNA 
 The cDNA was amplified to ensure there was sufficient available for SOLiD 
sequencing. This used components from the SOLiD Small RNA Expression Kit 
(Ambion 4397682). To prepare sufficient cDNA for the emulsion PCR step of 
SOLiD sequencing two PCR reactions were performed for each sample each using 
one of the gel pieces excised during size selection. Each PCR reaction required 100 
µl of PCR master mix made up of the following; 78 µl nuclease-free water, 10 µl 
10x PCR buffer I, 2 µl SOLiD PCR primers 1-10, 8 µl 2.5 mM dNTP Mix and 2 µl 
AmpliTaq DNA Polymerase. The PCR reaction was then run under the following 
conditions (Table 5.1). 
 
Stage Temperature (°C) Time 
Hold 95 5min 
Cycle (15 cycles) 95 30sec 
62 30sec 
72 30sec 
Hold 72 7min 
 
Table 5.1. PCR conditions for SOLiD library amplification of cDNA obtained from FEA cells 
infected with FCV-F9 and mock infected at 4 and 7 h p.i.. 
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The amplified cDNA was then purified using components from the Purelink PCR 
micro kit (Invitrogen K310050) to remove unincorporated primers which may have 
affected the final quantitation and emulsion PCR. The two 100 µl PCR reactions 
were combined and 800 µl of binding buffer (B2) was added to the tube and mixed. 
500 µl of this mixture was then added to the Purelink Micro Kit column and 
centrifuged at 10 000 × g for 1 min. the flowthrough was discarded and the process 
repeated with the remaining sample. The column was then washed with 600 µl of 
wash buffer (W1) and spun at 10 000 × g for 1 min before discarding the 
flowthrough, returning the column to the collection tube and spinning again at 14 
000 × g for 1 min. the bound DNA was eluted by adding 10 µl of elution buffer to 
the centre of the column membrane, incubating for 1min and centrifuging at 14 000 
× g for 1 min. This process is repeated to ensure that all of the cDNA is recovered 
from the column.    
5.2.5 Emulsion PCR 
Emulsion PCR (ePCR) and SOLiD sequencing was performed by Miss Suzanne Kay 
at the Centre for Genomic Research, School of Life Sciences, University of 
Liverpool. Briefly, this involved amplifying the short DNA fragments onto SOLiD 
P1 DNA beads using ePCR. Oil is used to create droplets of solution which aim to 
contain a single DNA bead and a single DNA fragment template. The emulsion was 
then placed on a thermal cycler and a standard PCR conditions run according to 
manufacturer instructions and during this amplification >30 000 copies of each 
template were amplified onto each SOLiD P1 DNA bead. Once amplification was 
complete the emulsion was broken with 2-butanol and the beads washed to clear 
away the remaining oil and emulsifiers. There then has to be an enrichment step to 
isolate template beads from non-amplified or poorly amplified DNA beads. To do 
this polystyrene beads with an adaptor attached were used to capture template beads 
before the mixture was centrifuged on a 60% glycerol cushion. This step resulted in 
separation of the enrichment beads along with attached DNA beads at the top of the 
mixture and the non-amplified beads in a layer at the bottom. The enriched beads 
were then extracted and denatured using a denaturing buffer to remove the 
enrichment beads from the solution. The enriched DNA beads are then prepared for 
the SOLiD sequencer by covalent bonding to a glass slide. 
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5.2.6 SOLiD sequencing 
Primers hybridise to the P1 adaptor sequence added during the ePCR stage and a set 
of four fluorescently labelled di-base probes are added. Once the correct di-base 
probe has ligated to the primer the fluorescent tag attached is cleaved and the colour 
emitted is recorded. The process is then repeated through multiple cycles to extend 
the sequence. This extended sequence is then removed from the template and a new 
primer is added to the adaptor but in a position n-1 of the first primer. The di-base 
probes are again added and the ligation – fluorescence – cleavage cycles repeated. 
Once the sequence has been extended it is again removed from the template and the 
whole process is repeated with another three primers (positioned at n-2, n-3 and n-4 
from the original primer position). This method ensures that each base of the 
template is interrogated twice and so sequencing errors should be minimised. 
5.2.7 Read mapping 
Once the reads had been generated by the SOLiD sequencer they then had to be 
mapped onto the cat genome. This process was performed by Dr Kevin Ashelford at 
the Centre for Genomic Research, School of Life Sciences, University of Liverpool. 
The cat genome was downloaded from Ensembl (Assembly CAT, Mar 2006. 
Database version 58.1g) and was artificially divided into 16 chromosomes as the 
current assembly consists of scaffolds which were unsuitable for processing. The 
artificial chromosomes were subdivided into eight chromosomes which contained all 
of the annotated genes from the genome whilst the other eight chromosomes 
contained those scaffolds without annotated genes. The Bioscope pipeline was used 
to map the SOLiD reads onto the cat genome chromosomes and this pipeline allows 
up to 10 mismatches against the reference genome per 50 bp read.  
5.2.8 DESeq 
Those reads that mapped to the annotated genes found on the cat genome were 
analysed for differential expression using DESeq which is an R package that is able 
to analyse gene expression based on the negative binomial distribution (Anders 
2010). Genes with an adjusted p-value of ≤0.01 were deemed to be significantly 
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differentially transcribed. The adjusted p-value is calculated by the Benjamini-
Hochberg procedure which controls with false discovery rate of the differentially 
transcribed genes (Benjamini and Hochberg 1995).  
5.2.9 Gene Ontology 
Those genes that were found to have an adjusted p-value ≤0.01 with an up or down 
regulation were selected for further analysis on the basis that using the adjusted p-
value means that there is a lesser likelihood of the selected genes containing false 
positives and the low p-value cut off means it is unlikely that any genes appear 
within the list by chance. The GO terms for biological processes were obtained by 
downloading those available for the annotated genes found on the cat genome from 
Ensembl using the BioMart tool.  
5.2.10 Pathway Studio 
The significantly differentially expressed genes were also analysed by pathway 
analysis software, Pathway Studio (Ariadne) (Nikitin et al., 2003). Those genes with 
recognised gene identifications were uploaded into the software and the genes were 
mapped onto created pathways in the software. 
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5.3 Results 
5.3.1 DESeq analysis 
There were 34 843 genes analysed by DESeq to find the log2 fold difference and 
adjusted p-value for each gene comparison between groups (Appendix VI). 
Comparisons were made between infected and mock infected groups at each time 
point and also between mock infected group‟s only and infected groups only. A 
summary of overall numbers of differentially transcribed genes by log2 fold 
difference and by adjusted p-value significance (p≤0.01) can be found below (Table 
5.2); the full list can be found in appendix VII.   
To ensure that the genes found to be significantly differentially transcribed between 
infected and mock infected groups are a result of viral infection and not an artefact 
of normal cellular processes, closer investigation of the genes found in the mock 4 h 
vs. mock 7 h comparison was performed. Table 5.3 shows the full list of the 
significantly differentially transcribed genes in the mock infected comparison and 
the log2 fold difference. Also included is the log2 fold differences from the other 
three comparisons provided the gene was found to be significantly differentially 
expressed by having an adjusted p value ≤0.01 for that comparison group. The table 
shows that of the genes found within the mock infected comparison correlate closely 
with the infected group‟s comparison, 61 of the 64 genes found in the uninfected 
comparison were also significantly differentially expressed in the infected group‟s 
comparison. All of these genes were up- or down-regulated in the same patterns in 
both comparisons which offers the conclusion that these genes were differentially 
transcribed as a result of normal cellular processes although the effects in the 
infected comparison were of a greater magnitude in all but one case. Within the 
mock vs. infected comparisons at both time points, the differentially transcribed 
genes shared with the mock infected comparison are all down-regulated whereas in 
the mock infected comparisons they are all up-regulated. These results would 
indicate that during infection the transcription of these genes is disrupted especially 
in the early stages of viral replication.  
With taking all of these findings into account it shows that the genes found to be 
differentially transcribed within the mock infected and infected comparisons can be 
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considered to be an effect of the infection rather than solely a result of cellular 
processes.  
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Comparison 
groups 
Genes with a log2 fold difference Significantly differentially transcribed 
gene (p≤0.01) 
 Total 
number of 
up-
regulated 
genes 
Total 
number of 
down-
regulated 
genes 
Genes up-
regulated 
with a ≥1 
log2 fold 
difference 
Genes 
down-
regulated 
with a ≥1 
log2 fold 
difference 
Genes up-
regulated 
with a ≥2 
log2 fold 
difference 
Genes 
down-
regulated 
with a ≥2 
log2 fold 
difference 
Total genes Up-
regulated 
genes 
Down-
regulated 
genes 
Mock 4 h vs. 
Infected 4 h 
12 087 11 972 2 651 3 261 769 1 069 172 32 140 
Mock 7 h vs. 
Infected 7 h 
12 582 11 786 3 575 3 017 1 223 779 182 174 8 
Mock 4 h vs. 
Mock 7 h 
12 482 12 538 2 837 2 076 714 572 64 61 3 
Infected 4 h 
vs. Infected 7 
h 
12 546 10 950 4 331 2 835 1 680 737 317 287 30 
Table 5.2. Table showing summary of overall numbers of differentially transcribed genes analysed by DeSeq by log2 fold difference and by adjusted p-value 
significance (p≤0.01). Genes were found to be significantly transcribed in FEA cells in response to infection with FCV-F9 or mock infection at 4 and 7 h p.i..  
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Table 5.3. Table showing all genes differentially transcribed (p<0.01) in FEA cells in the 
comparison of mock 4 h vs. 7 h and the log2 fold difference found in all comparisons within the 
experiment. Genes up-regulated are marked in green, genes down-regulated are marked in red. NA 
means that those genes were not transcribed significantly differently within that comparison 
(p>0.01). Infections were performed with FCV-F9. ID from cat genome Gene ID Mock 4 h vs 
Mock 7 h
Mock 4 h vs 
Infected 4 h
Mock 7 h vs 
Infected 7 h
Infected 4 h vs 
Infected 7 h
ENSFCAG00000019535 U5 3.72 NA NA 4.52
ENSFCAG00000019870 SNORD70 3.07 -2.79 NA 5.51
ENSFCAG00000019525 SNORA74 2.70 -2.30 NA 4.30
ENSFCAG00000020008 SNORD111 2.67 NA NA 4.31
ENSFCAG00000020237 SNORD79 2.62 -4.61 NA 5.87
ENSFCAG00000019817 SNORD72 2.68 -5.55 -2.61 5.62
ENSFCAG00000019540 SNORD112 2.21 -3.48 NA 4.37
ENSFCAG00000019860 No ID 2.30 -3.63 NA 4.45
ENSFCAG00000020177 SNORA65 2.36 -3.47 NA 4.61
ENSFCAG00000019548 snoZ40 2.50 -2.39 NA 4.67
ENSFCAG00000020113 SNORD63 4.00 NA NA 5.76
ENSFCAG00000019967 SNORD113 2.12 -3.59 NA 4.84
ENSFCAG00000019710 SNORA3 2.04 -2.83 NA 3.48
ENSFCAG00000019412 SNORD113 2.11 -3.52 NA 4.59
ENSFCAG00000019852 SNORD96 2.18 -3.88 NA 4.85
ENSFCAG00000020310 No ID 2.08 -3.52 NA 4.63
ENSFCAG00000020468 SNORA35 1.84 -5.44 -1.65 5.62
ENSFCAG00000019857 SNORA11 1.93 -2.50 NA 3.27
ENSFCAG00000019757 SNORA11 2.02 -3.48 NA 3.96
ENSFCAG00000019919 SNORA72 2.46 NA NA 4.31
ENSFCAG00000017742 U3 2.40 NA NA 4.52
ENSFCAG00000020135 SNORD15 1.76 NA NA 2.90
ENSFCAG00000019705 SNORA71 1.95 -2.48 NA 4.15
ENSFCAG00000020121 No ID 1.82 -1.98 NA 3.68
ENSFCAG00000019908 SNORA18 2.06 NA NA 3.05
ENSFCAG00000019682 SNORA5 2.13 -2.61 NA 3.84
ENSFCAG00000020027 SNORD52 2.09 -2.97 NA 4.68
ENSFCAG00000020119 SNORD113 1.82 -2.95 NA 4.29
ENSFCAG00000019800 SNORD35 1.79 -1.95 NA 3.58
ENSFCAG00000020098 snoU6-53 1.67 -2.37 NA 3.85
ENSFCAG00000013775 CYP1B1 -1.59 NA NA -1.67
ENSFCAG00000019570 SNORD18 2.50 NA NA 4.57
ENSFCAG00000017140 U2 2.86 NA NA NA
ENSFCAG00000003645_dup2 TXNRD1 -1.59 NA NA -2.23
ENSFCAG00000020281 SNORD71 1.49 -2.09 -1.45 2.13
ENSFCAG00000020040 SNORA21 2.08 -3.07 NA 4.78
ENSFCAG00000020262 SNORA27 1.78 -3.38 NA 5.19
ENSFCAG00000019725 SNORD113 1.55 -2.32 NA 3.06
ENSFCAG00000001125 KIAA1539 2.10 NA NA NA
ENSFCAG00000020211 U5 2.48 NA NA 3.52
ENSFCAG00000019827 SNORA64 1.76 -2.19 NA 3.75
ENSFCAG00000020187 No ID 1.85 NA NA 3.71
ENSFCAG00000019978 SNORA19 3.57 NA NA 4.30
ENSFCAG00000019820 U5 1.88 -3.18 NA 5.02
ENSFCAG00000019497 SNORND104 1.70 -2.96 NA 4.47
ENSFCAG00000020172 SNORD43 1.71 NA NA 3.24
ENSFCAG00000019687 SNORD62 1.79 NA NA 3.64
ENSFCAG00000019839 SNORD101 1.60 -2.94 NA 3.90
ENSFCAG00000019838 SNORD105 1.47 -1.88 NA 3.77
ENSFCAG00000020198 snoMe28S-Am982 1.76 -3.24 NA 2.79
ENSFCAG00000020194 SNORD49 2.26 -2.94 NA 4.04
ENSFCAG00000019574 SNORD83 1.52 NA NA 3.57
ENSFCAG00000007466 SLC40A1 -1.76 NA NA -3.43
ENSFCAG00000017534 5S_rRNA 1.99 NA NA 4.91
ENSFCAG00000019713 SNORA29 2.25 NA NA 4.70
ENSFCAG00000019614 SNORD18 4.09 NA NA NA
ENSFCAG00000019795 SNORD18 1.89 -1.17 NA 1.84
ENSFCAG00000020330 SNORA17 1.58 -2.46 NA 4.04
ENSFCAG00000019657 SNORA55 1.57 -2.11 NA 3.30
ENSFCAG00000019419 SNORD99 1.33 -1.65 NA 2.17
ENSFCAG00000020447 SNORA40 1.80 NA NA 4.81
ENSFCAG00000019994 SNORD25 1.56 -4.10 NA 5.35
ENSFCAG00000019961 SNORA46 1.33 -3.11 -1.61 2.83
ENSFCAG00000019465 SNORD75 1.49 -1.69 NA 2.49
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5.3.2 Gene Ontology 
Those genes that were found to have an adjusted p-value ≤0.01 were selected for 
further analysis by discovering the biological processes associated with each gene 
set. Not all of the differentially transcribed genes had this information available and 
so they had to be excluded from the functional analysis; a summary of these genes 
included can be found in Table 5.4. Each comparison group was interrogated for 
biological process functions and grouped according to the Gene Ontology (GO) 
definition. From these groupings, pie charts were constructed for all genes found 
within that comparison (Figs. 5.1 and 5.2). The overall pie charts show a large 
difference between the comparisons made at 4 h (Fig. 5.1) and 7 h p.i. (Fig. 5.2). In 
the comparison between the infected and mock infected groups at 4 h p.i. over 50% 
of the genes that had functional information available were found to be small 
nucleolar RNAs whereas this proportion drops dramatically in the comparison made 
between the infection states at 7 h p.i. where only 1% of the differentially transcribed 
genes were found to be small nucleolar RNAs. One the comparison is broken down 
further into up- and down-regulated transcripts (Figs. 5.3-5.6) then the picture 
becomes a little clearer. The vast majority of small nucleolar RNAs seen in the 
comparisons between infected and mock infected groups are down-regulated (Figs. 
5.4 and 5.6) which suggests that these RNAs are less useful to the virus during 
replication.  
Taking a closer look at the up-regulated genes from each infected vs. mock infected 
comparison it is clear that there are a vast range of genes undergoing transcriptional 
changes as a result of infection with FCV-F9. At 4 h p.i. the majority of the genes 
undergoing an increase in transcription were those involved in cellular signalling 
(11%), developmental processes (7%) and organ development (10%) whereas by 7 h 
p.i. the proportions of genes involved in these functions had dropped to 7% for 
signalling, 5% for developmental process and 5% for organ development. The 
majority of differentially transcribed genes at 7 h p.i. were genes involved in 
immune response (12%) and genes used in transcription (10%), the proportions of 
each of these gene functions were increased from the comparison made at 4 h p.i..  
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Comparison groups All genes Up-regulated genes Down-regulated genes 
With functional 
information 
Without 
functional 
information 
With functional 
information 
Without 
functional 
information 
With functional 
information 
Without 
functional 
information 
Mock 4 h vs. 
Infected 4 h 
149 23 22 10 127 13 
Mock 7 h vs. 
Infected 7 h 
132 50 124 50 8 0 
 
 
 
Table 5.4. Table showing summary of genes differentially transcribed (adjusted p value ≤ 0.01 from DeSeq analysis) in FEA cells in response to infection 
with FCV-F9 at 4 and 7 h p.i.. Only genes with functional information available from GO were included in further analyses. 
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0% 10% 20% 30% 40% 50%
Y RNA (0%)
Transport (2%)
Transcription (3%)
Spliceosomal RNA (3%)
Small nucleolar RNA (51%)
Signalling (5%)
Rnase (0%)
Response to virus (1%)
Response to stress (1%)
Response to protein stimulus (0%)
Response to external stimulus (3%)
Response to chemical stimulus (1%)
Regulation of cellular process (2%)
Regulation of cell proliferation (2%)
Regulation of biological process (4%)
Protein modification (0%)
Protein localisation (2%)
Organ development (5%)
Metabolic process (2%)
Immune response (3%)
Homeostatic process (1%)
Extracellular structure (0%)
Developmental process (3%)
Cytoskeletal organisation (0%)
Cell differentiation (0%)
Cell cycle (1%)
Cell adhesion (2%)
Apoptosis (1%)
Figure 5.1. Gene Ontology analysis of the biological processes of the genes significantly 
differentially transcribed in FEA cells in response to infection with FCV-F9 at 4 h p.i.. 
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0% 2% 4% 6% 8% 10% 12% 14%
Transport (1%)
Transcription (10%)
Small nucleolar RNA (1%)
Signalling (7%)
Response to virus (2%)
Response to stress (3%)
Response to stimulus (0%)
Response to radiation (0%)
Response to protein stimulus (1%)
Response to external stimulus (5%)
Response to chemical stimulus (6%)
Regulation of enzyme (1%)
Regulation of cellular process (1%)
Regulation of cell proliferation (2%)
Regulation of biological process (1%)
Proteolysis (1%)
Protein secretion (1%)
Protein modification (5%)
Protein localisation (1%)
Organelle organisation (1%)
Organ development (5%)
Metabolic process (8%)
Immune response (11%)
Homeostatic process (2%)
Extracellular structure (0%)
Developmental process (5%)
Cytoskeletal organisation (2%)
Cellular process (0%)
Cellular localisation (1%)
Cell differentiation (3%)
Cell cycle (1%)
Cell adhesion (7%)
Apoptosis (4%)
Adhesion to symbiont (0%)
Figure 5.2. Gene Ontology analysis of the biological processes of the genes significantly 
differentially transcribed in FEA cells in response to infection with FCV-F9 at 7 h p.i.. 
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Transport (5%)
Transcription (7%)
Small nucleolar RNA (1%)
Signalling (11%)
Response to virus (2%)
Response to stress (3%)
Response to protein stimulus (1%)
Response to external stimulus (7%)
Response to chemical stimulus(3%)
Regulation of cellular process (4%)
Regulation of cell proliferation (5%)
Regulation of biological process (9%)
Protein modification (1%)
Protein localisation (4%)
Organ development (10%)
Metabolic process (4%)
Immune response (6%)
Homeostatic process (2%)
Extracellular structure (1%)
Developmental process (7%)
Cytoskeletal organisation (1%)
Cell differentiation (1%)
Cell cycle (2%)
Cell adhesion (4%)
Apoptosis (2%)
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%
Y RNA (1%)
Spliceosomal RNA (5%)
Small nucleolar RNA (93%) 
Rnase (1%)
Figure 5.3. Gene Ontology analysis of the biological processes of the genes significantly 
up-regulated in FEA cells in response to infection with FCV-F9 at 4 h p.i.. 
Figure 5.4. Gene Ontology analysis of the biological processes of the genes significantly 
down-regulated in FEA cells in response to infection with FCV-F9 at 4 h p.i.. 
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Signalling (7%)
Response to virus (3%)
Response to stress (3%)
Response to stimulus (0%)
Response to radiation (0%)
Response to protein stimulus (1%)
Response to external stimulus (5%)
Response to chemical stimulus (6%)
Regulation of enzyme (1%)
Regulation of cellular process (1%)
Regulation of cell proliferation (2%)
Regulation of biological process (1%)
Proteolysis (1%)
Protein secretion (1%)
Protein modification (5%)
Protein localisation (1%)
Organelle organisation (1%)
Organ development (5%)
Metabolic process (7%)
Immune response (12%)
Homeostatic process (2%)
Extracellular structure (0%)
Developmental process (6%)
Cytoskeletal organisation (2%)
Cellular localisation (1%)
Cell differentiation (3%)
Cell cycle (1%)
Cell adhesion (7%)
Apoptosis (5%)
Adhesion to symbiont (0%)
0% 5% 10% 15% 20% 25% 30% 35% 40% 45%
Transcription (20%)
Small nucleolar RNA (33%)
Metabolic process (40%)
Cellular process (7%)
Figure 5.5. Gene Ontology analysis of the biological processes of the genes significantly up-
regulated in FEA cells in response to infection with FCV-F9 at 7 h p.i.. 
 
Figure 5.6. Gene Ontology analysis of the biological processes of the genes significantly down-
regulated in FEA cells in response to infection with FCV-F9 at 7 h p.i.. 
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5.3.3 Pathway analysis 
Significantly up-regulated and down-regulated genes were entered into the pathway 
analysis software, Pathway Studio (Ariadne) (Nikitin et al., 2003). The software has 
pre-constructed mammalian pathways available and once a gene list has been 
uploaded, the software automatically maps these genes onto the pathways and shows 
whether these genes have been up- or down-regulated. All of the significantly 
differentially transcribed genes from the comparisons mock vs. infected at 4 h, mock 
vs. infected at 7 h and also mock infected 4 h vs. mock infected 7 h were entered into 
the software.   
The results of the analysis showed that there were a number of pathways targeted 
during infection. Those pathways which had a number of genes which were 
transcriptionally up-regulated included actin cytoskeletal regulation (Figs. 5.7 and 
5.8), apoptosis regulation, B cell activation, natural killer cell activation and 
translation control (Appendix VIII). In each case the amount of genes up-regulated 
in a pathway as a result of infection increases with time. This could have been 
attributed to normal cellular processes becoming activated over time but the genes 
differentially transcribed in the mock infected group comparison were also inputted 
into the pathway analysis software and in each case none of the genes within these 
pathways were up- or down-regulated. These findings show that the up-regulation 
shown in the pathways is due to infection of the cell with FCV-F9 and as such it can 
be inferred that these pathways are important in viral replication and transmission 
but to what extent is unknown. The pathways found in this analysis match pathways 
found in the previous DIGE analyses (chapters 2 and 3) and also pathways identified 
by other studies. 
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Figure 5.7. Actin cytoskeletal regulation pathway. Pathway shows genes with up-regulated 
transcription in FEA cells during infection with FCV-F9 at 4 h p.i.. Those genes highlighted 
in red have up-regulated transcription in the infected samples, the brighter the colouration, 
the greater the up-regulation in transcription. A full key of gene identification can be found in 
the appendix (Table A8.1). 
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Figure 5.8. Actin cytoskeletal regulation pathway. Pathway shows genes with up-regulated 
transcription in FEA cells during infection with FCV-F9 at 7 h p.i.. Those genes highlighted 
in red have up-regulated transcription in the infected samples, the brighter the colouration, 
the greater the up-regulation in transcription. A full key of gene identification can be found in 
the appendix (Table A8.1). 
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5.4 Discussion 
This chapter describes the use of next-generation sequencing technology to relatively 
quantify transcripts from FEA cells infected with FCV-F9 at two time points post 
infection. By using SOLiD sequencing to rapidly sequence the RNA transcripts, a 
number of genes have been found to be differentially transcribed in response to 
infection and an accurate count of relative expression of these genes has been 
obtained.  
The genes analysed in this experiment were solely based upon those reads which 
mapped to existing genes on the current cat genome annotation although there were 
reads mapping to other unannotated areas found on the genome. In this current study 
there was not time to investigate these areas of mapping but these reads may be 
investigated in the future to aid further annotations of the cat genome through 
definition of gene exon boundaries and splice sites. There were also instances of 
reads from the SOLiD sequencing which did not map to the cat genome at all, again 
these reads will have to be revisited at a future date but they may be a useful tool in 
the development of a de novo method of SOLiD read assembly where a reference 
genome is not available or is not completed to a high enough standard for high 
quality mapping of reads. 
It has also been necessary to exclude the reads which have mapped to the FCV-F9 
genome in this analysis as the amount of reads mapping has given an average 
coverage of ~50 000x coverage of the viral genome. This coverage is too high for the 
details of the viral transcriptome to be elucidated and as such these reads will have to 
be bioinformatically processed much further before any discoveries about the way in 
which the viral genome is replicated can be found. However, this level of coverage 
does suggest that next-generation sequencing might now provide a cost-effective 
way of sequencing such variable genomes in a sequence independent manner, 
avoiding the difficulties of designing PCR primers (see chapter 6). 
5.4.1 DESeq 
Those genes which mapped to the genes already annotated on the current cat genome 
release were analysed using the DESeq statistical package (Anders, 2010) which 
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uses a negative binomial distribution based model to discover genes which are 
significantly up- or down-regulated within a sample with regard to a reference 
sample. The DESeq package is also able to calculate an adjusted p-value which takes 
into account the number of likely false discovery rate (Benjamini & Hochberg, 1995) 
and adjusts the p-value accordingly. Those genes with an adjusted p-value of <0.01 
were deemed to be truly differentially expressed and not just found as a result of 
chance. At present there is only one other study which has employed RNA-seq to 
compare the transcription levels in response to infection with a virus where RNA-seq 
was used in tandem with microarray and proteomic techniques to find differences in 
cells infected with hepatitis C virus (HCV) (Woodhouse et al., 2010). The results of 
their RNA-seq analysis found that 753 genes were differentially expressed in 
response to HCV infection whereas in this study we have found that 354 genes are 
up- and down-regulated in infected cells when compared to their uninfected 
counterparts. This would appear to show that HCV has a much greater effect on the 
transcription of genes within a cell than FCV. However, HCV was only sampled at 
one time point when ≥90% of cells were infected whereas in this study although a 
high m.o.i. was used it has been found that not all cells are infected at the same time 
which may have had an effect on the number of genes found to be differentially 
transcribed. The method used in the HCV study to assign differentially expressed 
status to genes was also different to the method described in our FCV experiment. 
They used the fold-difference coupled with the number of counts mapping to that 
gene as an arbitrary cut-off for differential expression rather than using a statistical 
package and this may have lead to an over estimation of differentially expressed 
genes in the HCV study. Finally, the HCV study was performed on infected human 
cells and so the transcript reads obtained in this study were matched to a genome that 
has much greater annotation than the feline genome. This should ensure that the 
majority of reads sequenced could be mapped to the genome and may be another 
factor in the apparent large discrepancy in identified gene numbers between this 
study and our FCV transcriptome study. Until more papers are published which use 
RNA-seq to establish gene transcription changes in cells infected with viruses it is 
difficult to know whether the results we have found during infection with FCV-F9 
are typical of a viral transcriptome experiment. 
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5.4.2 Pathway analysis 
Pathway analysis software (Pathway studio, Ariadne) (Nikitin et al., 2003) was used 
to group the differentially transcribed genes within known biological pathways. One 
pathway of interest which appears to contain a number of differentially expressed 
genes is the apoptosis regulation pathway which does correlate with previous 
research into FCV infection (Al-Molawi et al., 2003; Natoni et al., 2006; Roberts et 
al., 2003; Sosnovtsev et al., 2003). Studies have also shown that rather than just 
being a cellular response to combat viral infection, apoptosis is actually necessary 
for viral polypeptide processing through use of cellular caspase activity (Al-Molawi 
et al., 2003). There were very few examples of apoptotic proteins being identified 
within the two 2D-DIGE experiments (chapters 2 and 3), which suggests that these 
two techniques do not correlate with each other fully. 
Actin was found to be differentially expressed in both 2D-DIGE analyses (chapters 2 
and 3) and Figure 5.7 shows up-regulation of genes within the actin regulatory 
pathway which again suggests an importance in viral infection. As discussed in 
previous chapters (chapters 2, 3 and 4), the host cytoskeleton plays a large role in the 
movement of virions around an infected cell and also has a role in promoting cell-
cell spread (Cudmore et al., 1995; Sodeik, 2000). Further work is needed to ascertain 
exactly how FCV uses these proteins but these are the most consistently modulated 
genes and proteins found within all of the comparisons and so it clear that they have 
a role to play in FCV infection within the cell.  
The remaining three pathways, whilst not confirmed by the literature or the 
proteomic analyses, appear to be consistent with viral infection. Whilst the cells used 
in this experiment were neither B cells nor natural killer cells the genes necessary to 
activate these cells have been shown to be up-regulated within the infected cells. 
This may be part of the adaptive immune response to viral infection and as such may 
be a response that the virus elicits within the cell which is detrimental to its survival.  
The up-regulation of the translation control pathway is also, perhaps an expected 
consequence of viral infection. The virus, once it enters the cell has an aim to 
replicate as many times as possible, and for this to happen a large amount of 
translation of the viral genome would have to occur. Therefore, it would be 
advantageous to increase the amount of the control proteins available within the cell. 
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There are also genes present within this analysis which have an effect upon more 
than one pathway (Appendix VIII). For example, DUSP is present in four of the five 
pathways modulated during infection. DUSP is a dual specificity phosphatase which 
inactivates many proteins within the cell through dephosphorylation and so appears 
in many pathways of regulation and control (Patterson et al., 2009). With DUSP 
being so ubiquitous within many pathways, it is difficult to know whether all 
pathways are being affected by the up-regulation in transcription in this gene, or if 
perhaps the effects are more targeted through the modulation of surrounding genes 
and proteins. Until more specific assays are used to quantify the changes in these 
types of genes and of their target genes and proteins either by real-time PCR or 
quantitative proteomics (e.g. QconCAT (Pratt et al., 2006)) the ultimate effect of 
their up-regulation cannot be determined. 
5.4.3 Comparing RNA-seq and proteomic results 
With the RNA-seq experiment performed in this chapter mirroring the FCV strain 
and time points used in the proteomic experiments, a comparison of differentially 
expressed genes and proteins should be possible.  
Looking at all of the identifications of the differentially expressed proteins of the two 
2D-DIGE experiments (chapters 2 and 3, Appendix I and II) and the differentially 
transcribed genes in the RNA-seq study (Appendix VII) it would appear that there is 
very little correlation between the genes identified and the proteins expressed. There 
are also no significant matches in the GO analyses with the DIGE experiments 
proving to have a much larger proportion of cytoskeletal proteins than any of the 
RNA-seq comparisons. The pathway analysis of the RNA-seq genes, however, 
shows that there are some significant genes up-regulated within the actin cytoskeletal 
regulation pathway. This does correlate with the findings of the previous 2D-DIGE 
experiments and fits with the hypothesis that the virus is acting upon the host 
cytoskeleton in order to aid replication and spread.  
This poor correlation between transcription levels and protein expression is not 
uncommon amongst studies where transcriptomics and proteomics are run in parallel 
(Barros et al., 2010). Rogers et al, (2008) suggest that the relationship between 
transcription and translation diverges with evolution as organisms such as bacteria 
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and yeast often show good correlation whereas in mammalian samples the 
correlation becomes much weaker.  The authors hypothesise that the transcriptional 
and translational networks have evolved independently within the cell and so they 
are not directly linked which may explain the often seen discrepancies between 
transcriptomes and proteomes. Another analysis performed by Wang et al, (2010) 
gave a hypothesis that transcription and translation contained a time-delayed 
component and once this is taken into account then the correlation is much greater.  
The overall results from this study show that there are a large number of genes 
whose transcription is significantly altered as a result of FCV-F9 infection and 
although this investigation was only possible upon genes previously annotated upon 
the feline genome there was still a vast amount of data generated. Future 
interrogation of the data will rely heavily upon bioinformatics methods but now the 
data has been generated it may be useful in driving forward the annotation of the cat 
genome.   
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6 Chapter six 
Sequence analysis of a UK outbreak of virulent systemic FCV 
6.1 Introduction 
Infection with FCV has been shown to be associated with a wide range of clinical 
signs although until recently these clinical signs have generally been found to be self 
limiting with a low mortality rate. In recent times outbreaks of new, highly virulent 
strains of FCV have been reported in the USA and Europe which show much greater 
mortality rates and clinical signs.  
The first three outbreaks were reported in the USA (Hurley et al., 2004; Pedersen et 
al., 2000; Schorr-Evans et al., 2003) and followed similar patterns. Cats infected 
during the outbreaks showed clinical signs such as fever, anorexia, oedema of face 
and limbs, oral ulceration, ocular and nasal discharge, jaundice and a very high 
mortality rate of up to 50%. There have also been two similar outbreaks in Europe; 
one in the UK (Coyne et al., 2006b) and one in France (Reynolds et al., 2009). In 
France the outbreak occurred at a veterinary teaching hospital in 2005 and the 
clinical signs observed were similar to those from the US outbreaks. The overall 
mortality rate was even higher than the previous outbreaks reported with 63% of cats 
dying or being euthanised. 
The viruses used in this chapter have been isolated from the UK outbreak of VS-
FCV, reported by Coyne et al in 2006. The UK outbreak was traced back to three 
kittens being initially fostered from a local rescue shelter into the home of one of the 
workers at the shelter. During the fortnight following the fostering two of the kittens 
died. Subsequently, three of the four cats already living in this foster household went 
on to exhibit signs of infection with VS-FCV. All three of these cats suffered pyrexia 
and voice loss with two of the three also suffering some form of leg pain/lameness. 
Only one of the three cats infected in the foster household suffered lethargy, oedema, 
vomiting and jaundice. A fourth cat was also infected during this outbreak but this 
cat lived in the household next-door to the foster home. This cat experienced fever, 
lethargy, voice loss and jaundice during the course of infection and was eventually 
euthanised. In this outbreak five of the affected kittens and cats died or were 
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euthanised giving an overall mortality rate of 71% which again is in keeping with the 
previous reports. VS-FCV was isolated from the three dead adult cats and given the 
nomenclature UKOS-A, UKOS-B and UKOS-W. Capsid sequencing was performed 
upon these three isolates and the results were compared to the other outbreak strains, 
other published genomes and some unpublished lab strains using phylogenetic 
analysis (Fig. 6.1, reproduced from Coyne et al (2006b)). 
 
 
 
 
Also as part of the Coyne et al study into this outbreak, FCV isolates were collected 
58 days after the outbreak began from 28 of 42 cats housed in the local rescue shelter 
where the 3 kittens were fostered from. These types of shelters have previously been 
shown to have higher prevalences of FCV than private cat homes and that there are 
often a number of strains found circulating within them (Radford et al., 2001) 
(Bannasch & Foley, 2005). As such there are also more chances of recombination 
Figure 6.1. Phylogenetic tree based upon capsid sequence. Included in this analysis are the three 
UKOS strains; FCV-Ari (Pedersen et al., 2000), FCV-Kaos (Hurley et al., 2004), FCV-Diva 
(Schorr-Evans et al., 2003). Also included are FCV-F9 (Genbank M86379), LS012 (Genbank 
AF109467), LS015 (Genbank AF109464), F65 (Genbank AF109465), CF168 (Genbank U13992), 
255(Genbank U07131) and unpublished field viruses (S090 and V818) (Coyne et al., 2006b).  
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events occurring within these shelters and colonies which can aid rapid evolution of 
FCV strains (Coyne et al., 2006c). It has been hypothesised that such environments 
provide the ideal environment for the evolution of the hypervirulent phenotype 
(Coyne et al., 2006b). Selection pressures within the colony favour the selection of 
rapid high titre replication as such viruses are likely to have a high transmission 
advantage. Within the confines of the colony, cats in the shelters acquire and evolve 
immunity in a progressive, step-wise fashion, in parallel with this viral evolution, 
allowing the replication of these viruses to be controlled within relatively low limits, 
preventing manifestation of VS-FCV symptoms. However, when these virus strains 
are introduced to naïve populations, these newly infected cats have no strain-
matched acquired immunity and so are unable to fight off the infection in the same 
manner, such that the shelter viruses are able to fulfil their high titre/fast replication 
rate phenotype leading to the development of the severe clinical signs associated 
with VS-FCV. Such a mechanism would allow each outbreak of VS-FCV disease to 
be associated with a new strain of FCV. 
The collection of isolates from the UK outbreak has for the first time, allowed some 
analysis to be made on the relatedness of the UKOS strains to those found within the 
rescue shelter from where the putative index case kittens originated. This has already 
been done using sequence analysis of a small region of the polymerase gene (Coyne, 
2005), showing that the rescue shelter contained at least five strains of FCV. The 
most frequently recognised strain in the rescue shelter was FCV-UKOS, confirming 
the shelter as the likely source of this outbreak, despite the fact that the cats in the 
shelter were generally healthy. Within the shelter, viruses belonging to this strain 
were highly diverse, with some viruses being extremely similar to this found in the 
dead cats, whilst others were less similar. 
The aim of this chapter was two-fold. Firstly, further sequence analysis of the 
genome of one of the strains isolated from a cat which died during the outbreak 
(UKOS-A) was attempted to discover whether there are any characteristics found at 
the sequence level that are similar to other outbreak strains which have previously 
been sequenced and published. If there are areas of sequence which are very similar 
in strains isolated from VS-FCV outbreaks then it could be hypothesised that these 
areas are important in the increased virulence and mortality associated with these 
virus strains. 
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Secondly, we wish to capitalise on the unparalleled availability of viral strain 
variants of FCV-UKOS in the rescue shelter, to further characterise the diversity and 
evolution of FCV in this environment. In particular, by analysing sequence of the 
capsid gene (complimenting the already available polymerase sequence), it was 
hoped to discover how much strain variation was present in the shelter and whether 
there were any recombination events occurring that may have aided evolution of a 
hypervirulent strain.     
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6.2 Materials and methods 
6.2.1 Virus strains 
Virus strains used were recovered from a rescue shelter involved with an outbreak of 
virulent systemic FCV (Coyne, 2005).  
Partial polymerase gene sequences equivalent to 486 bp from position 4766-5251 of 
the genome, are already available for 27 viruses from this shelter. This suggested this 
colony contained only five strains. Using these viruses R564, R573, R572, R581, 
R580, R593, R591 and R584 were selected to have capsid gene sequence obtained as 
they represented a broad selection of viruses, including at least one of each of the 
strains found within the colony. 
6.2.2 RT-PCR of capsid gene and sequencing 
RNA extraction, reverse transcription and subsequent PCR were all performed as 
previously described (section 2.2.2). The primers used to amplify the hypervariable 
regions C and E of the capsid gene were also described previously (section 2.2.2.3) 
(Table 6.1). The PCR products were purified using the QIAquick PCR purification 
kit (Qiagen) and sequencing was performed by Eurofins MWG Operon (section 
2.2.2.5). 
 
Primer name Sequence (5’ – 3’) Binding site 
relative to F9 (nt) 
P1_degen 
(forward) 
GAG CGG ATA ACA ATT TCA CAC AGG CCG 
TTY GTG TTY CAR GCA AAY CG 
6381-6428 
P2_ext 
(reverse) 
CCT CAC CTA TAC CAG TGT AAC CAA G 6910-6935 
 
Table 6.1. Sequences of primers used to amplify the hypervariable regions C and E of the 
capsid gene of virus strains R564, R573, R572, R581, R580, R593, R591 and R584. 
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6.2.3 Sequence analysis 
The forward and reverse sequences obtained from each PCR product were aligned in 
Chromas Pro (Technelysium Pty Ltd) and a consensus sequence produced for each 
amplicon as previously described (section 2.2.2.6). 
Separate alignments of polymerase gene sequences and capsid gene sequences were 
then produced using Clustal as implemented in Mega 4 (Tamura et al., 2007). The 
phylogenetic trees were drawn using neighbour joining with the Kimura 2 parameter 
substitution model with the significance of the observed phylogeny assessed using 
1000 bootstraps. 
6.2.4 RT-PCR of polymerase gene to capsid gene and sequencing 
In order to further characterised viruses in this shelter, attempts were made to bridge 
the gap from the partial sequence of the polymerase gene to the partial sequence of 
the capsid gene for those viruses where available. Primers were designed based on 
the previously obtained (this study and Coyne (2005)) partial capsid and polymerase 
sequences. This PCR was successful for four virus strains; R580, R581, R591 and 
UKOS-A. The primers that allowed successful amplification are detailed in Table 
6.2. 
 
Virus 
amplified 
Primer 
name 
Sequence (5’ – 3’) Binding site 
relative to 
F9 (nt) 
R580 w580_for CGG CTT GAA ACC CAC ACG AGT AG 4858-4880 
w580_rev CGA TGT AAT CTG TTG CGA TCC C 6550-6529 
R581 w581_for GGC TGT TGA ATG TGA GGG ATT G 5169-5190 
w581_rev  CAG GAA CAA TGG AAT CAG TGG C 6553-6532 
R591 w591_for GGC AGA AAG AGC TGT GGA ATA CG 5146-5168 
w591_rev TCA GTT GCT ATT CCG GTG CC 6542-6523 
UKOS-A w494_for CGC CAG TCA ACA TGG TGT TG 5099-5118 
w494_rev GCC AGG AAC AAT AGA ATC AGT GGC 6558-6535 
Table 6.2. Primers used to amplify the region of the FCV genome from the polymerase 
gene to the capsid gene. 
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PCR was performed as previously described (section 2.2.2.4) and PCR products 
were purified using the QIAquick PCR purification kit. Where more than one band 
appeared on an agarose gel, the band of the correct size was excised from the gel and 
purified using QIAquick gel extraction kit (Qiagen).  
Sequencing was performed bidirectionally by MWG Eurofins according to their 
recommended protocols (section 2.2.2.5).  
6.2.5 Sequence analysis 
The forward and reverse sequences obtained from each PCR product were aligned in 
Chromas Pro (Technelysium Pty Ltd) and a consensus sequence produced as 
previously described (section 2.2.2.6). 
Each polymerase - capsid gene sequence was then aligned to each other in Mega 4 
(Tamura et al., 2007) and analysed using Simplot (Lole et al., 1999). Simplot creates 
similarity plots in comparison to one query sequence. In this experiment, each strain 
was compared to UKOS-A, the UK outbreak strain to discover how different or 
similar the different strains from the same shelter were. Simplot is also a useful tool 
in discovering whether any of the strains analysed could potentially be a recombinant 
strain.  
6.2.6 Sequencing the outbreak strain UKOS-A 
At the time of starting this project full genome sequence was only available publicly 
for two other strains of FCV associated with outbreaks around the world (Abd-
Eldaim et al., 2005). Therefore, we aimed to sequence the full genome of the UKOS-
A strain. Primer pairs were designed based upon consensus sequence of other viruses 
to produce PCR products that would span the whole genome and could be sequenced 
bidirectionally to give the full genome sequence. The primer pairs used and binding 
sites relative to FCV-F9 are given in Table 6.3. 
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Part 
name 
Primer name Sequence (5’ – 3’) Binding site 
relative to F9 
(nt) 
Part A vpol1_for GGACAACAGCTCTGGAATGCATG 5078-5100 
vRegionE2_rev TCACTGGGGATTGTTGTGTCTGG 6572-6594 
Part B vPart1_for CCAGTTTGTTACATTCTTACCGGCCC 1448-1473 
vMid1_rev AGCCCAGGCCAAATCAAACACCG 2457-2479 
Part H pcrH_for GGCTTGCCTCAAACATTAGGAGTG 7289-7312 
vPart3_rev CCCTGGGGTTAGGCGCAAGTGCG 7668-7690 
Part J J_for TCAAACTCTGAGCTTCGTGCT 25-45 
J_rev ACAAACCTCATTGCCTGTGT 1575-1595 
Part K A-H_for TCCTAGGTAATCGCCCAATCA 6358-6379 
A-H_rev AGCCCGAAGGGATACATGA 7647-7665 
 
6.2.7 RT-PCR and sequencing 
RNA extraction, reverse transcription and PCR were all performed as previously 
described (section 2.2.2.1). 
Purification of the PCR products was performed as before using the QIAquick PCR 
purification kit (Qiagen) if a single band was present after agarose gel 
electrophoresis or where multiple bands were produced, the band of the correct size 
was excised from the gel and purified using QIAquick gel extraction kit (Qiagen). 
Sequence analysis was performed as previously described to produce consensus 
sequence and each sequence part was then compared to F9 (Genbank accession 
m86379). 
Table 6.3. Primers pairs used in the sequencing of the UKOS-A strain of FCV along with 
binding sites relative to FCV-F9 
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6.3 Results 
6.3.1 Analysis of outbreak shelter strains. 
To try to understand the evolution of the strains involved in the VS-FCV outbreak in 
the UK isolates were obtained from the rescue shelter involved in the outbreak and 
polymerase sequence was obtained for 25 of the 28 isolates (Coyne, 2005). In this 
study capsid gene sequences were analysed to discover whether the groupings 
obtained from the polymerase sequences were consistent along the genome or 
whether possible recombination events had occurred within the colony. Of the eight 
strains selected based on the polymerase gene analysis for further capsid sequencing 
four were successfully amplified by PCR and sequenced bi-directionally. Figure 6.2 
shows a phylogenetic tree of the strains from the shelter successfully sequenced for 
the polymerase gene (work completed by Dr Karen Coyne) and those strains for 
which capsid gene sequence was obtained. Strains highlighted with asterixes are 
those obtained during this project; all other strains were obtained previously (Coyne, 
2005). From the results of the phylogenetic tree analysis two potential recombinants 
were identified. Strain R580 clustered in group 1 on the polymerase gene tree but 
was isolated from group 1 on the capsid gene tree. Strain R593 also clustered within 
group 1 on the polymerase tree but within group 2 on the capsid tree.  
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Figure 6.2. Phylogenetic tree analysis of capsid and polymerase gene sequences isolated from cats housed at the rescue shelter involved in the UKOS outbreak 
produced from Clustal W alignments through neighbour joining with Kimura 2 parameters. UKOS-A is the outbreak strain studied in this chapter, UKOS-W 
was recovered from one of the other dead cats. Capsid sequences obtained by the author during this study are marked with an asterixes. All other sequences 
were obtained by Dr Karen Coyne and the polymerase tree is reproduced from Coyne (2005). Scale bar represents percentage divergence. 
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To test the hypothesis that recombination had occurred within the shelter, primers 
were designed within the polymerase gene sequence and within the capsid gene 
sequence for strains which had both present. However; only R591, R581, R580 and 
UKOS-A were successfully amplified. Good polymerase-capsid bidirectional 
sequence was obtained for strains R591, R581 and R591 whereas the sequence 
obtained from R580 suggested this was a mixed infection. Figures 6.3 and 6.4 show 
the electropherograms of UKOS-A aligned with R580 in both the forward and 
reverse directions and these show evidence of a mixed infection within R580 which 
could be a cause of R580 grouping alongside different strains for the two genes 
sequenced. In Figure 6.3, the two sequences do not align well with each other but 
when you look at the minor sequence underneath the peaks in sequence from strain 
R580, the sequences seem to align much better and this may be evidence of two 
strains being amplified within this PCR. The other electropherogram (Fig. 6.4) 
shows that the sequences for R580 and UKOS-A align with each other. However, the 
sequence from strain R580 has much more background noise which again suggests 
that there are more than one strain being amplified by this PCR.    
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Figure 6.3. Electropherogram screenshot of forward sequence obtained for R580 (top panel) and 
UKOS-A (bottom panel). Sequence from UKOS-A appears to align with the “minor” sequence 
observed in the R580 sequence. 
Figure 6.4. Electropherogram screenshot of reverse sequence obtained for R580 (top panel) and 
UKOS-A (bottom panel). Sequence from R580 contains a large amount of background noise 
which may indicate difficulties in amplification of a single strain from a mixed infection. 
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To further scrutinise the sequence of R580 for possible recombination, a SimPlot 
analysis (Lole et al., 1999) was performed where the polymerase-capsid sequence 
obtained for R580, R581 and R591 was plotted against UKOS-A to find areas of 
similarity and differences. Figure 6.5 shows the result of this plot and the trace 
shows that the sequence obtained for R580 is very similar to the sequence it was 
compared against; UKOS-A. This provides further evidence that R580 was not a 
recombinant virus and that the differences found when analysing the phylogeny of 
the two genes was a result of a mixed infection. The original PCRs performed may 
have preferentially amplified different strains within the mixed infection for each 
gene and as a result grouped separately on the two trees. The other two viruses 
analysed against the UKOS-A strain behaved in the expected manner with R591 
being the least related to the UKOS strain which was anticipated from the 
polymerase and capsid gene phylogenetic tree analysis. 
Fig. 6.5. Simplot analysis of the polymerase-capsid sequence of R580, R581 and R591 compared 
to the UKOS-A strain. The strains which show greatest similarity to the query strain UKOS-A 
will plot a higher line on the graph. 
R580 
R581 
R591 
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6.3.2 Sequencing of the outbreak strain UKOS-A 
In order to discover whether there are any obvious signs of differences between the 
putative outbreak strain and other typical strains of FCV an attempt was made to 
sequence the whole genome of UKOS-A; the strain recovered from a cat which died 
of virulent systemic FCV. The capsid gene sequence of the UKOS outbreak strains 
including UKOS-A had previously been found to be unrelated to the capsid gene 
sequences recovered from the other outbreak strains (Fig. 6.1) or those of other 
published FCV genomes.  
At the beginning of this study 1436 bases of the UKOS-A virus were known. Within 
this experiment four further amplicons were obtained giving an additional 2087 
nucleotides of sequence and a total of 3523 bp of known UKOS-A sequence (Fig. 
6.6). Part B gave partial sequence for ORF 1 which encoded for the viral non-
structural protein; part A bridges the gap between the polymerase gene in ORF1 and 
part of the capsid gene encoding for protein VP1 in ORF2; part K also bridges the 
gap between ORF 2 and ORF3 from the VP1 protein to VP2 and part H includes the 
remaining sequence for ORF 3 which encodes for the viral protein VP2. For each of 
the new genome segments sequenced there was no evidence of global rearrangement 
or insertion/deletion (data not presented). 
 
 
 
 
Figure 6.6. Position of sequence parts A, B, H and K as compared to FCV-F9 (Genbank 
M86379). Numbers at the end of each arrow show the base position start number and end 
number.  Diagram above shows the position of the three open reading frames found upon FCV-
F9 including the position of the divisions labelled in nucleotides from 5‟ to 3‟. 
5‟ 3‟ 
5122 7170 
ORF1 ORF2 ORF3 
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Each of the parts obtained for strain UKOS-A were compared to published complete 
FCV genome sequences and a bootstrapped phylogenetic tree constructed (Figs. 6.7-
6.10). The list of genomes used in the alignment and comparison can be found in 
Table 6.4. 
 
 
FCV strain name Genbank Accession 
Number 
Reference 
FCV-F9 M86379 (Carter et al., 1992) 
FCV USDA AY560118 (Abd-Eldaim et al., 2005) 
FCV 2024 AF479590 (Thumfart & Meyers, 2002) 
FCV/DD/2006 DQ424892 Unpublished, submitted by Behm  et al 2006 
FCV F4 D31836 (Oshikamo et al., 1994) 
FCV GD GU214989 Unpublished, submitted by Hua  et al 2009 
FCV F65 AF109465 (Glenn et al., 1999) 
FCV CFI/68 U13992 Unpublished, submitted by Neill 1998 
FCV Urbana L40021 (Sosnovtsev & Green, 1995) 
FCV UTCVM-NH1 AY560113 (Abd-Eldaim et al., 2005) 
FCV UTCVM-NH2 AY560114 (Abd-Eldaim et al., 2005) 
FCV UTCVM-NH3 AY560115 (Abd-Eldaim et al., 2005) 
FCV UTCVM-H1 AY560116 (Abd-Eldaim et al., 2005) 
FCV UTCVM-H2 AY560117 (Abd-Eldaim et al., 2005) 
  
Table 6.4. Whole genome sequences used in alignments with UKOS-A partial sequences 
and phylogenetic tree construction. Strains UTCVM-H1 and UTCVM H2 are believed to be 
hypervirulent strains of FCV. 
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Figure 6.7. Bootstrapped phylogenetic tree based on alignment of whole genome sequences with part 
A of UKOS-A, polymerase gene to capsid gene sequence. Details of FCV whole genome sequences 
used in this comparison can be found in Table 6.4 . 
Figure 6.8. Bootstrapped phylogenetic tree based on alignment of whole genome sequences with part 
B of UKOS-A, partial ORF1 sequence coding for non-structural proteins. Details of FCV whole 
genome sequences used in this comparison can be found in Table 6.4  
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Figure 6.9. Bootstrapped phylogenetic tree based on alignment of whole genome sequences with part 
H of UKOS-A, ORF3 sequence encoding for VP2. Details of FCV whole genome sequences used in 
this comparison can be found in Table 6.4  
Figure 6.10. Bootstrapped phylogenetic tree based on alignment of whole genome sequences with part 
K of UKOS-A, ORF2 sequence encoding for viral protein VP1. Details of FCV whole genome 
sequences used in this comparison can be found in Table 6.4  
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The results of the phylogenetic tree analysis show that each part of the sequence 
obtained from UKOS-A is not related to any of the previously published full FCV 
genomes as it groups separately on every tree produced. Within the group of 
genomes used in the analysis were two hypervirulent strains isolated in USA in 1999 
and 2002 (Abd-Eldaim et al., 2005) designated UTCVM-H1 and UTCVM-H2. With 
the UKOS-A strain not grouping with either it appears that the strain evolved 
independently during each outbreak. 
The Abd-Eldaim et al study also found evidence of motifs (Fig. 6.11) included in the 
amino acid sequence of the capsid protein VP1 for the hypervirulent strains and so 
evidence of these motifs being conserved within the UKOS-A strain was examined 
alongside further possible motifs highlighted in the Foley et al study (2006). The 
result of this investigation can be seen in figure 6.11. 
   
 
Figure 6.11. Alignment of the amino acid sequence of five VS-FCV strains (FCV-Kaos 
Genbank accession number DQ910795.1, Cat 15 Genbank accession number L40021, 
FCV-Ari Genbank accession number DQ910794, FCV UTCVM-H1 Genbank accession 
number AY560116 and FCV UTCVM-H2 Genbank accession number AY560117) with 
FCV-F9 and UKOS-A for the VP1 protein from residue 426 to residue 480. * denotes 
positions of suspected hypervirulent motifs reported in Abd-Eldaim et al, 2005. # 
denotes positions of suspected hypervirulent motifs reported in Foley et al, 2006.  
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The alignment results in Fig 6.11 show that none of the motifs reported in the 
previous studies are consistent across all five hypervirulent strains included and 
UKOS-A. Only two of the substitutions observed within the two previous studies 
were found to be present in the UKOS-A strain, the first motif from Foley et al at 
amino acid position 430 and the first substitution found within the Abd-Eldaim et al 
study at amino acid position 441. The final substitution found within the Foley et al 
paper (amino acid position 452) is also an interesting potential marker of 
hypervirulent strains as although it does not appear within the UKOS-A sequence it 
is consistently changed within the confirmed VS-FCV strains from aspartic acid to 
glutamic acid. 
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6.4 Discussion 
The emergence of highly virulent strains of FCV has been a worrying development 
in recent times, with each outbreak of VS-FCV being associated with a high 
mortality rate and systemic clinical signs. Each reported outbreak has appeared to 
follow a very similar pattern, with the same symptoms being reported and with 
similar outcomes in each case. As the outbreaks appear to be so similar it may be 
most logical to assume that it is the same strain of virus circulating within each 
epizootic incident. However, each of the viral strains isolated and sequenced grouped 
separately on phylogenetic trees (Coyne et al., 2006b; Hurley et al., 2004; Pedersen 
et al., 2000; Reynolds et al., 2009; Schorr-Evans et al., 2003). These findings prove 
that the viral strains isolated from each outbreak have evolved independently and are 
not a result of transmission of a single strain.  
The origins of these strains and the evolution patterns associated with the outbreaks 
may be an important characteristic of the VS-FCV outbreaks and analysing them 
closely could give clues as to why these strains develop. In each of the VS-FCV 
reports, the outbreak is often anecdotally linked to the introduction of a cat or cats 
from a shelter into a veterinary hospital or private household. However, to date, this 
link has never been proven by molecular epidemiology and sequence analysis. In the 
UK outbreak, this link between the infection within the private households and the 
rescue shelter has been previously suggested based on partial polymerase gene 
sequences (Coyne et al., 2006a). In this study we have confirmed this finding by 
showing that capsid sequences from the outbreak also cluster closely with viruses 
within the rescue shelter (Fig 6.2). 
In previous studies within multi-cat colonies and shelters it has been shown that FCV 
evolves progressively within a population to allow re-infection of previously infected 
cats (Coyne et al., 2007) and also that two strains of FCV have the ability to 
recombine to provide an additional mechanism to rapidly evolve strains with a 
greater infectivity within a colony. From analyses performed within this chapter and 
previously (Coyne, 2005) there is evidence that both of these mechanisms may have 
been employed by the virus within the shelter at the time of the evolution of the 
UKOS strains. Figure 6.2 shows a large number of strains grouped within group 1 
for the polymerase gene which is the group that included the UKOS strains which is 
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indicative of a gradual evolution towards the outbreak strains. The capsid gene 
sequence analysis shown in Figure 6.2 also gave evidence that recombination may 
have been occurring within the FCV strains in the shelter with isolates R580 and 
R593 grouping differently on the capsid and polymerase genes. Further investigation 
of these possible recombination events was attempted by sequencing from 
polymerase gene to capsid gene; however, amplification of isolate R593 was 
unsuccessful. Analysis of the sequence obtained for isolate R580 suggested that the 
mismatched grouping between the polymerase and capsid gene was not a result of 
recombination but was more likely to be a product of a mixed infection. The 
alternate grouping along the polymerase and capsid trees is therefore most probably 
due to the PCRs performed for both of these genes preferentially amplifying 
different strains in the capsid and polymerase region, giving the false impression of a 
recombination event. A mixed infection may also be the reason R593 was difficult to 
amplify from polymerase gene to capsid gene. The primers used were designed from 
the sequences obtained from the capsid gene and polymerase gene amplifications 
and if these were generated from two separate strains then the primers pairs will have 
been unlikely to match up. This observation is why recombination events should 
only be formally defined based on sequencing a single molecule (Coyne et al., 
2006c). 
Within this chapter an attempt was also made to sequence the entire genome of 
UKOS-A to try and identify genetic lesions associated with its putative hypervirulent 
phenotype. Unfortunately whole genome sequence could not be obtained and this 
may be due to the method used as designing primer pairs for a virus known to have 
such a variable genome is difficult. As demonstrated in the previous chapter (chapter 
5) next-generation sequencing could be the answer to this problem as during the 
RNA-seq experiment the FCV-F9 genome was sequenced to a coverage of ~50 000x 
in a relatively short space of time and without the need to design primer pairs based 
upon variable genomes. 
Abd-Eldaim et al in 2005 did manage to obtain full genome sequence two VS-FCV 
strains and compare these to three FCV strains isolated from cats exhibiting clinical 
signs of more typical FCV infection. The results of the sequence analysis in this 
2005 study found that each strain was approximately 80% similar to other FCV 
strains suggesting that the VS-FCV strains sequenced are no more similar or 
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different than more typical FCV strains sequenced. These finding are consistent with 
those found in this chapter. In particular, in each of the four parts of UKOS-A 
sequenced, the virus was found to be equally distinct from other FCV strains, 
whether they were obtained from hypervirulent or more typical outbreaks of FCV-
related disease. 
The UKOS-A strain was also examined to discover whether it contained any of the 
sequence motifs previously observed to be a marker of hypervirulent strains in the 
amino acid sequence of the VP1 protein (Abd-Eldaim et al., 2005; Foley et al., 
2006) (Fig 6.11). There were no motifs identified that were consistently found in all 
of the hypervirulent strains studies and the UKOS-A strain. There were two amino 
acid substitutions found in these previous studies which also appeared within the 
translated UKOS-A sequence but there was also one motif found that had a 
consistent amino acid substitution within all of the VS-FCV strains but was absent 
from the UKOS-A strain. It is worth noting at this point that UKOS-A is a putative 
hypervirulent strain, it has not been used to recreate VSD experimentally in cats and 
so this may be a reason it does not share this consistent amino acid substitution with 
the confirmed VS-FCV strains. There is also evidence that these changes which are 
consistent within the VS-FCV strains may occur as part of the natural variation 
found within these regions of the capsid protein as a further brief search using this 
motif at amino acid position 452 shows that non-virulent strains from Australia 
(Genbank accession number AAF186244) and the UK (Genbank accession number 
ABD72469) also show the change from aspartic acid to glutamic acid at this 
position. 
The lack of consistent genetic changes associated with the virulent strains of FCV is 
not a trait that is unique within the Caliciviridae. Rabbit Haemorrhagic Disease 
Virus (RHDV) has also been found to have pathogenic and non-pathogenic strains of 
virus and analysis of the genetic diversity of these phenotypically different virus 
strains has been unable to find a genetic cause of virulence (Moss et al., 2002; White 
et al., 2004). It may therefore be a characteristic of the calicivirus family that 
pathogenesis associated with strains may be determined more by host-immune 
response than the genetic characteristics of the virus strains. However, since the 
hypervirulent phenotype can be reproduced experimentally for both RHDV and 
FCV, it suggests that as yet unidentified, subtle and perhaps inconsistent genetic 
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lesions are responsible for this complex phenotype in each outbreak. Ultimately, it 
will be necessary to sequence many more virulent viruses in order to identify any 
such subtle lesions within the complex diversity observed between distinct FCV 
strains. 
In summary, within this chapter we have been able to obtain sequence for 46% of the 
UKOS-A genome including all of ORF3 and all but 86 bases of ORF2. Analysis of 
the sequence has shown that there were no large scale genetic mutations identified 
and no substitution consistently found within VS-FCV strains was found within the 
UKOS-A strain. This suggests that these mutations may not be necessary for 
virulence however, UKOS-A is not a proven VSD causing strain and until 
experimental infections are conducted it is difficult to include this strain alongside 
the other VS-FCV strains.  
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7 Chapter seven 
General discussion and future perspectives 
This thesis aimed to use new post-genomic techniques and technologies to examine 
the molecular pathogenesis of feline calicivirus (FCV) infection and also the validity 
of using these techniques within a virological setting.  
Previous work has established FCV as a model virus for studying the Caliciviridae 
as it readily replicates in cell culture (Bidawid et al., 2003), has a well defined host 
and a broad spectrum of virulence and clinical signs exhibited by infected cats 
(Radford et al., 2007). These characteristics were desirable in this study as it meant 
that suitable quantities of cellular protein and mRNA could be produced for both 
infected and mock infected samples and also, a number of different strains could be 
examined to discover whether there were differences in the way the strains 
manipulated the host cell at the molecular level.  
Using FCV as a model virus in these systems was not without its difficulties, not 
least being the fact that the cat does not have a completely sequenced or annotated 
genome. The current release of the feline genome has a 1.9x coverage which means 
that there is only ~65% of the sequence available with ~20 000 putative genes 
annotated (Pontius et al., 2007). As a result bioinformatic analyses are not as 
straightforward as using a host with a fully annotated genome such as mice and 
humans. However, as genomes are constantly being re-annotated and updated the 
data collected and archived throughout this thesis can still be re-analysed and re-
evaluated as these new updates are released. There are also opportunities for using 
the data acquired within this thesis in aiding the feline genome project. The data 
collected from the proteomics and RNA-seq experiments contain information on 
actual gene transcripts obtained from a feline cell line and as such can be useful in 
defining exon boundaries and splice sites as has been proven with other mammalian 
(Liu et al., 2010; Mortazavi et al., 2008) and also pathogen genomes (Xia et al., 
2008). Within this thesis it has been shown that proteomic and transcriptomic studies 
can be used successfully upon virally infected cells in a non-model host and at the 
time of writing, is the first study to use RNA-seq to examine the effects of viral 
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infection upon the transcriptome in a host which currently does not have a deeply 
sequenced genome available.   
The most consistent results gained from the proteomic analysis of both a single FCV 
strain and comparison of four FCV strains is that modulation of proteins involved in 
maintaining the cellular cytoskeleton occurs during each viral infection. These 
results, whilst they are the first of their kind found during infection with FCV, are in 
keeping with findings presented by authors of studies using other viruses. One of the 
best characterised viral modulators of the host cytoskeleton is vaccinia virus which 
uses host actin proteins to form tails beneath the virion (Cudmore et al., 1995) and to 
create cellular projections to facilitate cell-to-cell spread (Sanderson et al., 1998). 
Vaccinia virus has also be shown to move within the cell using microtubules (Carter 
et al., 2003; Mallardo et al., 2001) which is consistent with the conclusions drawn by 
Sodiek in 2000 which stated that viruses moving by diffusion alone within the 
cytoplasm would take considerably longer than is observed in experimental analysis 
(Sodeik, 2000).  
There are now many other examples of cytoskeletal modulation during viral 
infections with bluetongue virus having been shown to need vimentin in order to exit 
the cell (Bhattacharya et al., 2007) and hepatitis E viral proteins having been 
demonstrated to interact with microtubules (Kannan et al., 2009). Not every virus 
has been found to interact with these proteins in the same manner and there have also 
been differences found within viral families and strains regarding the modulation of 
cytoskeletal proteins. For example, within the Picornaviridae foot-and-mouth 
disease virus (FMDV) has been shown to disrupt the tethering of microtubules to the 
microtubule organising centre. In contrast, another virus from the same family, 
bovine enteric virus (BEV), did not show the same effects (Armer et al., 2008). 
These two viruses also differed in their modulation of vimentin with FMDV drawing 
vimentin around the replication site whereas BEV proteins and vimentin were both 
found co-localised within the replication centre. Differences have also been found 
with different strains of the same virus. Two strains of equine herpesvirus 1 (EHV-1) 
were used to infect two different cell lines and their effects upon the host 
cytoskeleton were examined (Turowska et al., 2010). The authors discovered that 
each of the EHV strains had opposing effects in each of the cell lines examined with 
the attenuated strain disrupting actin polymerisation with equine cells but the wild-
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type strain not having the same effect. Within the second cell line used (Vero cells) 
the wild-type strain modulate both F-actin and microtubules but the attenuated cells 
had no discernable effects upon the cytoskeleton. These results tie in with the finding 
from the 2D-DIGE experiment performed in this thesis upon four FCV strains as the 
analysis showed that for the majority of modulated host cell proteins the viral strains 
appear to affect them in different ways and to different extents.  
The identification of host cytoskeletal proteins as targets for viral modulation could 
offer some new avenues for development of antiviral drugs for combating FCV 
infection. Tubulin binding agents are already used in the therapeutic treatment of 
tumour cells in cancer to prevent tumour spread by inhibiting the cells motility and 
its ability to perform mitosis and increase tumour spread (Dumontet & Jordan, 
2010). Whilst these therapeutic drugs do prevent tumour spread, they are not 
selective and also cause damage to non-cancerous cells. If a similar therapy was 
designed to combat virally infected cells then it would encounter the same problem 
in that whilst it may have an effect of preventing viral spread, it would also 
detrimentally affect the non-infected cells in the surrounding area. Cancer 
therapeutics combat this by carefully balancing these toxic side effects with the 
minimum dose necessary to inhibit tumour growth and it is possible that a balance 
could also be found for antiviral therapy. However, the severity of the clinical signs 
exhibited during the viral infection would have to outweigh the side effects caused 
by these types of therapeutic drugs.   
To examine these changes further, three proteins were chosen from the 2D-DIGE 
results from the single strain and multiple strain experiments and were tracked using 
immunofluorescent staining and confocal microscopy. The results of imaging 
showed that whilst all viral strains changed the fluorescent staining of tubulin and 
vimentin significantly there were also subtle differences exhibited in strain-to-strain 
comparisons. The most obvious differences were the presence and absence of 
cellular blebs and also the presence and absence of viral antigen within these blebs. 
The UKOS-A strain was the only strain not to produce blebbing on the cell periphery 
which may be a sign of a different mechanism of infection or may be because the 
blebs are transient in nature and the cells were simply fixed at the wrong time to 
capture them. Only strain R591 showed viral antigen co-localising within the blebs 
during infection at both 7 and 13 h p.i., this could be evidence of this strain of FCV 
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using the blebs for viral egress in a similar manner to the protrusions observed with 
vaccinia virus (Cudmore et al., 1995). This blebbing has been observed previously 
with FCV infection (Knowles, 1988) and is also thought to be a signature of 
apoptosis (Bovellan et al., 2010) which may confirm previous studies which showed 
that FCV induces apoptosis for use in viral protein processing (Al-Molawi et al., 
2003; Natoni et al., 2006). Further analysis of the confocal images has shown that 
there are significant changes to the expression of both tubulin and vimentin within 
cells infected with all strains of FCV examined; however, these images do not show 
the entire story and so further work would have to be performed. This may be as 
straightforward as repeating the examination with more time points to discover 
whether the modulation of the cytoskeletal proteins and blebbing occurs at different 
times with different strains or developing a live cell imaging assay to follow the 
effects of infection upon these proteins in real time. A live cell imaging assay would 
be a powerful tool for investigating host cell responses to infection and has been 
used successfully with other viruses such as vaccinia virus (Mercer & Helenius, 
2008) and vesicular stomatitis virus (Cureton et al., 2010). A molecular clone of 
FCV has already been shown to be able to replicate in cell culture and express 
fluorescent reporter proteins (Abente et al., 2010). If a cell line could be found which 
would express fluorescent proteins as well as being susceptible to infection with the 
FCV molecular clone then this system could be used with live cell imaging confocal 
microscopy to target some of the proteins identified as modulated within this thesis.     
It is also possible that these subtle differences in the modulation of the host cell 
proteome found with the different strains of FCV are possible markers of the 
differential virulence associated with each isolate. At present there are no consistent 
antigenic or genotypic markers (as examined in chapter 6) and the only phenotypic 
marker found to date is that VS-FCV strains grow quicker under multiple infection 
cycle conditions in vitro, but this phenotype could not be reproduced in this thesis 
(Ossiboff et al., 2007). Again, there is not enough information garnered from the 2D-
DIGE to confirm that any of the proteins identified could be used as markers for 
virulence but it has provided a list of potential  proteins which could be analysed 
further to discover whether the differential modulation patterns are consistent across 
the VS-FCV strains. There has also been the added complication within this thesis of 
using a putative hypervirulent strain of FCV to attempt to discover protein markers. 
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In order to confirm whether or not a FCV strain does cause VSD in cats an 
experimental infection would have to be performed and as such there are very few 
known VS-FCV strains available which is why a putative hypervirulent strain was 
used throughout this thesis. If experiments were to be repeated, the inclusion of a 
known VS-FCV strain alongside the putative UKOS-A strain could offer greater 
insights into which proteins are suitable markers for virulence which, in future, could 
be used in place of experimental infections in the confirmation of hypervirulence.  
As stated above, the blebbing observed in the confocal images may also be a sign 
that the infected cells are undergoing apoptosis which has been reported previously 
during infection with FCV (Natoni et al., 2006; Roberts et al., 2003; Sosnovtsev et 
al., 2003) and capsases activated during apoptosis have been shown to cleave the 
viral capsid protein (Al-Molawi et al., 2003). The analysis of the RNA-seq data also 
offered some correlation with these previous findings as a number of differentially 
transcribed genes were found to be up-regulated within the apoptosis regulatory 
pathway again suggesting that the virus is inducing apoptosis rather than inhibiting 
its onset.  
Overall comparison of the differentially expressed genes from the RNA-seq 
experiment to the differentially expressed proteins identified within the two 2D-
DIGE experiments does not appear to show a very strong correlation between the 
two data sets. This phenomenon is not entirely unexpected as alteration of gene 
transcript levels and alteration of protein levels, though they are obviously linked, 
are two very different measurements. It has been suggested that transcriptional and 
translational networks have evolved independently within the cell and that the 
relationship between the two diverges with evolution as bacterial transcriptome and 
proteomes often show good correlation whereas mammalian samples show a much 
poorer correlation (Rogers et al., 2008). Another hypothesis for these discrepancies 
in correlation is that there may be a time-delayed component to transcription-
translation correlation and if you are able to take that into account then the 
correlation is greater (Wang et al., 2010). By taking transcriptional data at the same 
time points as the proteomic data within this thesis the chances of the two data sets 
correlating may have been diminished. Therefore, in future studies where RNA-seq 
is to be used alongside proteomics it may be worthwhile to take these time delays 
into account during experimental design and possibly use different time points for 
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each analysis. A further complexity when looking at proteomes and transcriptomes is 
that genes do not act uniformly and the delays observed within a transcriptome-
translation comparison may be unique for each modulated gene as well as each 
transcript and protein having a unique degradation and turnover rate. For these 
complexities to be taken into account an experiment may have to be designed which 
can track protein turnover and expression in the face of viral infection such as a 
labelled pulse chase study which has been successfully employed in other studies 
examining the effects of viral infection upon host cell proteins (Bruce et al., 2009). 
A further outcome of the RNA-seq experiment was that transcripts generated from 
the FCV-F9 virus were sequenced and the reads could be mapped to the FCV-F9 
genome. This gave an average coverage of ~50 000x of the viral genome and 
demonstrates the possibility of using these next-generation sequence technologies in 
viral genome sequencing. As the attempt to sequence the whole genome putative 
virulent strain, UKOS-A, within this thesis was ultimately unsuccessful it may be 
useful in future to employ next-generation sequencers to guarantee rapid whole 
genome sequencing. This would eliminate the need for prior amplification through 
PCR and as such would eliminate the requirement to design primers based on 
homologous sequences that often fail to recognise their target sequence due to the 
variability present throughout the FCV genome. 
The undifferentiated cell line used within this thesis was chosen as a surrogate for a 
whole cat system. However, it may also be useful to use these techniques to 
investigate the effects of FCV infection upon a tissue culture derived from areas in 
which FCV virions can be isolated such as the upper respiratory tract. In vivo 
modelling would be the ideal environment in which to investigate host responses to 
FCV infection and now that it has been proven that post-genomic technologies can 
be applied to a feline host it may be worth investigating this option again in the near 
future.       
The work completed within this thesis has proven that proteomic and transcriptomic 
techniques can be used to investigate host changes in response to viral challenge 
even within a non-model host organism. The results have shown that during 
infection with FCV, the host cytoskeletal proteins are modulated and these effects 
have been followed successfully for two cytoskeletal proteins using confocal 
microscopy with immunofluorescent staining. As for the other proteins and genes 
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found to be differentially expressed, their significance to viral replication can only be 
speculated upon. The global nature of the experiments conducted gives a good 
preliminary examination of the mechanisms of viral modulation of the host but it 
cannot give a definitive answer as to whether these modulations are essential for 
viral replication. However, the genes and proteins highlighted within this study can 
act as a good starting point for further investigations such as providing a list of 
candidate proteins for absolute quantification and live cell imaging analysis.  
There is also scope for repeating this kind of post-genomic analysis with either a 
different in vitro model or even through use of an in vivo model. The discovery of 
murine norovirus (MNV) and its ability to grow in cell culture (Karst et al., 2003) 
means it would be a good candidate to use these post-genomic techniques upon 
especially as the host genome is sequenced and annotated to a high standard. Using a 
mouse virus within a murine cell line would also offer the advantage of readily 
available mouse-specific reagents and laboratory mice for in vivo experimentation. 
In conclusion, we have demonstrated the utility of modern “omic” technologies to 
the study of viral pathogenesis. Study of both the proteome and transcriptome of 
cells infected with FCV has identified new pathways that are modulated during 
infection and helped to confirm others. Our studies also suggest that such 
technologies may provide a new, sequence independent way of determining the 
sequence of variable viruses such as FCV. 
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Appendix I - Mascot identifications of differentially expressed FEA cell proteins from 2D-DIGE analysis of FCV-F9 
infection 
Protein 
Spot 
No 
Ensembl ID hit (Cat database) Mascot 
Score 
No of 
peptide 
hits 
Identification Gene ID MSDB ID hit Mascot 
Score 
No of 
peptide 
hits 
Identification 
5074 ENSFCAP00000004426 84 2 Thioredoxin TXN ACT_YARLI 129 6 Actin 
scaffold_8235_2912_3415_-1 53 7 Beta-actin ACTB COF1_BOVIN 120 4 Cofilin-1 
GeneScaffold_2764_3025_217086_-1 58 6 family with sequence 
similarity 171, 
member A1 
FAM171A1 THIO_BOVIN 110 2 Thioredoxin 
4924 - - - - - Q53YJ2_HUMAN 103 2 Proteolysis 
inducing factor 
Q1KMR5_RHIFE 85 3 Beta-actin 
4797 ENSFCAP00000012591 125 7 Transgelin TAGLN TAGL_BOVIN 270 6 Transgelin 
ENSFCAP00000006138 105 3 protein disulfide 
isomerase family A, 
member 3 
PDIA3 JC5704 168 3 Cyclophilin A 
GeneScaffold_2389_274827_323289_-1 85 10 fumarylacetoacetate 
hydrolase 
FAH O35248_CRISP 119 3 Beta actin 
GeneScaffold_2764_3025_217086_-1 74 2 family with sequence 
similarity 171, 
member A1 
FAM171A1 Q6ZYE7_RAT 85 2 Plectin 
ENSFCAP00000007128 52 3 Tubulin beta chain TUBB Q5DT20_HUMAN 77 3 Hornerin 
GeneScaffold_3763_4924_53472_-1 47 2 non imprinted in 
Prader-
Willi/Angelman 
syndrome 1 
NIPA1 Q9UVS5_9FUNG 76 2 Beta tubulin 
GeneScaffold_2798_18850_78140_1 43 3 Novel gene x ANXA2_BOVIN 60 2 Annexin A2 
4777 ENSFCAP00000008491 45 4 Cyclophilin A PPIA_FELCA Q53YJ2_HUMAN 128 3 Proteolysis 
Inducing Factor 
CSBOAB 100 3 Cyclophilin A 
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4376 scaffold_101245_108936_112032_-1 170 5 beta-actin ACTB ACTB_CAMDR 288 5 Actin 
GeneScaffold_2764_3025_217086_-1 87 3 family with sequence 
similarity 171, 
member A1 
FAM171A1 PPIA_FELCA 149 4 Cyclophilin A 
ENSFCAP00000008491 67 5 Cyclophilin A PPIA_FELCA 
4370 scaffold_101245_108936_112032_-1 849 27 beta-actin ACTB ACTB_CAMDR 619 26 Actin 
scaffold_181185_2388_3518_-1 305 12 actin, beta-like 2 ACTBL2 Q258K2_CANFA 342 6 Myosin 
ENSFCAP00000006138 95 6 Protein disulphide-
isomerase A3 
precursor 
PDIA3 JC5704 192 4 protein 
disulfide-
isomerase 
ENSFCAP00000004098 82 7 Annexin A5 ANXA5 AQHUP 150 3 annexin V 
4293 GeneScaffold_2798_18850_78140_1 151 12 solute carrier family 
22 
x LMNA_RAT 533 14 Lamin A 
ENSFCAP00000012591 123 8 Transgelin TAGLN Q5JQ13_HUMAN 254 5 Vinculin 
scaffold_101245_108936_112032_-1 88 3 beta-actin ACTB FAHUAA 148 6 alpha-actinin 1 
GeneScaffold_4125_187395_227637_-1 38 3 p21 protein 
(Cdc42/Rac)-
activated kinase 1 
PAK1 Q1KMR5_RHIFE 133 3 Beta-actin 
4290 scaffold_101245_108936_112032_-1 334 8 beta-actin ACTB ACTB_CAMDR 437 8 Actin 
3999 - - - - - - - - - 
3991 - - - - - - - - - 
3881 - - - - - - - - - 
3795 - - - - - - - - - 
3645 - - - - - - - - - 
3595 - - - - - - - - - 
3538 scaffold_101245_108936_112032_-1 1447 64 beta-actin ACTB Q9QZ83_MOUSE 745 58 Actin 
GeneScaffold_3749_426274_507033_-1 764 42 roundabout, axon 
guidance receptor, 
homolog 1 
ROBO1 
GeneScaffold_2764_3025_217086_-1 650 32 family with sequence 
similarity 171, 
member A1 
FAM171A1 
ENSFCAP00000000438 132 7 Peroxiredoxin-2 PRDX2 
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3516 scaffold_101245_108936_112032_-1 959 34 beta-actin ACTB ACTB_CAMDR 787 33 Actin 
GeneScaffold_2764_3025_217086_-1 262 15 family with sequence 
similarity 171, 
member A1 
FAM171A1 Q17QM7_BOVIN 534 17 Vimentin 
GeneScaffold_3175_2520_86852_-1 93 2 NEDD8 activating 
enzyme E1 subunit 1 
NAE1 
ENSFCAP00000007281 87 3 annexin A2 ANXA2 
scaffold_124947_7729_58479_-1 58 2 Peroxiredoxin-1 PRDX1 
GeneScaffold_2254_325966_333780_1 48 4 thrombospondin, type 
I, domain containing 
4 
THSD4 
3503 - - - - - - - - - 
3357 GeneScaffold_2254_325966_333780_1 100 5 thrombospondin, type 
I, domain containing 
4 
THSD4 VIME_HUMAN 902 31 Vimentin 
GeneScaffold_2428_5475_79246_1 43 4 Novel gene x Q7SYF4_ACIBE 108 4 Desmin 
3351 scaffold_101245_108936_112032_-1 110 4 beta-actin ACTB ACTB_CAMDR 224 5 Actin 
3177 - - - - - - - - - 
3174 - - - - - - - - - 
3129 scaffold_101245_108936_112032_-1 62 4 Beta-actin ACTB ACTB_CAMDR 156 4 Actin 
ENSFCAP00000001042 61 2 myosin, heavy chain 
9 
MYH9 Q3KQJ4_MOUSE 93 3 Hspa8 protein 
MYH9_HUMAN 86 2 Myosin-9 
Q7T275_CYPCA 83 2 HSP70 
S11456 63 3 dnaK-type 
molecular 
chaperone 
hsc70 
3032 scaffold_101245_108936_112032_-1 92 6 beta-actin ACTB ACTB_CAMDR 239 6 Actin 
A39638 76 2 Plectin 
2775 - - - - - - - - - 
2661 - - - - - Q76II5_9ZYGO 125 4 Elongation 
factor 1 alpha 
2319 ENSFCAP00000010586 41 2 Filamin-A FLNA - - - - 
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1843 - - - - - - - - - 
1354 - - - - - - - - - 
1084 - - - - - - - - - 
1073 - - - - - - - - - 
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Appendix II - Mascot identifications of differentially expressed FEA cell proteins from 2D-DIGE analysis of FCV-
F9, LS015, R591 and UKOS-A infection 
Protein 
Spot 
No 
Ensembl ID hit (Cat database) Masco
t 
Score 
No of 
peptide 
hits 
Identification Gene ID MSDB ID hit Mascot 
Score 
No of 
peptide 
hits 
Identification 
2390 GeneScaffold_3760_7502_2983
16_1 
53 2 activated leukocyte 
cell adhesion 
molecule 
ALCAM - - - - 
2551 
  
scaffold_59989_186_324_-1 41 2 hypothetical protein - CAF01065  66 
  
4 ubiquitin-
conjugating 
enzyme E2O 
  
GeneScaffold_2406_52531_181
244_-1 
38 2 elongation factor Tu 
GTP-binding 
domain-containing 
protein 1 
EFTUD1 
2700 scaffold_101097_76774_76917
_1 
54 4 phospholipase C, 
gamma 2 
Plcg2 Q4CE28_CLO
TM  
59 2 Fe-S type hydro-
lyases 
tartrate/fumarate 
alpha region 
2758 GeneScaffold_4664_2439_1372
9_1 
79 2 protein kinase C 
substrate 80K-H 
Prkcsh AAQ14482 56 2 protein kinase C 
substrate 80K-H 
2945 
  
  
  
GeneScaffold_1627_9781_7091
8_1 
  
  
  
86 
  
3 
  
  
  
FK506 binding 
protein 9 
  
Fkbp9 
  
  
  
LMNA_RAT  214 5 Lamin-A 
HHRTGB  189 4 dnaK-type 
molecular 
chaperone 
precursor 
Q2VA67_9AP
IC 
102 4 Putative heat 
shock protein 70 
AAI05408 68 3 FK506 binding 
protein 9 
precursor 
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2954 
  
  
GeneScaffold_3211_19329_792
11_1 
127 2 lamin a/c Lmna VEHULC  280 5 lamin C 
GeneScaffold_2827_365420_48
0146_1 
126 7 dihydrolipoamide S-
acetyltransferase 
Dlat Q3B7V7_RA
T  
118 4 Dihydrolipoamide 
S-
acetyltransferase 
GeneScaffold_3126_74284_369
431_1 
40 2 calsyntenin 2 Clstn2 Q2VA67_9AP
IC  
65 3 Putative heat 
schock protein 70 
3012 
  
  
  
  
GeneScaffold_1158_811146_81
4937_-1 
342 11 heat shock 70kDa 
protein 8 
Q670L1_
FELCA 
Q3TH56_MO
USE  
787 24 heat shock protein 
8 
GeneScaffold_1158_811146_97
3521_-1 
224 9 heat shock 70kDa 
protein 8 
Q670L1_
FELCA 
Q2KJF1_BOV
IN  
  
129 
  
  
  
5 
  
Alpha-1-B 
glycoprotein 
  
  
  
GeneScaffold_762_340398_342
317_1 
183 5 heat shock 70kDa 
protein 2 
HSPA2 
scaffold_176644_45903_47090
_-1 
163 5 heat shock 70kDa 
protein 8 
Q670L1_
FELCA 
GeneScaffold_3635_490733_69
4556_-1 
37 2 Eukaryotic 
translation initiation 
factor 2C 
Eif2c2 
3087 
  
  
GeneScaffold_1955_712509_72
9649_-1 
126 4 heat shock 70kDa 
protein 9 
HSPA9 Q3TW93_MO
USE  
174 4 heat shock 
protein, A 
GeneScaffold_3211_19329_792
11_1 
111 3 lamin a/c Lmna VEHULA  
  
162 
  
3 
  
lamin A 
  
scaffold_136947_1406_3132_-1 37 2 RNA 
pseudouridylate 
synthase domain-
containing protein 4 
C15orf19 
3100 
  
  
  
  
scaffold_92712_2520_4533_-1 112 2 histone cluster 1, 
H2b 
Hist1h2ba VEHULA 234 3 lamin A 
scaffold_124187_37582_71984
_-1 
97 2 enolase 1 Eno1 ENOA_MOU
SE 
186 2 Alpha-enolase 
GeneScaffold_3211_68494_792 78 2 lamin a/c Lmna VEHY 130 2 Vimentin 
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  11_1 
GeneScaffold_762_340398_342
317_1 
74 2 heat shock 70kDa 
protein 2 
HSPA7 Q4U3C7_9TR
EM 
107 3 Actin 
GeneScaffold_3528_1141909_1
206005_1 
69 4 vimentin Vim 1KAZ 102 2 70kd heat shock 
cognate protein 
scaffold_181185_2388_3518_-1 58 3 actin Actb         
3133 
  
  
GeneScaffold_762_340398_342
317_1 
92 3 heat shock 70kDa 
protein 2 
HSPA2 1ATR 180 4 heat shock 
cognate protein 
70 kD 
GeneScaffold_1158_811146_97
3521_-1 
  
67 3 
  
heat shock 70kDa 
protein 8 
HSPA8 
  
ABBOS 150 3 serum albumin 
precursor 
KABOSB 121 3 alpha-s1-casein 
precursor 
3150 scaffold_101245_108936_1120
32_-1 
102 4 beta-actin Actb ACTB_CAM
DR 
304 6 Actin 
  
  
  
  
  
  
GeneScaffold_2556_264487_33
7382_1 
92 3 actin Actb AAH06551  125 2 lamin B2 
scaffold_8235_2912_3415_-1 82 2 actin Actb Q8MJ76_PIG  71 2 Alpha-fetoprotein 
GeneScaffold_3168_3407_2543
69_-1 
74 2 actin Actb Q2WG65_PL
UXY 
  
60 
  
  
  
2 
  
Heat shock 
cognate 70 
  
  
  
GeneScaffold_1158_811146_97
3521_-1 
55 2 heat shock 70kDa 
protein 8 
HSPA8 
GeneScaffold_4790_320911_36
1683_-1 
55 2 G7c G7c 
GeneScaffold_3341_245_47680
_1 
54 3 albumin ALB 
3160 
  
GeneScaffold_4038_1699_9138
_-1 
52 2 lamin b2 Lmna AAH06551 185 3 lamin B2 
GeneScaffold_3341_245_47680
_1 
40 3 albumin ALB Q8MJ76_PIG 69 3 Alpha-fetoprotein 
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3162 GeneScaffold_3341_245_47680
_1 
53 2 albumin ALB LMNA_RAT  151 2 Lamin-A 
3167 
  
  
  
scaffold_217191_43844_49826
_1 
40 4 G-protein coupled 
receptor-associated 
sorting protein 2 
GPRASP
2 
- 
 
- 
 
 
 
- 
 
- 
 
 
 GeneScaffold_1083_156145_27
7749_-1 
39 6 acetyl-Coenzyme A 
carboxylase alpha 
Acaca 
GeneScaffold_1788_133919_21
6524_-1 
39 4 transmembrane 
protein 120A 
Tmem120
a 
GeneScaffold_2406_52531_181
244_-1 
39 2 elongation factor Tu 
GTP-binding 
domain-containing 
protein 1 
EFTUD1 
3235 
  
GeneScaffold_805_95206_3719
96_-1 
73 9 laminin alpha 1 Lama1 - 
 
- 
 
- 
 
- 
 
GeneScaffold_4991_901280_96
9073_-1 
65 8 hypothetical protein - 
3292 
  
GeneScaffold_4226_44961_169
647_1 
39 4 obscurin OBSCN CAA23753 
  
63 
  
3 
  
albumin 
  
GeneScaffold_805_95206_4264
26_-1 
40 2 laminin alpha 1 Lama1 
3256 GeneScaffold_4226_44961_169
647_1 
38 3 obscurin OBSCN Q1RU50_ME
DTR 
67 2 AAA ATPase 
3289 GeneScaffold_3211_19329_792
11_1 
101 2 lamin a/c Lmna VEHULA 361 6 lamin A 
3389 
  
  
GeneScaffold_3211_19329_792
11_1 
  
  
89 
  
2 
  
  
lamin a/c 
  
Lmna 
  
  
VEHULC  407 6 lamin C 
KABOSB  223 7 alpha-s1-casein 
precursor 
LGBO 149 3 beta-lactoglobulin 
precursor  
3491 GeneScaffold_4107_135960_25 77 2 calmodulin-like 3 Calml3 MCHUNB  56 2 calmodulin-
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  5019_1       related protein 
NB-1 
  
GeneScaffold_3375_32777_178
692_1 
39 3 PDZ domain 
containing 6 isoform 
4 
- 
3494 
  
  
GeneScaffold_3474_76305_343
178_1 
106 3 chaperonin HSPD1 Q38L19_HU
MAN  
1214 20 Heat shock 
protein 60 
GeneScaffold_3946_188733_18
9698_1 
103 3 chaperonin HSPD1 Q803B0_BRA
RE  
  
735 
  
12 
  
Hspd1 protein 
  
scaffold_162142_6364_35406_-
1 
100 4 chaperonin Hspd1 
3497 
  
  
  
GeneScaffold_3474_76305_343
178_1 
212 11 chaperonin HSPD1 A32800  1995 41 chaperonin 
GroEL precursor 
scaffold_162142_6364_35406_-
1 
122 6 chaperonin HSPD1 CAI29638  
  
1787 
  
  
38 
  
60 kDa heat 
shock protein 
  
  
GeneScaffold_3093_3883_1245
17_-1 
105 4 cell division cycle 
protein 27 
Cdc27 
GeneScaffold_3946_188733_18
9698_1 
58 3 chaperonin HSPD1 
3498 
  
  
  
GeneScaffold_2462_28221_794
23_-1 
125 3 JUP protein Jup Q3KQP2_MO
USE  
581 10 Hspd1 protein 
GeneScaffold_3474_76305_343
178_1 
97 2 chaperonin HSPD1 Q38L19_HU
MAN  
581 11 Heat shock 
protein 60 
GeneScaffold_3093_3883_1245
17_-1 
73 2 cell division cycle 
protein 27 
Cdc27 Q7L3S5_HU
MAN 
  
184 
  
3 
  
JUP protein 
  
GeneScaffold_2556_264487_33
7382_1 
60 2 actin Actb 
3499 GeneScaffold_3609_122715_16
3311_1 
119 5 protein disulphide 
isomerase 
PRDX2 Q4VIT4_CER
AE 
322 6 protein disulfide 
isomerase family 
A 
  
  
GeneScaffold_385_5798_12371
4_-1 
52 2 
  
procollagen-proline P4ha1 
  
Q3KQP2_MO
USE 
61 2 Hspd1 protein 
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  CAG31521  61 2 60 kDa heat 
shock protein, 
3514 GeneScaffold_4226_44961_169
647_1 
38 3 obscurin OBSCN Q56SZ8_9AV
ES 
76 2 Recombination 
activating protein 
1 
3516 
  
GeneScaffold_4321_1497121_1
527549_1 
  
46 3 
  
zinc finger, DHHC-
type containing 18 
Zdhhc18 
  
Q1DCD7_MY
XXA 
63 2 Response 
regulator receiver 
domain/DnaJ 
domain protein 
H97196 56 2 glycosyltransferas
e 
3559 GeneScaffold_3548_151228_16
6150_-1 
44 2 pyruvate kinase KPYM_F
ELCA 
- - - - 
3612 
  
  
  
  
  
GeneScaffold_3474_76305_343
178_1 
135 3 chaperonin HSPD1 Q38L19_HU
MAN  
1034 19 Heat shock 
protein 60 
GeneScaffold_3528_1141909_1
206005_1 
88 6 vimentin Vim Q3KQP2_MO
USE  
908 14 Hspd1 protein 
GeneScaffold_3528_1196033_1
199831_1 
85 4 vimentin Vim VIME_HUM
AN 
  
293 
  
  
  
7 
  
Vimentin 
  
  
  
GeneScaffold_3946_188733_18
9698_1 
76 2 chaperonin HSPD1 
scaffold_162142_6364_35406_-
1 
47 3 chaperonin HSPD2 
GeneScaffold_4213_849006_92
8448_1 
38 2 protein tyrosine 
phosphatase 
Ptp4a1 
3690 
  
GeneScaffold_3609_122715_16
3311_1 
  
76 
  
2 
  
protein disulphide 
isomerase 
  
PDIA3 
  
Q3TEI9_MO
USE  
64 3 glucose regulated 
protein 
Q53YJ2_HU
MAN  
59 2 Proteolysis 
inducing factor 
3698 
  
GeneScaffold_3528_1196033_1
199831_1 
429 24 vimentin Vim VIME_HUM
AN  
1044 44 Vimentin 
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  GeneScaffold_3528_1141909_1
206005_1 
373 31 vimentin Vim Q6IP60_XEN
LA  
246 8 Hspd1 protein 
GeneScaffold_3973_532871_57
4596_-1 
142 4 alpha-tubulin Tuba1a Q5YLV6_BR
ARE  
184 7 Glial fibrillary 
acidic protein 
  
  
  
GeneScaffold_2584_191620_21
1797_1 
  
  
114 3 
  
  
alpha-tubulin Tuba1a 
  
  
Q6P869_XEN
TR   
164 7 Desmin 
S43425  144 13 tubulin alpha 
chain 
AQHUP  88 4 annexin V  
3777 
  
  
  
  
  
  
  
  
  
  
GeneScaffold_4223_531307_55
0048_-1 
436 17 mitochondrial ATP 
synthase 
Q0QEN3
_FELCA  
VIME_HUM
AN  
342 23 Vimentin 
GeneScaffold_3528_1141909_1
206005_1 
177 26 vimentin Vim Q3TFD7_MO
USE  
506 20 ATP synthase 
GeneScaffold_3528_1196033_1
199831_1 
177 11 vimentin Vim Q5YLV6_BR
ARE   
178 6 Glial fibrillary 
acidic protein 
GeneScaffold_1393_514148_54
4856_-1 
119 5 protein disulfide 
isomerase associated 
6 
PDIA6 PDIA6_MOU
SE  
  
76 
  
  
  
  
  
  
  
3 
  
Protein disulfide-
isomerase A6 
precursor 
  
  
  
  
  
  
  
GeneScaffold_2584_328853_33
6667_1 
71 5 desmin Des 
GeneScaffold_4554_9087_5302
1_-1 
70 2 cathepsin d precursor Ctsd 
GeneScaffold_3168_3407_2543
69_-1 
53 4 actin Actb 
scaffold_166313_3103_9882_-1 49 2 alpha-N-
acetylgalactosaminid
ase 
NAGA 
GeneScaffold_2028_484482_50
7249_1 
40 2 dihydrolipoamide S-
succinyltransferase  
Dlst 
GeneScaffold_4556_244215_42
7858_-1 
39 2 retinoblastoma 
binding protein 7 
Rbbp7 
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GeneScaffold_2777_5475_7924
6_1 
38 2 alpha-internexin INA 
3808 
  
  
  
GeneScaffold_630_86315_2043
72_1 
131 2 lysozyme LYZ AAA30032  144 4 actin 2 
scaffold_8235_2912_3415_-1 69 3 actin Actb LZHU  124 
  
  
4 lysozyme 
  
  
GeneScaffold_3168_3407_2543
69_-1 
60 3 actin Actb 
scaffold_132537_6120_47775_-
1 
60 3 actin Actb 
  
  
GeneScaffold_1554_151383_20
0166_-1 
54 4 low density 
lipoprotein receptor-
related protein 11 
Ldlr     
  
    
  
scaffold_101701_7494_37474_
1 
40 2 A-kinase anchor 
protein 2 
AKAP2 
3839 
  
  
GeneScaffold_4226_3314_1696
47_1 
  
  
38 
  
2 
  
  
obscurin 
  
OBSCN 
  
  
Q9G986_VES
GE 
68 13 Cytochrome b  
Q9M699_CA
TRO  
63 2 Putative glycine-
rich RNA-binding 
protein 2 
Q4UH60_TH
EAN 
54 2 Myosin a tail 
domain 
interacting protein 
mtip 
3892 
  
  
GeneScaffold_3168_3407_2543
69_-1 
  
  
49 2 
  
  
actin Actb 
  
  
Q3U8X1_MO
USE  
110 4 eukaryotic 
translation 
initiation factor 3 
Q8I861_GLO
RO  
63 2 Actin 2 
Q9G986_VES
GE  
54 12 Cytochrome b  
3936 GeneScaffold_5179_297902_30 45 6 calreticulin Calr JH0819 131 6 calreticulin 
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1190_1 precursor 
4098 GeneScaffold_4554_9087_5302
1_-1 
90 4 cathepsin d precursor Ctsd LMNA_RAT  135 3 Lamin-A 
4104 
  
GeneScaffold_4554_9087_5302
1_-1 
83 4 cathepsin d precursor Ctsd LMNA_RAT   
  
62 
  
2 
  
Lamin-A 
  
scaffold_171890_524_612_1 35 2 sulfate ABC 
transporter 
- 
4105 
  
GeneScaffold_4554_9087_5302
1_-1 
116 5 cathepsin d precursor Ctsd AQHUP  
  
128 
  
4 
  
annexin V 
  
GeneScaffold_3382_25337_117
455_-1 
74 3 annexin A5 Anxa5 
4256 GeneScaffold_3211_68494_792
11_1 
100 4 lamin a/c Lmna - - - - 
4270 GeneScaffold_3211_68494_792
11_1 
127 6 lamin a/c Lmna Q3SZI2_BOV
IN  
477 14 LMNA protein 
4271 
  
  
  
  
scaffold_156020_24876_33658
_-1 
58 4 peptidase Pepb LGBUI 412 19 beta-lactoglobulin 
GeneScaffold_2241_72789_295
895_1 
50 2 sortilin-related 
receptor 
preproprotein 
SORL1 Q3SZI2_BOV
IN  
264 5 LMNA protein 
GeneScaffold_3211_68494_792
11_1 
39 2 lamin a/c Lmna KABOSB 
  
172 
  
  
12 
  
alpha-s1-casein 
precursor 
  
  
scaffold_9462_8927_14629_1 39 2 envelope 
glycoprotein 
syncytin-B 
- 
GeneScaffold_2664_17707_783
45_1 
37 2 pleckstrin and Sec7 
domain containing 2 
Psd2 
4397 GeneScaffold_2404_187013_25
5811_1 
38 2 Loricrin Lor Q66J53_XEN
LA 
261 9 acyl-coenzyme A 
dehydrogenase 
4810 
  
GeneScaffold_4261_38206_965
80_-1 
111 3 annexin A2 Anxa2 ANXA2_BOV
IN  
121 
  
3 
  
Annexin A2  
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  GeneScaffold_4261_4924_5373
2_-1 
83 4 annexin A2 Anxa2       
GeneScaffold_2878_80075_110
256_1 
36 2 piccolo PCLO 
4852 
  
GeneScaffold_2096_57622_764
74_1 
164 6 annexin A1 Anxa1 Q6BCI9_FEL
CA 
136 4 Lipocortin-1 
(annexin II) 
GeneScaffold_4261_4924_5373
2_-1 
78 3 annexin A2 Anxa2 LUHU 80 3 annexin I 
4859 
  
  
GeneScaffold_4261_38206_965
80_-1 
132 8 annexin A2 Anxa2 Q6N0B3_HU
MAN 
221 7 annexin A2 
isoform 1 
GeneScaffold_2096_57622_764
74_1 
76 3 annexin A1 Anxa1 Q6BCI9_FEL
CA 
  
104 
  
3 
  
Lipocortin-1 
  
GeneScaffold_616_113865_116
741_-1 
39 2 acidic ribosomal 
phosphoprotein P0 
- 
4869 
  
GeneScaffold_2582_288979_51
4454_-1 
74 2 ATPase, Ca++ 
transporting, plasma 
membrane 2 
Atp2b2 Q6BCI9_FEL
CA 
  
58 
  
2 
  
Lipocortin-1 
  
GeneScaffold_2096_33194_105
616_-1 
72 2 Annexin A1 Anxa1 
4985 
  
GeneScaffold_4261_38206_965
80_-1 
460 18 annexin A2 Anxa2 Q8TBV2_HU
MAN 
534 18 ANXA2 protein 
GeneScaffold_4261_4924_5373
2_-1 
207 10 annexin A2 Anxa2 Q6JVS7_9PA
ST 
54 2 ATP synthase 
beta subunit 
5020 scaffold_156020_24876_33658
_-1 
38 2 peptidase Pepb LGBUI 78 4 beta-lactoglobulin 
5105 
  
GeneScaffold_2096_57622_764
74_1 
173 10 annexin A1 Anxa1 Q6BCI9_FEL
CA 
235 7 Lipocortin-1 
GeneScaffold_668_2874_10965
8_-1 
36 2 Sodium channel 
protein type XI alpha 
SCN11A Q659U4_HAL
GR  
189 6 Annexin 1 
5106 
  
scaffold_149331_31069_70108
_1 
74 3 voltage-dependent 
anion channel 2 
- Q5VWK3_HU
MAN 
236 
  
6 
  
Voltage-
dependent anion 
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  GeneScaffold_4261_4924_5373
2_-1 
65 3 annexin A2 Anxa2     channel 2 
  
  GeneScaffold_4546_152267_27
0655_-1 
36 3 intestinal cell kinase ICK 
5456 
  
GeneScaffold_4226_44961_169
647_1 
39 2 obscurin OBSCN - 
 
 
- 
 
- 
 
- 
 
GeneScaffold_2000_280932_39
9261_-1 
37 2 multiple C2 and 
transmembrane 
domain-containing 
protein 1 
MCTP1 
5558 GeneScaffold_2975_39350_961
63_1 
42 2 MYB DNA-binding 
domain protein 
Mybbp1a - - - - 
5666 
  
  
GeneScaffold_3612_312285_32
0583_-1 
234 16 prohibitin Phb Q4R5M5_MA
CFA  
581 25 similar to human 
prohibitin  
scaffold_101245_108936_1120
32_-1 
81 5 beta-actin Actb ACTB_CAM
DR 
112 4 Actin 
GeneScaffold_2905_96136_153
267_-1 
42 3 ARMET-like protein 
1 precursor 
- Q6JVS7_9PA
ST  
55 3 ATP synthase 
beta subunit 
5676 GeneScaffold_4226_3314_1696
47_1 
50 5 obscurin OBSCN Q3B3F0_PEL
LD 
52 2 Fe-S type hydro-
lyases 
tartrate/fumarate 
alpha and beta 
region 
5806 GeneScaffold_2000_280932_39
9261_-1 
37 4 multiple C2 domains, 
transmembrane 1 
Mctp1 Q6JVS7_9PA
ST 
58 3 ATP synthase 
beta subunit  
6113 GeneScaffold_2000_280932_39
9261_-1 
47 2 multiple C2 domains, 
transmembrane 1 
Mctp1 - - - - 
6440 
  
scaffold_156020_24876_33658
_-1 
  
47 
  
2 
  
peptidase 
  
Pepb 
  
LGBUI 192 5 beta-lactoglobulin 
S52094  74 2 sorcin  
6970 GeneScaffold_5226_230166_23 47 2 60S ribosomal RPL12 Q8I9M1_9BI 61 3 Ribosomal 
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4031_-1 protein L12 VA protein L12 
7246 scaffold_184291_104232_1513
40_-1 
104 3 40S ribosomal 
protein S14 
RPS14 Q1HR24_AE
DAE 
101 3 40S ribosomal 
protein S141 
7401 
  
GeneScaffold_4224_169830_17
2759_1 
139 7 myosin, light 
polypeptide 6, alkali, 
smooth muscle and 
non-muscle 
MYH1 MOHU6E 
  
196 
  
7 
  
myosin alkali 
light chain 6 
  
GeneScaffold_4213_139484_16
0246_-1 
40 4 Myosin light 
polypeptide 3 
MYH1 
7732 GeneScaffold_3577_286209_33
0946_-1 
49 2 alpha 2 
macroglobulin 
A2m - - - - 
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Appendix III - Average greyscale values of FCV capsid stain and tubulin stain in infected and mock infected FEA cells 
 
Distance 
(µm) 
FCV-F9 LS015 UKOS-A R591 Mock infected 
7 h p.i. 13h p.i. 7 h p.i. 13h p.i. 7 h p.i. 13h p.i. 7 h p.i. 13h p.i. 7 h p.i. 13h p.i. 
FCV Tubulin FCV Tubulin FCV Tubulin FCV Tubulin FCV Tubulin FCV Tubulin FCV Tubulin FCV Tubulin FCV Tubulin FCV Tubulin 
0.0 86.0 35.3 114.3 65.2 108.3 154.3 65.2 152.0 97.9 86.1 210.1 114.7 172.4 161.7 199.0 142.3 0.0 35.3 3.7 55.9 
0.2 90.7 54.2 109.7 66.1 118.5 151.3 69.9 152.1 96.9 87.8 202.0 108.5 176.3 147.7 199.2 149.2 0.9 50.8 0.9 41.1 
0.4 92.2 38.8 118.6 78.6 121.5 141.9 74.2 154.6 114.0 93.8 185.9 107.2 171.1 144.4 196.8 144.0 1.3 49.9 0.3 37.9 
0.7 94.0 39.2 124.3 70.8 122.1 127.9 61.8 154.0 113.1 107.2 184.5 118.4 168.7 150.1 200.2 144.6 0.8 46.3 1.3 40.2 
0.9 93.5 42.2 128.4 76.0 121.6 128.5 66.6 162.1 114.0 106.4 189.7 110.8 160.2 139.4 201.6 147.6 0.9 38.2 0.4 41.5 
1.1 98.2 40.4 128.8 99.9 106.9 139.3 75.5 168.5 121.7 99.3 195.2 102.6 158.1 142.1 202.3 135.0 0.2 49.9 0.2 35.7 
1.3 117.3 40.9 134.8 92.3 98.6 128.2 78.5 171.0 122.0 105.7 193.0 102.4 158.6 146.5 194.5 142.1 0.7 43.7 1.3 36.3 
1.6 120.9 42.9 132.7 96.9 98.3 120.9 69.0 163.7 116.7 123.1 187.5 132.9 159.3 139.7 189.5 143.1 0.3 52.1 1.2 59.3 
1.8 119.9 48.4 141.2 92.7 102.9 133.4 69.7 167.1 119.6 126.6 183.8 143.3 157.5 136.0 179.9 129.8 0.0 58.1 0.3 45.5 
2.0 121.4 52.5 135.8 86.7 102.5 141.3 58.9 164.2 113.0 136.7 180.6 136.3 154.1 144.4 185.8 128.6 0.0 37.5 0.1 55.5 
2.2 113.1 64.3 129.0 94.8 108.6 147.9 69.7 153.5 121.4 133.1 183.0 143.1 156.3 154.6 193.9 129.1 0.0 40.8 0.5 67.8 
2.5 119.6 64.8 137.3 102.7 93.2 154.9 73.7 164.6 117.2 135.0 178.7 132.7 150.1 152.4 183.4 129.6 0.0 45.9 0.0 38.4 
2.7 125.4 66.8 127.9 115.1 94.9 147.2 81.1 162.6 108.6 131.8 180.2 136.9 147.3 155.7 185.4 151.0 0.0 51.4 0.0 43.6 
2.9 127.4 75.5 139.5 113.8 92.7 155.2 89.0 173.3 119.2 132.9 195.4 135.1 141.1 157.6 190.9 152.4 0.0 49.8 0.0 37.1 
3.1 144.2 68.0 138.7 113.0 92.6 144.3 77.6 171.2 114.8 139.9 192.6 128.7 143.3 173.5 179.8 144.6 0.0 66.3 0.0 53.2 
3.4 143.6 61.0 154.0 116.7 96.9 156.2 79.0 171.5 106.6 132.3 194.0 144.2 153.4 169.7 172.6 135.1 2.3 54.6 0.0 57.2 
3.6 140.8 65.7 157.8 123.3 92.3 146.1 77.0 166.5 102.4 121.1 202.5 147.8 158.1 181.8 178.0 151.2 0.2 45.7 0.6 48.7 
3.8 141.0 73.1 160.9 119.8 98.4 142.7 82.6 154.2 97.4 123.5 194.5 130.8 166.2 170.8 176.7 162.3 0.0 48.0 0.4 57.3 
4.0 148.9 86.3 148.8 113.1 94.9 158.4 80.6 160.9 95.4 124.9 197.6 139.8 166.1 175.5 171.3 145.8 0.4 39.5 0.1 65.0 
4.3 137.3 76.0 148.8 123.9 93.3 146.5 76.1 169.3 102.8 121.0 197.0 156.7 165.6 186.6 160.8 162.3 0.5 51.7 0.6 66.5 
4.5 130.6 86.7 149.2 131.9 97.5 147.6 81.5 168.1 95.7 136.1 184.0 155.9 166.2 188.8 156.0 156.2 0.1 60.6 2.0 66.5 
4.7 129.7 83.6 129.7 131.5 94.3 162.3 76.0 174.0 91.3 115.2 190.6 138.6 173.3 182.2 160.6 142.2 0.0 60.0 1.9 53.5 
4.9 131.1 92.9 108.4 126.3 94.9 157.6 72.7 156.6 87.1 102.9 187.4 141.3 179.5 191.6 162.2 143.7 0.0 83.2 0.8 63.8 
5.2 135.1 96.2 106.7 136.8 97.9 158.8 68.0 165.5 85.1 117.5 189.7 158.3 182.2 183.4 151.4 141.9 0.1 97.4 0.3 94.0 
5.4 126.7 105.4 91.8 145.2 98.6 160.4 69.1 153.5 76.8 107.1 187.8 159.0 180.9 195.4 150.4 150.0 0.5 76.9 0.2 87.4 
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5.6 123.6 102.0 83.6 144.2 99.0 167.4 61.3 164.6 81.7 110.1 174.6 161.4 175.8 189.2 152.6 126.1 0.2 84.8 0.1 95.3 
5.8 135.9 126.6 76.9 138.7 95.3 162.6 54.1 150.7 85.8 109.3 177.5 158.9 172.4 197.6 154.1 134.9 0.4 90.5 0.3 95.7 
6.1 129.3 121.9 64.1 126.4 95.3 160.3 44.3 146.2 73.4 93.2 169.6 156.6 161.3 190.4 152.8 139.6 0.3 74.7 0.1 82.0 
6.3 130.6 132.6 61.2 124.2 86.2 155.6 41.8 146.7 78.2 90.8 153.3 168.8 152.9 178.7 150.0 143.8 0.3 78.2 0.4 71.9 
6.5 128.8 129.8 54.9 126.9 90.2 161.8 32.0 135.0 71.7 92.5 151.8 156.2 144.4 179.4 144.5 140.8 0.1 76.2 0.6 65.0 
6.7 107.0 113.5 46.7 112.4 90.0 141.1 32.1 130.0 72.9 84.3 144.7 151.6 127.8 180.3 139.7 139.5 0.0 97.9 0.4 77.9 
7.0 112.1 116.3 37.6 104.9 91.1 145.3 32.2 130.3 79.7 90.2 136.3 148.6 119.3 170.8 133.1 141.7 1.2 100.2 2.0 80.5 
7.2 113.7 121.1 27.3 100.1 81.7 138.5 25.5 111.9 84.0 96.9 125.0 132.7 111.3 181.7 115.8 137.1 0.3 89.7 0.2 76.3 
7.4 107.6 132.8 30.6 107.0 83.8 141.7 21.7 106.3 85.8 98.2 124.9 144.0 100.8 173.2 118.2 139.6 0.2 102.1 0.2 77.6 
7.6 105.2 125.9 39.2 119.8 74.7 141.1 14.7 119.4 83.2 94.2 113.5 139.3 91.2 171.5 119.3 136.8 0.4 105.2 0.5 84.5 
7.9 95.8 109.9 39.3 122.1 74.0 137.8 19.6 116.1 80.5 93.3 101.9 128.6 83.0 163.4 111.2 126.4 0.4 102.0 0.3 80.5 
8.1 78.5 109.1 36.6 114.8 74.6 116.9 14.9 121.9 81.9 90.9 83.9 152.7 80.6 150.5 96.4 123.6 0.3 107.6 0.6 82.2 
8.3 83.3 122.1 30.6 109.8 64.5 122.4 11.6 114.2 91.0 95.8 73.6 139.5 70.5 165.8 94.9 121.1 1.7 113.1 0.9 75.7 
8.5 83.4 112.6 28.0 107.8 57.0 129.4 11.2 115.1 74.3 98.9 80.8 148.6 62.1 154.1 92.3 135.9 0.4 110.3 0.8 75.2 
8.8 74.8 106.7 23.2 123.8 49.9 121.4 8.3 118.1 62.7 100.0 82.7 150.0 59.7 165.8 79.4 114.8 0.4 100.5 1.6 81.3 
9.0 55.6 106.3 19.7 113.2 42.0 124.2 8.0 114.1 46.1 76.6 81.4 163.5 49.1 159.7 80.3 128.3 0.2 113.9 0.6 99.7 
9.2 57.9 120.5 21.9 108.5 35.5 113.2 6.0 109.0 36.7 58.2 74.1 159.2 41.1 157.1 84.7 120.0 0.4 115.2 0.2 81.5 
9.4 53.8 97.4 18.0 96.5 32.6 113.5 6.1 94.0 38.4 57.4 68.4 168.8 35.0 146.3 89.0 113.0 0.1 120.2 0.3 86.5 
9.7 46.7 91.5 10.8 89.6 22.6 112.0 5.0 90.9 38.4 68.6 55.2 161.5 32.2 155.8 82.3 122.5 0.0 128.0 0.4 81.8 
9.9 53.9 94.8 6.8 85.6 18.1 106.6 6.8 101.3 38.5 80.0 55.8 156.4 30.7 163.9 67.7 109.7 0.1 122.8 2.3 97.6 
10.1 46.1 90.7 7.4 82.2 17.7 108.4 4.7 83.5 39.5 76.6 59.5 152.1 26.1 156.6 68.1 104.7 0.3 125.4 0.7 97.2 
10.3 46.5 99.2 10.0 78.5 15.3 105.5 3.3 84.1 33.0 87.4 57.6 158.1 25.9 145.3 69.4 108.7 0.0 150.6 0.3 107.2 
10.6 39.9 80.4 9.8 83.4 8.7 88.2 3.9 92.3 31.5 80.9 63.4 165.0 26.8 142.5 57.6 113.0 1.7 119.7 0.0 112.2 
10.8 43.6 94.2 7.3 77.1 7.6 85.0 3.7 92.4 27.0 72.9 62.4 178.3 26.7 154.9 51.0 124.5 0.0 122.4 0.1 130.0 
11.0 39.7 87.6 6.2 80.7 8.1 93.0 4.1 89.6 25.9 75.1 56.2 163.7 25.7 142.6 45.8 114.1 0.0 134.0 0.1 113.0 
11.2 38.8 89.4 5.3 91.1 10.5 81.2 4.0 82.5 26.1 75.5 54.6 166.2 21.2 147.0 48.1 109.8 0.0 120.0 0.2 106.7 
11.5 29.0 85.9 4.2 91.9 5.6 75.3 2.7 92.8 20.6 69.6 62.2 136.3 18.4 145.1 56.2 115.6 0.3 127.3 0.5 101.3 
11.7 24.4 83.5 4.1 81.5 5.0 87.8 3.7 86.6 28.7 55.2 71.3 131.2 17.3 150.2 57.2 113.1 0.7 115.8 0.7 105.7 
11.9 26.4 81.9 6.8 92.2 5.4 82.6 6.9 81.6 20.6 70.4 66.9 131.0 11.2 154.7 45.3 108.2 0.1 106.6 0.2 89.4 
12.1 32.1 82.0 3.1 89.6 4.1 85.6 5.2 73.1 13.0 84.9 51.1 119.3 13.4 134.1 50.9 117.8 0.9 115.2 0.3 90.5 
12.4 29.0 96.4 3.4 84.6 4.7 81.3 3.8 79.5 12.1 96.7 41.5 128.1 12.5 135.1 47.3 120.1 0.3 105.8 1.1 96.9 
12.6 26.0 94.7 6.4 95.7 6.0 77.2 3.8 78.8 14.0 90.0 48.4 134.9 9.9 148.6 52.0 127.6 0.4 90.7 0.2 87.7 
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12.8 22.7 69.5 10.1 100.3 3.5 73.7 3.6 92.5 10.7 82.0 47.0 123.5 9.6 149.4 50.3 136.5 0.3 92.9 0.3 97.0 
13.0 22.0 77.3 5.5 99.9 3.4 87.9 3.2 87.8 9.4 79.8 41.0 114.1 8.4 131.1 53.7 128.5 0.2 88.9 0.2 84.3 
13.3 22.9 83.7 1.6 93.6 1.3 70.9 1.9 71.8 10.5 83.3 49.8 113.4 6.0 135.3 50.4 119.0 0.3 84.3 0.3 80.8 
13.5 25.9 68.4 1.0 94.8 4.5 90.5 3.9 70.5 12.7 79.3 51.8 120.2 5.8 128.3 35.6 123.8 0.0 83.1 0.0 70.2 
13.7 24.1 68.0 3.0 91.9 3.5 91.0 6.1 76.4 6.8 91.4 40.7 111.4 5.3 126.8 32.5 138.8 0.1 106.7 0.2 84.5 
13.9 22.4 78.9 3.7 86.4 1.0 90.3 1.2 84.2 8.4 90.1 38.5 109.1 4.9 122.0 25.1 144.7 0.8 87.9 0.0 86.1 
14.2 24.8 88.3 2.1 84.1 4.4 89.5 2.0 85.7 8.9 89.6 42.7 107.7 6.3 119.4 27.1 132.7 0.4 81.3 0.2 78.7 
14.4 19.9 81.6 3.1 83.9 6.1 98.7 1.4 63.2 11.7 80.3 38.1 105.6 5.8 112.4 29.5 113.6 0.9 70.2 0.1 82.6 
14.6 13.4 72.9 4.6 67.8 5.8 105.3 0.7 85.8 10.5 91.2 34.0 116.0 4.6 109.0 30.2 118.9 1.1 63.5 0.2 88.0 
14.8 10.8 79.3 7.2 70.9 5.8 90.1 0.5 92.0 10.0 88.8 46.6 113.8 5.6 112.2 32.5 141.4 0.9 70.9 0.8 96.3 
15.1 17.3 89.0 8.3 88.5 6.0 93.4 0.9 90.8 7.5 82.4 47.6 112.2 5.3 112.5 25.6 126.7 0.0 68.2 1.1 76.6 
15.3 23.0 82.2 3.5 82.4 7.0 97.1 3.0 83.5 11.6 89.8 54.9 97.2 7.9 112.3 22.6 109.5 0.1 71.2 0.2 65.5 
15.5 28.1 72.7 6.5 71.1 6.3 91.6 1.8 80.7 8.1 98.1 45.6 112.6 4.5 118.8 20.0 112.0 0.2 75.3 0.2 81.7 
15.7 31.7 64.7 2.6 63.1 4.5 99.5 0.9 83.7 7.8 99.7 47.6 94.0 3.6 89.8 19.6 130.2 0.8 62.4 0.1 87.8 
16.0 21.9 65.5 2.9 74.8 5.5 89.8 1.4 78.0 11.5 100.7 48.1 85.5 4.2 89.2 20.2 122.2 0.9 71.3 0.3 70.3 
16.2 20.5 57.6 5.3 66.8 5.0 82.0 1.8 76.4 10.0 90.4 33.8 85.1 4.0 105.9 23.8 102.0 0.3 59.5 0.3 69.3 
16.4 20.1 51.2 11.9 71.3 6.1 80.2 2.6 75.9 7.2 97.2 29.1 70.4 4.0 98.6 14.7 105.3 0.7 47.4 1.1 76.0 
16.6 17.0 46.9 8.8 65.8 5.0 89.9 1.0 68.3 7.1 89.8 31.8 71.6 2.0 76.9 17.2 103.9 0.6 45.8 0.3 76.6 
16.9 16.2 35.0 3.9 57.1 4.1 98.8 1.0 63.4 8.2 90.3 33.9 69.1 1.1 82.8 20.1 102.6 0.1 50.8 0.1 63.1 
17.1 18.7 37.2 2.7 63.0 3.9 74.5 1.5 61.4 6.4 88.1 29.4 62.1 0.2 68.2 23.7 94.3 0.1 47.0 0.3 76.2 
17.3 16.0 36.6 4.6 75.2 3.1 78.7 1.8 62.7 8.0 81.1 22.8 70.4 0.3 71.9 23.4 81.0 0.8 62.2 0.2 72.0 
17.5 18.2 34.5 4.4 62.7 3.2 66.4 0.7 52.4 4.8 76.2 25.4 74.5 1.1 81.2 22.6 81.1 1.1 52.0 1.6 70.2 
17.8 16.4 42.2 4.4 66.5 4.0 58.0 1.5 65.7 5.8 69.2 26.4 76.4 2.1 81.0 34.0 80.1 1.3 42.2 0.5 58.2 
18.0 10.6 28.7 3.3 68.8 3.4 59.7 0.5 60.3 11.6 60.4 36.4 62.9 1.6 66.9 31.2 81.4 0.7 45.4 0.1 65.4 
18.2 13.8 23.4 2.5 71.8 2.1 66.4 0.9 64.7 10.4 56.1 37.0 69.4 1.1 67.6 25.8 83.7 0.0 51.5 0.3 63.5 
18.4 30.3 29.0 4.2 68.8 2.8 73.3 0.3 63.9 4.5 48.0 29.1 65.6 0.5 56.6 29.8 67.3 0.0 66.1 0.0 59.3 
18.7 29.0 23.5 4.3 56.0 3.8 64.7 0.5 67.7 5.5 47.7 28.4 63.4 0.8 52.4 27.3 65.4 0.1 49.8 0.1 47.8 
18.9 21.5 28.9 2.4 65.6 3.9 62.3 1.1 71.4 4.1 43.8 19.9 59.5 2.0 55.8 22.1 66.3 0.2 49.4 1.0 46.7 
19.1 22.2 24.8 4.3 62.2 4.5 63.5 0.8 67.7 6.8 46.0 31.0 62.9 2.0 71.3 24.3 76.5 0.3 43.1 0.2 58.7 
19.3 18.3 27.8 6.4 62.4 6.0 52.9 1.1 69.2 11.0 37.4 30.1 68.9 0.8 53.7 29.7 70.7 0.3 52.9 0.2 67.0 
19.6 22.3 25.6 6.9 55.9 5.0 59.9 0.8 67.9 5.8 38.3 27.5 59.5 1.7 49.7 22.0 71.0 1.1 61.8 0.2 57.0 
19.8 15.7 19.8 2.7 54.0 4.3 51.8 1.7 71.3 5.4 47.8 34.5 54.7 0.3 59.4 25.2 70.1 0.1 65.8 0.1 51.0 
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Appendix IV - Average greyscale values of FCV capsid stain and vimentin stain in infected and mock infected FEA cells 
Distance 
(µm) 
FCV-F9 LS015 UKOS-A R591 Mock infected 
7 h p.i. 13h p.i. 7 h p.i. 13h p.i. 7 h p.i. 13h p.i. 7 h p.i. 13h p.i. 7 h p.i. 13h p.i. 
FCV Vimentin FCV Vimentin FCV Vimentin FCV Vimentin FCV Vimentin FCV Vimentin FCV Vimentin FCV Vimentin FCV Vimentin FCV Vimentin 
0.0 189.7 218.7 182.0 99.8 57.4 168.5 28.2 162.0 62.5 172.6 85.1 144.5 169.2 243.4 134.3 70.6 10.0 90.4 9.1 83.3 
0.2 193.7 219.2 183.2 103.4 62.0 164.7 27.5 163.5 66.7 175.5 77.6 146.9 171.7 244.6 135.0 67.6 6.6 89.4 7.8 74.9 
0.4 197.1 215.0 189.6 99.4 65.4 162.6 28.9 166.9 67.7 176.2 81.8 142.8 172.7 243.7 128.7 62.7 6.7 92.1 8.0 80.0 
0.7 194.8 218.5 186.8 102.2 60.4 160.3 31.1 170.1 69.2 171.9 81.0 147.2 175.2 240.2 132.2 66.8 6.8 91.8 5.6 81.7 
0.9 197.0 217.1 186.7 105.9 60.3 164.8 42.4 168.2 69.4 172.2 79.7 147.1 177.8 239.1 129.6 66.9 6.3 84.3 5.6 80.2 
1.1 188.5 221.6 186.7 107.3 55.1 163.1 37.3 166.5 68.8 167.8 84.0 143.0 179.0 240.9 132.7 64.9 6.2 78.5 8.9 77.5 
1.3 190.2 223.2 190.1 106.9 64.3 159.1 43.0 168.5 65.9 176.4 81.9 149.5 174.9 240.1 139.0 67.7 9.3 77.3 9.8 82.3 
1.6 189.2 223.0 192.6 111.8 67.0 160.9 45.4 171.2 67.7 182.6 85.5 147.4 171.0 241.1 141.2 69.9 9.6 77.9 8.0 83.7 
1.8 189.1 221.8 194.4 112.9 62.8 156.4 41.7 175.3 69.3 175.9 79.4 149.7 165.6 241.0 137.9 72.0 11.4 73.8 5.5 83.2 
2.0 198.2 221.9 191.4 112.7 49.7 153.7 43.8 171.3 69.2 175.2 85.5 154.2 167.8 239.9 136.7 73.0 9.6 77.9 7.4 87.3 
2.2 197.8 222.7 195.6 114.5 52.1 154.4 41.8 168.0 66.5 175.4 87.0 155.7 160.1 239.2 131.7 74.2 9.8 73.2 8.3 84.0 
2.5 200.4 224.4 195.2 114.7 56.1 154.5 52.8 169.4 68.6 179.9 85.0 155.9 161.6 241.7 136.1 70.4 8.1 72.3 7.5 88.3 
2.7 199.4 223.0 199.7 117.6 49.1 151.1 52.2 169.6 64.9 172.5 95.3 158.2 157.7 239.8 136.0 70.4 7.9 68.7 6.2 89.3 
2.9 198.9 226.7 199.3 119.5 52.9 152.4 57.2 166.5 66.2 163.3 91.0 158.1 165.0 241.3 140.6 71.6 9.8 68.1 5.1 92.6 
3.1 204.3 224.3 201.8 123.0 52.2 148.5 58.8 171.3 61.3 173.9 92.2 164.6 154.3 238.7 138.4 72.2 7.7 71.7 7.3 91.7 
3.4 204.6 224.8 207.1 122.9 47.5 140.9 52.8 166.0 66.5 171.0 94.3 168.6 143.9 237.7 143.0 68.0 6.1 71.6 8.0 92.5 
3.6 210.0 224.1 207.7 124.2 49.0 142.0 55.9 161.4 59.7 165.3 91.9 169.7 147.9 237.0 144.3 72.8 6.7 70.1 6.6 99.0 
3.8 207.7 221.6 212.3 125.9 51.0 142.8 58.3 165.0 59.3 163.7 98.6 168.4 144.0 236.8 145.7 69.7 6.2 72.5 6.2 98.0 
4.0 200.9 220.9 211.0 126.2 50.8 147.5 59.9 154.8 59.1 157.6 93.5 174.7 150.7 233.2 146.3 74.4 8.1 74.6 5.6 100.2 
4.3 206.1 219.9 215.6 128.3 51.1 141.1 55.1 160.9 57.6 157.8 92.6 171.3 144.0 232.4 151.6 72.9 6.4 74.2 7.0 100.7 
4.5 198.5 220.6 213.5 127.1 47.4 140.2 54.7 162.5 56.8 157.2 87.1 172.2 133.0 233.9 149.1 71.3 7.9 72.2 8.2 98.2 
4.7 194.7 217.9 213.2 132.3 47.5 138.1 50.6 156.0 56.3 154.7 93.3 173.5 127.6 228.0 146.1 72.8 6.7 72.1 7.8 99.6 
4.9 186.3 212.1 211.3 133.1 47.0 144.9 50.3 148.9 55.7 158.7 88.0 167.9 125.9 224.1 141.5 69.6 7.7 73.6 6.8 99.0 
5.2 181.0 204.6 211.6 131.7 45.9 147.4 46.1 144.0 56.8 152.7 92.3 166.4 112.6 221.5 147.0 69.8 9.6 73.6 6.9 99.9 
5.4 178.1 201.3 212.0 131.7 48.0 146.3 49.3 139.7 58.4 152.3 83.5 164.6 114.0 218.6 142.8 67.3 9.0 78.6 6.8 95.8 
5.6 170.6 195.1 207.4 129.7 46.4 145.3 52.2 133.0 54.7 150.2 83.8 166.2 111.8 212.0 143.4 70.2 5.4 80.2 8.7 92.8 
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5.8 163.4 189.6 208.8 130.2 43.9 146.1 50.3 127.6 53.2 150.9 81.2 164.4 107.5 205.3 144.0 73.9 5.6 80.8 8.3 93.7 
6.1 159.8 187.1 202.4 127.7 47.9 141.0 57.2 120.0 51.3 147.0 83.0 161.6 103.8 201.7 143.9 71.5 4.7 75.9 7.7 94.7 
6.3 155.1 180.1 197.0 127.4 44.6 142.5 60.1 122.6 51.9 144.5 87.1 156.9 107.1 203.1 142.6 72.7 7.1 76.6 7.7 95.0 
6.5 153.0 182.3 199.2 124.4 43.4 142.7 57.3 120.9 47.9 143.9 92.9 157.0 103.1 196.6 140.2 66.2 7.4 81.0 6.8 98.6 
6.7 151.1 179.4 202.1 119.8 41.1 143.2 57.5 114.9 50.8 140.8 95.9 147.1 98.3 196.8 130.3 62.4 6.5 81.1 9.7 92.3 
7.0 148.1 176.1 203.4 120.2 38.2 142.5 56.2 115.3 53.6 132.8 91.0 147.2 91.5 194.7 127.4 68.3 4.8 83.6 9.2 88.8 
7.2 142.2 170.4 201.2 118.3 35.6 133.7 54.0 112.1 50.8 134.3 92.8 137.1 94.7 190.8 123.1 62.0 5.4 89.6 8.9 86.0 
7.4 135.0 165.8 207.8 114.5 35.6 134.0 49.0 106.9 45.6 125.3 90.0 138.0 84.0 186.9 120.1 65.1 5.8 89.7 6.8 95.2 
7.6 126.5 161.2 208.5 111.9 30.3 129.9 43.4 105.5 48.2 123.9 97.7 135.3 88.4 186.1 116.6 64.8 4.9 95.5 6.9 91.8 
7.9 119.2 159.1 209.6 111.8 29.2 125.0 37.6 110.0 48.0 116.2 85.8 131.4 80.9 185.9 115.4 67.6 5.1 98.0 10.7 90.8 
8.1 113.8 155.6 205.1 108.3 29.9 119.2 30.2 110.3 45.1 116.1 78.7 125.3 83.1 183.4 112.0 60.0 5.8 98.9 12.9 91.7 
8.3 109.8 151.7 208.1 104.3 28.1 117.4 22.9 110.0 43.3 113.0 78.5 121.6 83.8 180.7 107.4 62.0 4.5 99.1 11.6 92.0 
8.5 106.5 147.5 210.4 101.3 30.5 109.8 15.0 102.8 44.0 109.5 69.2 121.0 80.9 179.0 101.8 62.4 6.1 105.3 9.3 88.3 
8.8 108.2 146.3 207.7 101.3 28.1 108.5 12.1 98.9 40.9 111.7 59.6 114.7 81.1 167.8 98.6 63.0 5.9 103.7 7.1 90.1 
9.0 104.3 144.9 202.5 97.7 27.0 105.2 9.4 95.1 35.9 107.7 58.2 112.2 87.6 168.2 96.2 55.9 4.6 109.7 8.9 92.5 
9.2 95.9 141.0 198.7 92.7 25.3 104.7 11.7 95.2 32.4 109.3 52.5 109.5 85.2 165.2 88.6 55.3 4.1 109.9 9.3 99.2 
9.4 91.5 138.1 191.0 90.9 24.6 106.3 13.5 89.9 31.9 106.5 47.3 112.0 80.9 160.4 84.2 54.5 4.9 105.0 7.7 94.6 
9.7 87.3 136.8 181.8 90.7 25.0 103.9 11.8 93.3 37.3 102.5 45.8 106.4 79.7 159.6 80.7 51.0 4.5 108.6 4.7 96.6 
9.9 83.5 136.2 182.7 86.8 27.4 96.2 9.8 82.7 34.9 103.2 40.3 105.9 73.8 147.8 77.7 51.6 6.3 105.3 6.1 97.1 
10.1 78.2 133.2 177.1 85.0 28.3 95.3 11.4 80.2 29.8 101.0 37.7 103.5 70.6 136.8 71.2 48.5 6.9 105.4 6.2 97.1 
10.3 74.2 131.9 174.3 83.8 27.4 95.2 11.9 85.7 30.5 100.2 43.6 98.6 69.3 134.9 68.4 47.5 6.9 103.2 5.0 100.5 
10.6 69.8 131.9 167.1 78.6 28.9 94.8 11.2 87.6 36.3 98.9 38.8 94.2 61.6 136.0 63.9 50.6 6.3 100.9 6.7 100.2 
10.8 68.1 133.1 161.3 77.3 28.2 91.2 10.8 90.3 32.1 93.6 43.4 94.7 51.8 130.4 55.7 46.4 6.3 97.3 6.4 101.4 
11.0 66.1 132.2 154.4 78.7 27.3 89.2 12.8 83.0 28.1 97.0 39.8 92.0 48.9 133.0 52.6 44.0 9.6 95.5 7.2 102.4 
11.2 65.5 132.9 146.6 76.4 25.0 92.4 13.5 85.7 35.4 96.4 33.0 89.7 45.4 131.5 42.8 40.7 6.7 97.7 6.8 98.9 
11.5 62.6 133.9 145.4 77.0 22.0 87.6 15.3 87.3 32.3 96.1 33.1 85.8 41.0 133.1 39.2 38.9 6.7 96.8 10.8 98.5 
11.7 62.0 131.4 136.2 75.2 21.4 85.4 9.4 90.4 24.4 102.5 29.0 80.6 39.2 136.4 35.9 38.2 5.9 97.9 10.4 97.2 
11.9 61.8 129.8 130.2 71.1 20.2 85.1 8.2 84.1 25.8 100.3 27.2 76.2 37.4 130.3 35.6 40.6 4.9 97.8 10.0 92.1 
12.1 61.0 125.4 119.2 70.0 18.4 84.1 10.6 90.4 23.6 94.6 30.5 70.0 33.8 133.1 32.0 38.3 5.3 101.2 6.7 97.5 
12.4 58.5 125.6 108.3 67.7 23.0 82.8 11.4 94.8 20.4 91.4 31.4 71.9 29.3 136.6 29.6 37.8 5.0 99.8 5.9 95.9 
12.6 54.2 124.6 100.2 65.7 19.9 84.8 10.7 95.9 21.2 92.5 28.6 68.4 28.8 136.3 29.7 37.8 7.9 97.5 5.2 92.8 
12.8 51.7 122.8 91.2 64.7 20.4 83.3 11.6 89.3 21.3 96.2 26.4 64.4 30.7 135.9 32.9 39.6 7.3 97.6 6.8 92.0 
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13.0 48.9 124.3 89.6 61.0 17.5 82.0 10.0 92.9 21.5 92.1 29.7 66.5 30.6 130.0 31.7 39.0 8.6 95.7 5.4 92.2 
13.3 44.8 118.4 80.7 63.1 17.8 78.3 11.5 97.9 17.1 93.3 28.9 62.1 28.3 126.3 27.3 37.2 6.6 97.8 4.5 95.8 
13.5 43.0 118.4 72.4 61.1 17.2 82.4 10.3 98.0 18.7 96.5 27.7 60.7 29.6 132.1 29.7 37.7 4.1 101.4 4.4 94.3 
13.7 41.0 113.7 67.7 59.5 15.0 80.3 10.8 104.7 17.7 97.9 26.0 61.1 23.7 135.2 29.9 38.2 5.6 111.0 5.3 94.3 
13.9 40.5 119.0 65.7 58.7 12.1 79.0 9.5 102.5 15.3 91.6 23.7 62.1 22.1 136.7 28.1 36.9 6.0 112.3 6.1 94.5 
14.2 41.9 115.2 63.8 58.6 10.7 79.7 10.6 98.0 13.8 96.1 24.6 54.1 22.1 130.4 27.6 37.3 7.2 111.0 8.1 97.2 
14.4 36.3 117.4 60.5 58.4 11.6 73.3 13.3 100.3 13.2 94.1 22.3 55.2 14.2 126.2 25.3 36.1 10.2 107.8 9.5 94.6 
14.6 35.7 114.5 63.4 59.9 11.2 68.4 11.8 94.4 13.5 96.2 24.9 58.1 14.8 130.4 25.2 37.1 5.5 111.5 9.0 97.6 
14.8 33.4 118.1 59.8 60.3 9.8 70.6 13.4 93.0 16.6 95.4 26.4 53.8 11.8 134.5 24.5 35.3 7.1 108.0 6.6 101.0 
15.1 33.8 114.7 57.3 58.6 9.0 71.2 11.5 92.7 16.3 88.0 28.1 52.9 13.2 138.8 20.2 35.2 6.6 108.5 8.0 103.0 
15.3 32.4 112.4 57.1 59.6 8.7 69.2 10.0 94.7 12.3 91.6 28.4 57.1 9.8 140.4 22.7 39.7 6.4 100.6 8.6 105.5 
15.5 29.4 113.6 54.1 59.9 9.3 70.4 11.7 96.2 10.7 85.7 25.6 58.6 9.8 139.6 18.6 35.1 4.9 98.2 9.7 99.2 
15.7 24.3 113.9 51.5 58.0 10.6 70.4 11.1 97.2 10.6 89.2 27.6 60.0 9.3 139.0 13.7 35.2 3.9 96.6 7.1 92.8 
16.0 24.0 114.4 47.0 58.2 10.3 66.5 11.0 97.3 9.2 83.8 26.6 60.3 8.9 140.2 13.7 36.6 6.6 92.4 7.0 92.4 
16.2 24.0 116.1 49.1 63.3 9.5 70.9 8.8 92.7 7.8 82.2 28.2 57.4 10.0 139.2 13.1 34.9 9.1 96.7 4.1 93.3 
16.4 22.5 119.1 47.8 62.7 12.9 68.4 6.8 88.7 8.4 76.2 25.2 59.5 9.1 141.9 12.0 34.4 6.1 89.2 4.2 96.4 
16.6 22.6 115.6 46.3 63.2 7.7 71.5 5.5 93.2 9.1 73.3 25.1 62.3 7.2 135.3 11.7 34.7 6.7 89.1 4.4 88.9 
16.9 23.2 114.7 44.0 66.5 6.3 73.4 6.1 103.0 10.1 74.9 23.6 61.8 5.0 130.3 8.2 33.1 7.6 87.9 4.5 93.0 
17.1 21.4 115.6 44.2 68.0 7.1 71.1 6.1 106.1 8.1 73.0 31.8 63.9 4.7 127.9 10.7 33.4 8.8 91.8 4.4 87.8 
17.3 20.7 113.1 39.1 71.4 7.4 72.1 4.9 98.2 8.7 70.6 30.3 66.3 3.9 128.3 10.1 34.7 7.0 98.1 5.3 92.8 
17.5 20.6 118.0 33.8 70.2 8.4 70.7 4.8 102.1 8.3 80.5 34.2 71.6 5.2 132.2 8.5 34.4 6.6 97.1 5.2 90.8 
17.8 19.5 122.8 37.0 71.9 8.5 70.1 4.7 98.8 8.9 82.7 30.7 69.7 7.2 133.7 9.2 34.5 6.0 102.2 4.8 92.6 
18.0 21.0 125.5 34.9 73.3 7.3 66.2 6.7 97.1 10.2 82.5 28.1 67.3 6.8 130.1 6.7 36.3 4.6 99.9 6.2 92.7 
18.2 23.6 131.5 31.2 73.4 7.7 68.6 5.8 96.4 9.0 87.3 29.8 69.9 6.7 129.1 6.2 37.6 4.6 99.7 9.2 94.0 
18.4 20.5 130.2 36.3 73.9 5.4 66.7 5.6 91.9 8.3 89.2 29.3 72.0 7.3 125.2 6.1 36.6 4.7 110.5 7.0 84.2 
18.7 19.2 129.9 34.9 71.6 5.2 71.2 6.6 90.8 13.3 88.0 32.3 72.8 7.2 120.4 5.2 31.0 4.9 113.2 7.2 90.2 
18.9 15.5 133.2 35.6 70.2 6.5 75.4 6.5 92.0 13.1 92.0 30.0 74.0 7.4 121.4 7.5 33.6 5.3 114.7 7.2 94.5 
19.1 12.0 128.5 34.6 68.3 5.1 74.1 3.9 94.6 10.5 95.0 30.8 77.4 8.9 125.0 7.0 36.5 4.7 112.3 8.9 94.2 
19.3 9.5 121.9 31.4 71.3 4.4 75.2 4.6 89.3 9.3 99.5 31.5 80.5 5.7 123.8 7.1 34.9 5.6 114.7 7.2 93.9 
19.6 9.1 124.7 32.3 73.6 6.0 68.2 4.3 88.2 9.3 97.2 28.2 76.6 6.3 122.4 8.1 33.6 7.2 112.7 7.9 86.8 
19.8 8.7 126.6 33.0 75.3 4.7 67.1 4.6 89.7 8.8 95.0 26.5 82.3 6.3 125.7 8.0 37.3 8.3 115.9 8.0 89.5 
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Appendix V - Mann Whitney U test results comparing tubulin and 
vimentin expression between infected and uninfected 
FEA cells 
FCV-F9 Tubulin  
Mann-Whitney Test and CI: Average 
Tubulin 7pi I, Average Tubulin 7pi UI  
 
                         N  Median 
Average Tubulin 7pi I   45   91.46 
Average Tubulin 7pi UI  44   71.09 
 
 
Point estimate for ETA1-ETA2 is 24.35 
95.1 Percent CI for ETA1-ETA2 is (11.86,36.46) 
W = 2456.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0002 
Mann-Whitney Test and CI: Average 
Tubulin 13pi I, Average Tubulin 13pi UI  
 
                          N  Median 
Average Tubulin 13pi I   45  113.03 
Average Tubulin 13pi UI  44   76.13 
 
 
Point estimate for ETA1-ETA2 is 33.34 
95.1 Percent CI for ETA1-ETA2 is (26.13,41.26) 
W = 2825.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
  
  
UKOS-A Tubulin  
Mann-Whitney Test and CI: Average 
Tubulin 7pi I, Average Tubulin 7pi UI  
 
                         N  Median 
Average Tubulin 7pi I   45  102.90 
Average Tubulin 7pi UI  44   81.01 
 
 
Point estimate for ETA1-ETA2 is 27.31 
95.1 Percent CI for ETA1-ETA2 is (17.77,37.21) 
W = 2745.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
Mann-Whitney Test and CI: Average 
Tubulin 13pi I, Average Tubulin 13pi UI  
 
                          N  Median 
Average Tubulin 13pi I   45  143.30 
Average Tubulin 13pi UI  44  108.38 
 
 
Point estimate for ETA1-ETA2 is 39.66 
95.1 Percent CI for ETA1-ETA2 is (27.71,52.23) 
W = 2655.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
  
  
R591 Tubulin  
Mann-Whitney Test and CI: Average 
Tubulin 7pi I, Average Tubulin 7pi UI  
 
                         N  Median 
Average Tubulin 7pi I   45  165.75 
Average Tubulin 7pi UI  44  112.35 
 
 
Point estimate for ETA1-ETA2 is 55.65 
95.1 Percent CI for ETA1-ETA2 is (41.46,71.50) 
W = 2915.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
Mann-Whitney Test and CI: Average 
Tubulin 13pi I, Average Tubulin 13pi UI  
 
                          N  Median 
Average Tubulin 13pi I   45  139.64 
Average Tubulin 13pi UI  44  110.88 
 
 
Point estimate for ETA1-ETA2 is 28.88 
95.1 Percent CI for ETA1-ETA2 is (21.44,36.93) 
W = 2817.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
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LS015 Tubulin  
Mann-Whitney Test and CI: Average 
Tubulin 7pi I, Average Tubulin 7pi UI  
 
                          N  Median 
Average Tubulin 7pi I   133  128.53 
Average Tubulin 7pi UI   44   83.79 
 
 
Point estimate for ETA1-ETA2 is 46.15 
95.0 Percent CI for ETA1-ETA2 is (33.94,54.57) 
W = 13793.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
Mann-Whitney Test and CI: Average 
Tubulin 13pi I, Average Tubulin 13pi UI  
 
                          N  Median 
Average Tubulin 13pi I   45  153.51 
Average Tubulin 13pi UI  44   77.22 
 
 
Point estimate for ETA1-ETA2 is 74.32 
95.1 Percent CI for ETA1-ETA2 is (63.68,81.57) 
W = 3010.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
  
  
Mock Infected Tubulin  
Mann-Whitney Test and CI: Average 
Tubulin 7pi I, Average Tubulin 7pi UI  
 
                         N  Median 
Average Tubulin 7pi I   45   74.68 
Average Tubulin 7pi UI  44   71.02 
 
 
Point estimate for ETA1-ETA2 is -5.02 
95.1 Percent CI for ETA1-ETA2 is (-16.08,6.72) 
W = 1920.0 
Test of ETA1 = ETA2 vs. ETA1 not = ETA2 is NOT 
significant at 0.3911 
Mann-Whitney Test and CI: Average 
Tubulin MI 13pi I, Average Tubulin MI 
13pi UI  
 
                          N  Median 
Average Tubulin 13pi I   45   66.55 
Average Tubulin 13pi UI  44   79.72 
 
 
Point estimate for ETA1-ETA2 is -12.99 
95.1 Percent CI for ETA1-ETA2 is (-21.99,-4.64) 
W = 1654.0 
Test of ETA1 = ETA2 vs. ETA1 < ETA2 is significant 
at 0.0012 
  
  
FCV-F9 Vimentin  
Mann-Whitney Test and CI: Average 
vimentin 7 pi I, Average vimentin 7 pi UI  
 
                           N  Median 
Average vimentin 7 pi I   64  173.27 
Average vimentin 7 pi UI  63  125.49 
 
 
Point estimate for ETA1-ETA2 is 48.59 
95.0 Percent CI for ETA1-ETA2 is (25.18,71.42) 
W = 5630.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
Mann-Whitney Test and CI: Average 
vimentin 13pi I, Average vimentin 13pi UI  
 
                           N  Median 
Average vimentin 13pi I   64  106.45 
Average vimentin 13pi UI  63   83.20 
 
 
Point estimate for ETA1-ETA2 is 26.21 
95.0 Percent CI for ETA1-ETA2 is (18.20,33.22) 
W = 5212.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
  
  
R591 Vimentin  
Mann-Whitney Test and CI: Average 
vimentin 7pi I, Average vimentin 7pi UI  
 
                          N  Median 
Average vimentin 7pi I   64  192.73 
Average vimentin 7pi UI  63  123.56 
 
 
Point estimate for ETA1-ETA2 is 70.54 
95.0 Percent CI for ETA1-ETA2 is (52.81,90.09) 
W = 5925.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
Mann-Whitney Test and CI: Average 
vimentin 13pi I, Average vimentin 13pi UI  
 
                           N  Median 
Average vimentin 13pi I   64  64.837 
Average vimentin 13pi UI  63  37.437 
 
 
Point estimate for ETA1-ETA2 is 26.553 
95.0 Percent CI for ETA1-ETA2 is (22.065,29.347) 
W = 5769.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
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UKOS-A Vimentin  
Mann-Whitney Test and CI: Average 
vimentin 7pi I, Average vimentin 7pi UI  
 
                          N  Median 
Average vimentin 7pi I   64  133.59 
Average vimentin 7pi UI  63   85.71 
 
 
Point estimate for ETA1-ETA2 is 45.84 
95.0 Percent CI for ETA1-ETA2 is (26.87,62.62) 
W = 5934.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
Mann-Whitney Test and CI: Average 
vimentin 13pi I, Average vimentin 13pi UI  
 
                           N  Median 
Average vimentin 13pi I   64  140.38 
Average vimentin 13pi UI  63   69.46 
 
 
Point estimate for ETA1-ETA2 is 68.12 
95.0 Percent CI for ETA1-ETA2 is (51.59,78.10) 
W = 5676.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
  
  
LS015 Vimentin  
Mann-Whitney Test and CI: Average 
vimentin 7pi I, Average vimentin 7pi UI  
 
                          N  Median 
Average vimentin 7pi I   64  136.05 
Average vimentin 7pi UI  63   70.67 
 
 
Point estimate for ETA1-ETA2 is 59.60 
95.0 Percent CI for ETA1-ETA2 is (40.35,69.98) 
W = 6005.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
 
Mann-Whitney Test and CI: Average 
vimentin 13pi I, Average vimentin 13pi UI  
 
                           N  Median 
Average vimentin 13pi I   64  113.53 
Average vimentin 13pi UI  63   89.94 
 
 
Point estimate for ETA1-ETA2 is 28.25 
95.0 Percent CI for ETA1-ETA2 is (18.68,46.92) 
W = 5498.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is significant 
at 0.0000 
 
  
  
Mock Infected Vimentin  
Mann-Whitney Test and CI: Average 
vimentin, Average vimentin  
 
                               N  
Median 
Average vimentin mock 7pi I   64  
91.068 
Average vimentin mock 7pi UI  63  
92.389 
 
 
Point estimate for ETA1-ETA2 is -2.575 
95.0 Percent CI for ETA1-ETA2 is (-7.381,1.871) 
W = 3855.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 
P>0.05 NOT SIGNIFICANT 
Mann-Whitney Test and CI: Average 
vimentin, Average vimentin  
 
                                N  
Median 
Average vimentin mock I 13pi   64  
93.979 
Average vimentin mock UI 13pi  63  
92.827 
 
 
Point estimate for ETA1-ETA2 is 0.615 
95.0 Percent CI for ETA1-ETA2 is (-0.989,2.394) 
W = 4230.0 
Test of ETA1 = ETA2 vs. ETA1 > ETA2 is NOT 
significant at 0.2599 
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Appendix VIII - Pathway analysis of differentially transcribed        
genes in FEA cells in response to FCV-F9 infection   
Figure A8.1. Apoptosis regulation pathway. Pathway is the comparison of mock infected and 
infected FEA cells at 4 h p.i.. Those genes highlighted in red are up-regulated in the infected 
samples, the brighter the colouration, the greater the up-regulation in transcription. A full key 
of gene identification can be found in the appendix (Table A8.1). 
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Figure A8.2. Apoptosis regulation pathway. Pathway is the comparison of mock infected and 
infected FEA cells at 7 h p.i.. Those genes highlighted in red are up-regulated in the infected 
samples, the brighter the colouration, the greater the up-regulation in transcription. A full key 
of gene identification can be found in the appendix (Table A8.1). 
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Figure A8.3. B cell activation pathway. Pathway is the comparison of mock infected and 
infected FEA cells at 4 h p.i.. Those genes highlighted in red are up-regulated in the infected 
samples, the brighter the colouration, the greater the up-regulation in transcription. A full key 
of gene identification can be found in the appendix (Table A8.1). 
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Figure A8.4. B cell activation pathway. Pathway is the comparison of mock infected and 
infected FEA cells at 7 h p.i.. Those genes highlighted in red are up-regulated in the infected 
samples, the brighter the colouration, the greater the up-regulation in transcription. A full key 
of gene identification can be found in the appendix (Table A8.1). 
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Figure A8.5. Natural killer cell activation pathway. Pathway is the comparison of mock 
infected and infected FEA cells at 4 h p.i.. Those genes highlighted in red are up-regulated in 
the infected samples, the brighter the colouration, the greater the up-regulation in transcription. 
A full key of gene identification can be found in the appendix (Table A8.1). 
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Figure A8.6. Natural killer cell activation pathway. Pathway is the comparison of mock 
infected and infected FEA cells at 7 h p.i.. Those genes highlighted in red are up-regulated in 
the infected samples, the brighter the colouration, the greater the up-regulation in transcription. 
A full key of gene identification can be found in the appendix (Table A8.1). 
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Figure A8.7. Translation control pathway. Pathway is the comparison of mock infected and 
infected FEA cells at 4 h p.i.. Those genes highlighted in red are up-regulated in the infected 
samples, the brighter the colouration, the greater the up-regulation in transcription. A full key 
of gene identification can be found in the appendix (Table A8.1). 
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Figure A8.8. Translation control pathway. Pathway is the comparison of mock infected and 
infected FEA cells at 4 h p.i.. Those genes highlighted in red are up-regulated in the infected 
samples, the brighter the colouration, the greater the up-regulation in transcription. A full key 
of gene identification can be found in the appendix (Table A8.1). 
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Gene ID Gene name Gene ID Gene name 
ADCY Adenylate cyclase MAP4K Mitogen-activated protein kinase 4 
AKT v-akt murine thymoma viral 
oncogene homolog 
MAPKAPK MAP kinase-activated protein kinase 
ALK Anaplastic lymphoma kinase mDia Diaphanous homolog 
AMP Adenosine monophosphate MDK Midkine 
AMPK AMP-dependent protein kinase MDM2/4 p53-binding protein 
aNKCR Activatory natural killer cell 
receptor 
MEK1/2 Mitogen-activated protein kinase 1/2 
APAF1 Apoptotic peptidase activating 
factor 1 
MKK3/6 Mitogen-activated protein kinase kinase 
3/6 
ATM/ATR ATM/ATR protein kinase MKP MAP kinase phosphatase 
Bcl Bcl2-like anti-apoptotic regulator MLCP Myosin light chain phosphatase 
BCR Breakpoint cluster region MNK1/2 MAP kinase interacting serine/threonine 
kinase 
Bid BCL2-antagonist mTOR FK506 binding protein 12-rapamycin 
associated protein 1 
BTK Bruton agammaglobulinemia 
tyrosine kinase 
NAAD Nicotinate-nucleotide adenylyltransferase 
C/EBP C/EBP NAADP Nicotinic acid adenine dinucleotide 
phosphate 
Ca2+ Calcium NCR Natural Cytotoxicity Triggering receptor 
CADP Cadherin 3 NCS1 Neuronal calcium sensor 1 
cADPR Cyclic ADP-ribose Neurexin Neurexin 
calcineurin Protein phosphatase 3 NF-AT Nuclear factor of activated T-cells 
calmodulin Calmodulin NF-Kb Nuclear factor of kappa light polypeptide 
gene enhancer in B-cells 1 
CAMK CaM kinase NFKBI NF kappa B inhibitor 
CAMKK CaM kinase kinase NGF family Nerve growth factor family 
cAMP Adenosine 3',5'-cyclic 
monophosphate 
NGFR Nerve growth factor receptor 
CASP12 Caspase 12 NIK Mitogen-activated protein kinase 14 
CASP3/6/7 Caspase 3/6/7 NKCR Natural killer cell receptor 
CASP8/10 Caspase 8/10 Nogo Nogo ligand 
CASP9 Caspase 9 NogoR Nogo receptor 
CBL Ubiquitin-ligase of receptor 
protein-tyrosine kinases 
NTRK Neurotrophic tyrosine kinase 
CD38 NAD+ nucleosidase NXPH Neurexophilin 
CD3Z T-cell receptor zeta chain P130CAS Breast cancer anti-estrogen resistance 1 
CDK1 Cyclin-dependent kinase 1 P13K Phosphatidylinositol 3-kinase 
Chemokine Chemokine P38 Mitogen-activated protein kinase 
11/12/13/14 
CREB CREB p53 p53 kinase 
Crk v-crk sarcoma virus CT10 
oncogene homolog (avian) 
p70S6K p70 ribosomal S6 kinase 
CSK c-src tyrosine kinase PAK p21/Cdc42/Rac-activated kinase 
CytC Cytochrome c PDPK1 3-phosphoinositide dependent protein 
kinase-1 
Cytokine Cytokine PI3K Phosphatidylinositol 3-kinase 
CytokineR Cytokine receptor PIP3 Phosphatidylinositol 3,4,5-triphosphate 
DAG Diacylglycerol PKA Protein kinase A 
DAP10 Hematopoietic cell signal 
transducer 
PKC Protein kinase C 
DAP12 Killer activating receptor 
associated protein 
PLA Outer membrane protease 
DAXX Fas death domain-associated 
protein 
PLC Phospholipase C 
DIABLO Diablo homolog PP2A Protein phosphatase 2 
DOCK Dedicator of cytokinesis PP5/2CB Protein phosphatase 5/1B 
DUSP Dual specificity phosphatase PTEN Phosphatase and tensin homolog 
EEF2K Eukaryotic elongation factor-2 
kinase 
PTN Pleiotrophin 
Egr/Krox Egr transcription factor PTPRZ Protein tyrosine phosphatase, receptor 
type, zeta polypeptide 
ERK1/3 Mitogen-activated protein kinase Rac/CDC42 Rho family small GTP-binding protein 
Table A8.1. Pathway studio gene identification key 
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1/3 
ETS ETS-domain containing Rac/Cdc-
GAP 
SLIT-ROBO Rho GTPase activating 
protein 
FAK Focal adhesion kinase Rac/CDC-
GEF 
Rac/Cdc42 guanine nucleotide exchange 
factor 
FCeR Fc IgE receptor Raf Raf proto-oncogene serine/threonine 
protein kinase 
FIP3 Fungus-Induced Protein RAP Ras family small GTP binding protein 
FLIP CASP8 and FADD-like apoptosis 
regulator 
RAP-GAP RAP1 GTPase activating protein 
G12CR G12/13-coupled receptor RAP-GEF Rap guanine nucleotide exchange factor 
Ga12/13 G protein alpha 12/13 Ras Ras oncogene homolog 
GATA Glutamyl-tRNA amidotransferase 
subunit A 
RAS-GAP RAS GTPase activating protein 
Gb/g G protein beta/gamma RAS-GRF Ras-specific guanine nucleotide-releasing 
factor 
GDNF Glial cell line derived neurotrophic 
factor 
Rho Rho GTPase 
GDNFR Glial cell line derived neurotrophic 
factor receptor 
Rho-GAP Rho GTPase activating protein 
GF Growth Factor Rho-GEF RhoA-specific guanine nucleotide 
exchange factor 
GFR Growth factor receptor ROCK1/2 Rho-associated, coiled-coil containing 
protein kinase 
GiCR Gi-coupled receptor RPS6K Ribosomal protein S6 kinase 
Gq/12CR Gq/12/13-coupled receptor RYR Ryanodine receptor 
Gq/iCR Gq/i-coupled receptor Selectin Selectin 
Grb Growth factor receptor-bound 
protein 
SELLG Selectin L 
Gs/12CR Gs/12/13-coupled receptor SH2B SH2B adaptor protein 
IAP Apoptosis inhibitor Shc Src homology 2 domain containing 
IGFBP Insulin-like growth factor binding 
protein 
SHP1 Protein tyrosine phosphatase, non-
receptor type 6 
IKBK IkappaB kinase SHP2 Protein tyrosine phosphatase 
IL1 family Interleukin 1 complex SLP76 Lymphocyte cytosolic protein 2 
IL1i Inhibit the activities of IL1 family SMAD Pathway-specific SMAD proteins 
IL1R IL1/18 receptor SOCS Suppressor of cytokine signaling 
IL1Rd IL1R decoy SOS Son of sevenless homolog 
IL1RL1 IL1R-like SP Transcription factor Sp 
ILK Integrin-linked kinase Src Src family 
iNKCR Inhibitory natural killer cell 
receptor 
SRF Serum response factor 
INSR Insulin receptor STC Stanniocalcin 
Insulin Insulin SYK Spleen tyrosine kinase 
IP3 Inositol 1,4,5-triphosphate Tetraspanin Tetraspanin 
iPAR virB  transcriptional activator TGF family Transforming growth factors 
Irf Iron regulatory protein TGFBR TGF-beta receptor 
IRS Insulin receptor substrate TGFi TGF-beta inhibitor 
iSMAD Inhibitory SMADs TIGIRR Three immunoglobulin domain-
containing IL-1 receptor-related 
ITG Integrin TIRAP Toll-interleukin 1 receptor adaptor 
protein 
ITGL Novel Integrin Ligand TLR Toll receptor 
ITPK Inositol 1,4,5-triphosphate kinase TNF family Tumor necrosis factors 
ITPR Inositol 1,4,5-triphosphate receptor TNFR Tumor necrosis factor receptor 
JAK Janus kinase TNFRAP Tumor necrosis factor receptor associated 
factor 
LAT Linker for activation of T cells TSC Tuberous sclerosis 
LIMK LIM domain kinase VAV Rac/Cdc42 guanine nucleotide exchange 
factor 
MAP3K Mitogen activated protein kinase 3   
